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1. Pseudorabies virus, an alphaherpesvirus 
1.1. History 
The first reports of sporadic outbreaks of animal disease consistent with pseudorabies (PRV) date 
from 1813 in the United States and from 1889 in Europe. The disease was first described as “mad 
itch” in cattle and was characterized by heavy itching (Hanson, 1954; Strebel, 1889). In 1902, the 
Hungarian veterinarian Aládar Aujeszky demonstrated the etiological agent of the disease. Aujeszky 
was the first to isolate PRV from an ox, a dog and a cat and confirmed the infectious nature of the 
disease by inoculation of the recovered isolates into rabbits (Aujeszky, 1902). Because symptoms 
reminiscent but distinguishable from rabies were observed, the disease was called pseudorabies. 
Later, the viral nature of the disease was demonstrated by ultrafiltration experiments and identified 
as the cause of “mad itch” (Elford & Galloway, 1936; Schmiedhoffer, 1910; Shope, 1931). Until 1920, 
PRV was mainly observed in cattle and dogs (Wittmann & Rziha, 1989). From 1920 onwards, sporadic 
problems in pigs were observed worldwide and pigs were identified as a reservoir for PRV (Köhler & 
Köhler, 2003). 
1.2. Alphaherpesvirus taxonomy 
Pseudorabies virus (PRV), also known by its taxonomic name, suid herpesvirus 1, or by its original 
name, Aujeszky’s disease virus, is a porcine virus belonging to the family of the Herpesviridae.  
Together with the family of the Alloherpesviridae and the Malacoherpesviridae, the Herpesviridae 
family forms the order of the Herpesvirales. The Alloherpesviridae contain several viruses infecting 
fish and amphibians. The Malacoherpesviridae contain only three viruses infecting invertebrates. The 
family of the Herpesviridae can infect a broad range of hosts, among which several mammals, birds 
and reptiles. Based on their biological properties and genome content and organization, most viruses 
belonging to this family can be subdivided into three major subfamilies: Alphaherpesvirinae, 
Betaherpesvirinae and Gammaherpesvirinae (ICTV, 2016). These subfamilies differ in their host 
range, the cell type where latency is established and the length of their productive replication cycle. 
Alphaherpesviruses have the broadest host range, replicate very rapidly in cell cultures and typically 
establish latency in neurons of sensory ganglia. Betaherpesviruses have a rather restricted host 
range, the slowest replication rate which is often accompanied by cell enlargements, called 
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cytomegalia, and establish latency in a number of tissues and cells, including secretory glands, 
kidneys and lymphoreticular cells. Gammaherpesviruses infect T and B lymphocytes and establish 
latency in lymphoid tissue (Pomeranz et al., 2005). 
The Alphaherpesvirinae, to which PRV belongs, is the largest subfamily of the herpesviruses. Other 
well-studied animal alphaherpesviruses that are important to agriculture include bovine 
herpesviruses (BHV-1 and BHV-5), equine herpesviruses (EHV-1 and EHV-4), ovine herpesvirus, and 
avian herpesviruses such as Marek’s disease virus and infectious laryngotracheitis virus (ILTV). Also, 
three human viruses belonging to this subfamily are known: herpes simplex virus type 1 (HSV-1) and 
type 2 (HSV-2) and varicella zoster virus (VZV). Within the alphaherpesviruses, five genera have been 
established based on molecular criteria and sequence analysis: Simplexvirus, Varicellovirus, 
Mardivirus, Iltovirus and Scutavirus (ICTV, 2016). PRV has been assigned to the Varicellovirus genus 
together with VZV, BHV-1, BHV-5, EHV-1 and EHV-4. HSV-1 and -2 are members of the Simplexvirus 
genus. 
1.3. PRV virion structure 
Historically, the assignment of viruses to the Herpesviridae family was based on their distinct virion 
architecture. PRV virions resemble others in the family and are composed of four structural 
elements: the genome, the capsid, the tegument and the envelope (Figure 1).  
The inner core of the virus particle consists of a double stranded linear DNA molecule of 
approximately 143 kbp. The genome consists of two covalently bound segments, a unique long (UL) 
and a unique short (US) segment. The US region is flanked by two large inverted repeat sequences, 
the internal repeat sequence and the terminal repeat sequence, resulting in the formation of two 
possible PRV genome isomers with oppositely oriented US regions (Ben-Porat et al., 1983; Davison & 
Wilkie, 1983). The genome consists of a large latency transcript (LLT) and 72 open reading frames 
(ORF), encoding 70 different proteins, which all have orthologues in other alphaherpesviruses (Klupp 
et al., 2004). The genomic DNA is densely packed within an icosahedral (T=16) capsid which consists 
of 162 capsomers (150 hexons and 12 pentons). The hexons of the capsid are composed of six 
molecules of UL19 (VP5) and six molecules of UL35 (VP26) and form the capsid edges and faces. The 
12 pentons comprise the vertices. Eleven of the pentons are pentamers of UL19 (VP5), while the 
twelfth vertex is a unique cylindrical portal made of 12 molecules of UL6 (Newcomb et al., 2001). The 
portal’s ring-like channel allows one copy of the viral DNA genome to be packaged into the 
preformed capsid (Homa & Brown, 1997). Both hexons and pentons are connected in groups of three 
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by triplexes, UL38 (VP19C) /UL18 (VP23) /UL18 (VP23) heterotrimers (Newcomb & Brown, 1991; 
Pomeranz et al., 2005). The capsid together with the DNA is referred to as the nucleocapsid. This 
nucleocapsid is embedded in a largely amorphous, electron dense protein layer, called the tegument, 
which fills the space between the capsid and the envelope membrane in mature virus particles. The 
tegument consists of two distinct structures: an inner layer tightly associated with capsid proteins 
and an outer layer interacting with the cytoplasmic domains of viral membrane proteins (Grünewald 
et al., 2003). Besides playing an important structural role in virion morphogenesis, tegument proteins 
play important roles during viral entry and assist in host-cell takeover (Pomeranz et al., 2005). The 
PRV envelope forms the outermost layer of the virus particle. This lipid bilayer membrane is derived 
from intracellular membranes of vesicles from the trans-Golgi network (Granzow et al., 1997; Whealy 
et al., 1991). The genome of PRV encodes 16 membrane proteins. Eleven membrane proteins are 
modified by N- or O-linked sugars (glycoproteins) designated as gB, gC, gD, gE, gG, gH, gI, gK, gL, gM, 
and gN (Mettenleiter, 2000). Four additional transmembrane proteins are not glycosylated: UL20, 
UL43, US9, and possibly UL24. The envelope protein UL34 is found in the primary virion envelope but 
not in mature virion particles (Klupp et al., 2000). The membrane proteins function in virus entry, 
egress and cell-to-cell spread. As surface constituents of virions and infected cells, glycoproteins 
represent dominant targets for the host’s immune defence (Mettenleiter, 1996; Pomeranz et al., 
2005). 
 
 
Figure 1: PRV virion structure. Transmission electron microscopic image (a) and schematic representation (b) 
of a PRV virion (Granzow et al., 1997 and Pomeranz et al., 2005, respectively). 
(a) (b) 
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1.4. Viral replication cycle 
The PRV replication cycle in a host cell can be subdivided in four major stages: 1) virion attachment 
and entry, 2) cytoplasmic transport and entry into the nucleus, 3) transcription and replication of the 
PRV genome, 4) virion assembly (Figure 2). 
1.4.1.  Virus attachment and entry 
Infection of cells by herpesviruses is initiated by attachment of free virions to target cells followed by 
fusion of the virion envelope and the cellular cytoplasmic membrane. The PRV virion first initiates 
weak interactions between the viral envelope and the cellular membrane, mainly by gC and, to a 
lesser extent, gB binding with heparan sulphate-containing proteoglycans in the extracellular matrix. 
Although this binding significantly enhances the efficiency of infection, it is not absolutely essential 
(Karger et al., 1995; Mettenleiter et al., 1990; Spear & Longnecker, 2003). This primary, relatively 
labile interaction converts into a stable binding which is mediated by interaction of gD with its 
 cellular receptor (Karger & Mettenleiter, 1993). Three cellular entry receptors for PRV gD have been 
described: herpesvirus entry mediator B (HveB, also called nectin 2, CD112, poliovirus receptor-
related protein (PRR) 2), HveC (nectin 1, CD111, PPR1) and HveD (CD155, poliovirus receptor (PVR)) 
(Spear et al., 2000). Two additional receptors, HveA (TNFRSF14) and 3-O-sulfated heparan sulphate, 
have been described for HSV-1 (Spear, 2001; Spear et al., 2000). In contrast to the labile and non-
essential gB/gC binding to heparan sulphate, the interaction between gD and one of its receptors is 
required for infection (Campadelli-Fiume et al., 2000; Mettenleiter, 2002; Spear, 2004). The stable gD 
binding to its receptor results in a conformational modification of gD by which it is able to interact 
with and/or recruit the gB and gH-gL fusion complex. Absence of glycoproteins gB or gH-gL abolishes 
viral entry (Klupp et al., 1997; Rauh & Mettenleiter, 1991). Although entry via direct fusion at the 
plasma membrane is still considered as the major route of entry for herpesviruses, more recently, 
viral entry by endocytosis has also been described (Akula et al., 2003; Clement et al., 2006; Delboy et 
al., 2006; Devadas et al., 2014; Nicola et al., 2003; Nicola & Straus, 2004; Raghu et al., 2009; Tsvitov 
et al., 2007). 
1.4.2. Transport to the nucleus 
During fusion with the plasma membrane (or endosome membrane), virions lose their envelope and 
part of the tegument dissociates from the capsid. Tegument proteins of the outer layer (UL11, UL41, 
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Figure 2: PRV replication cycle. PRV infection is initiated by attachment of the virion to the host cell (1) after 
which the virion envelope fuses with the cell membrane (2). Upon fusion, part of the tegument proteins 
dissociate from the nucleocapsid which is transported along microtubules towards the cell nucleus (3). At the 
nuclear pore complex, the viral DNA is released into the nucleus (4). Following transcription of the immediate 
early viral gene IE180 (5), early viral genes (6), late viral genes (7) and viral genome replication (8) new capsids 
assemble (9) and the newly formed PRV genomes are packaged into these capsids (10). The tegument and 
envelope are added via a complex envelopment process. During the primary envelopment capsids leave the 
nucleus by budding through the inner nuclear membrane (11) followed by a de-envelopment step by fusion 
with the outer nuclear membrane releasing the nucleocapsid into the cytoplasm (12). During the secondary 
envelopment, the tegument and final envelope are added to the nucleocapsid which occurs in a compartment 
derived from the trans-Golgi network (13). Secretory vesicles containing the mature virions are transported to 
the plasma membrane, where vesicle and plasma membranes fuse (14) and virions are released into the 
extracellular space (15)(Mettenleiter, 2004). 
Chapter 1: General Introduction 
 
  
8 
  
UL46, UL47, UL48 and UL49) quickly dissociate from the capsid, while the inner layer tegument  
proteins (UL36, UL37, and US3) remain associated during transport across the cytoplasm to the 
nuclear pore (Granzow et al., 2005; Luxton et al., 2005). The viral nucleocapsids are transported via 
cellular dynein, a microtubule-associated motor protein that moves the capsids along microtubules 
from the cell periphery to the nucleus. After reaching the nucleus, the viral capsids interact with the 
nuclear pore complex and viral DNA is rapidly released into the nucleus (Döhner et al., 2002; 
Granzow et al., 2005; Sodeik et al., 1997). 
1.4.3. Viral transcription activators and the transcription cascade 
Upon entry in the host nucleus, circularization of the linear viral DNA genome occurs by blunt end 
ligation. The circular genomes serve as the template for DNA synthesis which occurs through a rolling 
circle mechanism, leading to the formation of concatameric DNA strands that contain several viral 
genomes (Ben-Porat & Kaplan, 1985; Pomeranz et al., 2005). 
The transcription cascade consists of a temporally ordered sequence of RNA polymerase II-directed 
gene transcription, which is a molecular hallmark of herpesvirus infection. The viral genes can be 
divided into three major temporal classes of successively expressed transcripts: immediate-early (IE), 
early (E), and late (L) genes (Ben-Porat & Kaplan, 1985; Pomeranz et al., 2005).  
Immediate-early genes are synthesized directly following infection without prior need of viral protein 
synthesis. PRV encodes only one immediate-early protein, IE180. The tegument protein UL48 (VP16) 
forms a complex with cellular host transcription factors resulting in cellular RNA polymerase II-
dependent transcription of IE180 (Fuchs et al., 2002a; Stern et al., 1989). Immediate-early genes 
usually function either to activate the viral transcription cascade, to modulate host antiviral defence, 
and/or to exploit cell physiology required for productive viral infection. IE180 acts as a potent 
transcriptional activator for several cellular and viral promoters (Pomeranz et al., 2005; Taharaguchi 
et al., 1994; Wong et al., 1997). Two copies of the PRV IE180 gene are present in the genome, 
located in the IRS and TRS. Most of the gene is overlapping with the oppositely transcribed LLT (Klupp 
et al., 2004). 
Subsequently, different early genes are expressed and often require the viral transactivator encoded 
by IE180. These early genes encode viral products required for DNA replication (e.g. UL5, UL8 & UL52 
= primase helicase complex; UL30 & UL34 = DNA dependent DNA polymerase) and nucleotide 
metabolism (e.g. UL 23 = thymidine kinase, UL39/40 = ribonucleotide reductase, UL50 = dUTPase) or 
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act as transactivators (e.g. EP0, US1 and UL54 (ICP27)) to induce expression of late genes 
(Mettenleiter, 2000; Pomeranz et al., 2005).  
The late genes mainly encode proteins required for virion assembly and egress and hence encode 
mainly structural proteins like capsid, tegument and envelope proteins. These genes can be 
subdivided into early-late and true-late genes, with true-late gene expression initiating only after 
replication of the viral genome has started (Mettenleiter, 2000; Pomeranz et al., 2005).  
1.4.4. Virion assembly and egress 
Capsid assembly occurs in the nucleus of the cell, and requires the mature capsid constituents (UL38, 
UL35, UL25, UL19, UL18, and UL6), and two scaffolding proteins (UL26 and UL26.5) that participate in 
capsid formation but are not found in the mature virion. During DNA encapsidation, the replicated 
concatameric DNA is cleaved into monomeric units and simultaneously packaged into newly formed 
capsids (Ladin et al., 1980). DNA packaging in herpesviruses involves a two-subunit terminase made 
up of UL15 and UL28 which associates with portal protein UL6 to form a powerful molecular motor to 
package DNA (Homa & Brown, 1997; White et al., 2003). 
After intranuclear assembly of the nucleocapsids, the tegument and envelope are added via a 
complex envelopment process ultimately leading to the release of virus particles into the 
extracellular space. This envelopment process consists out of a primary and a secondary 
envelopment. During primary envelopment, nucleocapsids bud through the inner nuclear membrane 
into the perinuclear space, providing the capsid with a primary envelope. Subsequent fusion of this 
primary envelope with the outer nuclear membrane (de-envelopment) releases the nucleocapsids in 
the cytoplasm (Mettenleiter et al., 2006). A key role in this primary envelopment/de-envelopment 
process is attributed to at least three viral proteins encoded by US3, UL34, UL31 (Fuchs et al., 2002b; 
Klupp et al., 2001; Paßvogel et al., 2015; Wagenaar et al., 1995). During the secondary envelopment, 
the tegument and final envelope are added to the nucleocapsid. This process occurs in a 
compartment derived from the trans-Golgi network (Granzow et al., 1997; Whealy et al., 1991). 
Tegumentation of cytoplasmic capsids is thought to be initiated by the direct interaction of the major 
capsid protein VP5 (UL19) and the UL36 tegument protein which in turn can interact with another 
tegument protein, UL37 (Fuchs et al., 2004; Kelly et al., 2014; Klupp et al., 2002). The addition of the 
more distal parts of the tegument is less well defined. The protein-protein interactions within the 
tegument proteins and between tegument and envelope proteins are likely to drive the secondary 
envelopment process and may be regulated by phosphorylation (Morrison et al., 1998). The net 
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result of the secondary envelopment process is an enveloped virion within a secretory vesicle. The 
vesicle is transported to the plasma membrane, where vesicle and plasma membranes fuse and 
mature virions are released from the infected cell into the extracellular space (Owen et al., 2015). 
2. Sus scrofa, the natural host of the virus  
Members of the family Suidae, including domestic swine and wild boar, are the only natural hosts of 
PRV able to survive a productive infection and serve as a virus reservoir. In addition to infection of its 
natural host, PRV infects nearly all mammals. Higher primates, including humans, are however not 
susceptible and odd-toe ungulates, including horses, appear to be relatively resistant to PRV 
infection. Infection of the non-natural hosts with a wild-type PRV strain is uniformly lethal (Kimman 
et al., 1991; Mettenleiter, 1994; Pomeranz et al., 2005). In its natural host, the clinical outcome of a 
PRV infection is dependent on the age and the immunological status of the pig on the one hand and 
on the route of inoculation, the inoculation dose and the virulence of the PRV strain on the other 
hand (Baskerville, 1972a, b; Kluge et al., 1999; Pol et al., 1989).  
There is evidence that PRV infections in domestic pigs and in wild swine represent epidemiologically 
distinct infection cycles (Capua et al., 1997a, b; Müller et al., 1998a; Pannwitz et al., 2012) and PRV 
strains circulating within both populations have evolved separately. Whereas PRV strains of wild boar 
appear to be exquisitely adapted to their host as shown by the modest pathogenicity, PRV strains 
infecting domestic swine have become more virulent over time, which probably is the result of a 
disequilibrium promoted by human activity (Davison, 2002). The specific characteristics and virulence 
of strains circulating within both populations will be described in the next sections.  
2.1. Domestic pigs 
2.1.1. Evolution of virulence in domestic pigs 
Since the first description of Aujeszky’s disease in pigs in 1920, the disease was reported only 
sporadically in pigs and was restricted to CNS disorders in a low number of animals.  
From the 1960-70s onwards, severe outbreaks of PRV in pigs associated with a change in clinical 
symptoms were observed, indicative of the emergence of more virulent PRV strains (Kluge et al., 
1999; Nauwynck et al., 2007). Upper respiratory tract problems accompanied by severe general 
symptoms such as fever and anorexia became more prominent. The increase in invasive character at 
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the level of the respiratory tract allowed the virus to find more access to nerves, to increase viremia 
and to replicate to high levels in the internal organs, including reproductive organs (Nauwynck et al., 
2007). Accordingly, an increase in neurological symptoms and mortality was observed in piglets, and 
mortality and abortion also appeared in older animals. This evolution in the severity of Aujeszky’s 
disease was comparable on the European continent, in Northern Ireland and in the USA. Although it 
has been postulated that the virulence of the virus increased, a cell biological and molecular basis for 
such increased virulence is still lacking (Nauwynck et al., 2007). 
2.1.2. Clinical symptoms 
The age at which a domestic pig is infected with PRV is an important factor influencing the clinical 
disease outcome. Morbidity and mortality associated with PRV infection are higher in younger pigs 
and are typically associated with neurological symptoms, whereas older swine mostly exhibit 
symptoms of respiratory and reproductive disease. In suckling piglets, infected animals first develop 
a fever and become listless and uninterested in nursing. Quickly after developing these general 
symptoms, the piglets progressively start to exhibit CNS symptoms including trembling, excessive 
salivation, incoordination, walking in circles, ataxia, seizures, and hind limb paralysis. Mortality is very 
high in sucking piglets, approaching 100 %. Mortality rates decrease significantly for weaned pigs, 
aged 3 to 10 weeks, with a typical mortality rate of 50 % for 3- to 4-week-old and 10 % for 5- to 10-
week-old piglets. Both CNS and respiratory symptoms can be observed in weaned pigs, with a 
decrease of CNS symptoms and a rise in respiratory symptoms with increasing age. CNS symptoms 
are highly reminiscent of those described for suckling piglets. Respiratory disease is characterized by 
symptoms such as sneezing, nasal discharge, a severe cough, and difficulty breathing. Although 
respiratory signs typically resolve after 5 to 10 days, they are often accompanied by a significant loss 
in body weight, which translates into economic loss for swine producers. In adult swine, respiratory 
signs are the hallmark of PRV infection although, sporadically, adult animals may exhibit CNS 
abnormalities. Mortality in adult swine after infection with the classical PRV domestic strains is low, 
and rarely exceeds 1-2%. However, higher mortality of 10-30 % were observed for the new emerging 
PRV strains in China (An et al., 2013; Wu et al., 2013; Yu et al., 2014).  
Furthermore, reproductive symptoms can occur after PRV infection of pregnant sows. Pregnant 
animals infected with PRV in the first trimester of pregnancy will usually reabsorb the foetuses in 
utero. If infection occurs within the second or third trimester of pregnancy, infection typically results 
in abortion, stillbirths, or weak piglets that die soon after birth (Kluge et al., 1999; Pomeranz et al., 
2005).  
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The cause of high mortality in piglets after PRV infection had historically been attributed to viral 
encephalitis, although the underlying mechanisms remain unknown (Pomeranz et al., 2005). More 
recent, one study using a murine flank inoculation model suggests that a peripheral host immune 
response to viral infection may be a significant determining factor in the death of infected animals 
(Brittle et al., 2004). Age-dependency in disease symptoms has also been proposed for wild boar 
strains (Hahn et al., 1997), but no comparative studies have yet been performed. However, 
compared to domestic piglets, young wild boar appear to be more resistant to infection, probably 
because of the earlier maturation of the important CD8+ T cells (Page et al., 1992). 
2.1.3. Eradication and current situation in domestic pigs 
Because of the important economic impact of the disease, eradication campaigns against PRV were 
set up worldwide. Important tools in the eradication of Aujeszky’s disease included widespread 
vaccination programs with DIVA (“Differentiating Infected from Vaccinated Animals”) vaccines in 
which the viral gE gene was deleted, selective culling of PRV-positive herds, restricted import of 
swine, improved herd management practices such as avoiding contact with wild swine, and 
serological surveillance and monitoring (Müller et al., 2003; Pensaert & Morrison; Pomeranz et al., 
2005).  
In Belgium, Aujeszky’s disease became a notifiable disease in 1987. Starting from 1993, efforts to 
control the disease were taken based on compulsory vaccination with a marker vaccine and culling of 
infected pigs. In 1998, the eradication program was intensified and approved by the European 
Commission. PRV seroprevalence rates decreased significantly from then onwards and the last PRV 
outbreaks date back to 2002. Preventive vaccination of domestic pigs ceased down from 2009 and 
was prohibited since 1 January of 2011. At 5 October 2011, the European Commission granted 
Belgium the Aujeszky’s disease free status (Decision 2011/648/EU). Since, an ongoing surveillance 
program is in place to prevent Aujeszky’s disease from being introduced into the Belgium domestic 
swine population. This includes biosafety measurements for pig farms and slaughter houses, 
precautions concerning national and intracommunautary transport and epidemiological monitoring 
(compulsory serological testing of all swine herds at least once a year and three times a year for 
farms with free-ranging facilities) (FAVV, 2011; Naassens, 2013). 
Currently, 16 European Union (EU) member states are officially free from Aujeszky’s disease in 
domestic pigs: Austria, Belgium, Cyprus, Czech Republic, Germany, Denmark, Finland, France, 
Hungary, Ireland, Luxembourg, Netherlands, Slovakia, Slovenia, Sweden and United Kingdom. 
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Furthermore, the Bolzano region in Italy is also declared free from the disease. Eradication programs 
are in place in Spain and Poland (Decision 2015/398/EU). Also in the USA, PRV has been eradicated 
from the domestic swine population since 2004 (Anderson et al., 2008). The virus remains however 
endemic in Latin America, Africa and Asia.  
Importantly, since the end of 2011, the emergence of new PRV variants has been reported in China in 
Bartha-K61 vaccinated pigs (An et al., 2013; Wu et al., 2013; Yu et al., 2014). These highly virulent 
strains cause great economic losses in the swine industry and are characterized by severe general 
(high fever, depression, anorexia, diarrhoea), respiratory, and systemic neurologic symptoms. High 
mortality is observed in piglets up to 50 %, but even in growing and finishing pigs mortality rates of 
10-30 % were observed (An et al., 2013; Wu et al., 2013; Yu et al., 2014). While the Bartha-K61 
vaccine provided complete protection against lethal challenge with classical PRV strains, it induced 
only partial protection against the new emerging Chinese variant PRV TJ both in sheep and pigs (An 
et al., 2013; Gu et al., 2015; Luo et al., 2014; Wang et al., 2014). Therefore, several PRV gE and/or gI 
deleted mutants originating from the new emerging Chinese variants were constructed. These 
mutants provided complete protection against lethal challenge with the new emerging variants and 
could therefore be promising vaccine candidates for the control of the current PRV epidemic in China 
(Gu et al., 2015; Tong et al., 2016; Wang et al., 2014, 2015). Recently, it was shown that one of these 
vaccine candidates, a live attenuated gE/gI-deleted mutant of the new emerging JS-2012 PRV strain, 
was able to protect 2-week-old piglets from lethal infection both with the JS-2012 as well as with the 
classical SC strains, a virulent Chinese reference strain isolated in 1980. Furthermore, vaccination of 
pregnant sows induced maternal antibodies in their offspring, that were able to protect the piglets 
from lethal infection with the JS-2012 strain (Tong et al., 2016). Phylogenetic analysis based on the gE 
gene showed that the new Chinese emergent PRV variants form a novel branch relatively distant 
from previously isolated strains (Luo et al., 2014; Ye et al., 2015). Several extensive variations, 
including substitutions, insertions and/or deletions occurred in most viral genes of the new emerging 
PRV variants compared with previous isolates worldwide. The genetic basis for the increased 
pathogenicity of these variants remains currently unknown (Fan et al., 2015; Luo et al., 2014; Ye et 
al., 2015, 2016). 
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2.2. Wild boar 
2.2.1. Wild boar as carrier of disease 
The true wild boar represents genuine wildlife in Europe and Asia. They are considered the ancestor 
of modern domestic pig hybrids, that were independently domesticated across Europe and Asia 
(Larson et al., 2005). In the USA, the so-called feral swine or wild swine originate from different 
ancestral pools of multiple introductions from European wild boar and pigs descendent from 
domestic stock that has been released during the last centuries (Müller et al., 2011; Nettles & 
Erickson, 1984). The wild boar has one of the widest geographic distributions of all terrestrial 
mammals and their territories expand on all continents, except Antarctica. In Europe, the wild boar 
population has increased consistently over the last decades (Massei et al., 2015). Also in Belgium, the 
wild boar population has considerably increased in Wallonia over the last decade and they invaded 
Flanders, where they are especially found in Limburg and around Bruges (Scheppers & Casaer, 2012; 
‘www.waarnemingen.be’).  
Wild boar are a known reservoir for a number of viruses (e.g. PRV, classical swine fever, African swine 
fever, Hepatitis E virus, swine influenza), bacteria (e.g. Brucella suis, Mycobacterion bovis, Leptospira 
interrogans) and parasites (Toxoplasma gondii, Trichinella). The increasing density and distribution of 
wild boar populations are likely to promote transmission of these disease, not only among wild boar 
but also from wild boar to livestock or humans and vice versa (Meng et al., 2009; Ruiz-Fons et al., 
2008).  
2.2.2. PRV seroprevalence in wild boar 
PRV infections in wild boar appear to be more widespread than originally thought. Serosurveys have 
reported the presence of PRV infections in wild boar in at least 14 European countries, including 
Belgium, Croatia, Czech Republic, France, Germany, Greece, Italy, Netherlands, Poland, Romania, 
Russia, Slovenia, Spain and Switzerland. Important differences in average seroprevalence have been 
observed for the investigated time period, ranging from 0.3 to 66 % at national or regional level 
(Denzin et al., 2013; Keros et al., 2014; Marinou et al., 2015; Müller et al., 2011; Verin et al., 2014). In 
Belgium, seroprevalence rates of 1.2 % and 28.2 % have been reported for Flanders and Wallonia in 
2013, respectively (personal communication M. Vervaeke & A. Linden). Two long-term spatial-
temporal analyses in the eastern part of Germany revealed that PRV seroprevalence in wild boar has 
consistently increased over the recent years, which might be related to the increase in wild boar 
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density (Denzin et al., 2013; Pannwitz et al., 2012). Also in the USA, PRV is endemic in feral swine 
populations in the southern and central states (Müller et al., 2011; Pedersen et al., 2013). 
2.2.3. Virulence of PRV strains circulating within the wild boar population 
The limited information available on the virulence of wild boar PRV isolates comes from two 
experimental infection studies and some field observations. Field observations in Europe and the 
USA suggest that PRV infection in wild swine may produce only mild respiratory symptoms and may 
go unnoticed (Müller et al., 2000). However, some cases with central nervous symptoms have been 
reported in south-central Spain and in East Germany (Gortázar et al., 2002; Schulze et al., 2010).  
Furthermore, two in vivo infection studies suggest an attenuated nature of PRV isolates from wild 
boar or feral swine origin in adult domestic pigs and wild boars. Inoculation of feral swine and 
domestic pigs with a PRV isolate obtained from feral swine in the USA resulted in subclinical, latent 
infection (Hahn et al., 2010). In another study, a wild boar isolate from Germany induced mild clinical 
symptoms in experimentally infected wild boar and domestic pigs, but only when higher inoculation 
doses (107 TCID50) were used (Müller et al., 2001). Although wild boar strains appear to be only mildly 
virulent, they are able to induce seroconversion of infected wild boar and domestic pigs and can 
induce nasal and/or genital shedding of the virus (Hahn et al., 1997; Müller et al., 2001). Currently it 
is however unknown whether PRV strains from wild boar origin are able to induce clinical symptoms 
in young domestic or wild boar piglets nor if they are able to induce reproductive symptoms in wild 
boar or domestic swine. 
2.2.4. Risk of reintroduction of PRV from wild boar into the domestic swine population 
Although tremendous progress has been made towards controlling and eliminating PRV from the 
domestic swine population, the presence of PRV in the wild boar population still poses a threat for a 
reintroduction of the virus into the unprotected domestic swine population. Some recent PRV 
reintroductions in domestic swine populations in France, the Czech Republic and the USA have, 
however, been attributed to PRV circulating in wild boars (Bronner et al., 2010; Hahn et al., 2010; 
‘OIE (2004), ProMED archive number 20100923.3442).  
The most probable routes of transmission from wild boar to domestic pigs are aerosol transmission 
and transmission via direct contact. Furthermore, in wild boar also the venereal route is indicated as 
an important route of transmission within the wild boar population and should be considered as a 
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possible route of transmission between wild boar and domestic swine (Romero et al., 1997, 2001, 
2003). Spillover via non-porcine species, including rodents, cannot be excluded as a possible route of 
transmission (Gagrcin et al., 1989). Aujeszky’s disease is also occasionally diagnosed in hunting dogs 
that had confirmed or suspected close contact to wild boar during hunting (Cay & Letellier, 2009; 
Moreno et al., 2015; Müller et al., 2010; Schöniger et al., 2012; Steinrigl et al., 2012; Thaller et al., 
2006). Therefore, contact between domestic pigs and dogs used for hunting or hunters should be 
avoided in the days after hunting. In general, the implementation of adequate biosecurity measures 
is necessary to prevent contact between domestic pigs and wild boar, especially in pig farms where 
animals are held in open air since they are at higher risk (Wyckoff et al., 2009). 
2.3. Genetic characterization of PRV strains of domestic pigs and wild boar 
Genetic characterization of PRV strains of both domestic and wild boar strains are performed to 
increase the understanding of the epidemiology of PRV infection in wild boar and to provide tools to 
trace back possible spillover into domestic swine. Two molecular techniques are commonly used to 
define genetic relationships among pathogenic organism: restriction fragment length polymorphism 
(RFLP) analysis and direct nucleotide sequencing. RFLP analysis is a fast and inexpensive technique 
that can detect variation across large genomic regions, but allows only a small proportion of the total 
genetic variation to be detected. Sequencing on the other hand yields more complete genetic 
information, but because of the greater expense and technical requirements, its application is often 
limited to small regions which are not necessarily representative for the total genetic variation 
(Goldberg et al., 2001). The use of both techniques for the genetic characterization of PRV strains is 
described in the next sections. 
2.3.1. Restriction fragment length polymorphism (RFLP) analysis using BamHI 
During RFLP analysis, the genomic DNA of a virus is enzymatically digested resulting in a specific 
pattern of bands of different sizes when separated on an agarose gel. The BamHI restriction enzyme 
is most commonly used for RFLP analysis of PRV strains and allows classification into distinct 
genotypes (Herrmann et al., 1984). Restriction of the PRV genome with the restriction enzyme 
BamHI generates a distinctive pattern of 14 major fragments varying in size between 1.1 and 28.5 
kbp (Szpara et al., 2011) (Figure 3 b). The restriction map was first established for the Kaplan PRV 
strain (Rixon & Ben-Porat, 1979), which is therefore often used as a reference for RFLP analysis, but 
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also other PRV reference strains like NIA3 and Becker show a similar pattern and can be used as a 
reference for RFLP analysis. 
RFLP analysis allows to subdivide PRV strains into four major genotypes (Herrmann et al., 1984) 
(Figure 3 a). Genotype I viruses are similar to or identical with the published BamHI DNA pattern of 
the Kaplan strain. Genotype II strains are characterized by an extra cleavage site within fragment 2. 
This results in the loss of this fragment, which appears as two smaller fragments that are located just 
above and just below fragment 4, 2a and 2b. Genotype III strains show the loss of the cleavage site 
between fragment 2 and 9 which results in a large fragment that is located below fragment 1. 
Genotype IV shows the loss of fragment 1 and 2 resulting in a new fragment located above the 
original fragment 1 (Herrmann et al., 1984). Also intermediates of genotype I and II strains are 
frequently found (Gielkens et al., 1985; Herrmann et al., 1984; Müller et al., 1998a, 2010; Yamada et 
al., 1992).  
 
Figure 3: Schematic overview of RFLP patterns and BamHI restriction sites in the PRV genome. (a) Four 
genotypes of PRV strains can be distinguished by RFLP analysis using the restriction endonuclease BamHI. 
Genotype I and II are the only ones currently still circulating and can be discriminated by the presence or 
absence of fragment 2. (b) Location of BamHI fragments along the PRV Kaplan genome. Fragments are 
identified by historical fragment numbering. Genome position in kilobase pairs (kbp) is listed below the 
fragments, with the large inverted repeats IR and TR shown as green boxes (Szpara et al., 2011). 
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RFLP patterns with the endonuclease BamHI have shown to be associated to viral geographic and 
temporal distribution in many countries (Herrmann et al., 1984). In Europe, both type I and type II 
PRV strains have circulated in domestic pigs (Gielkens et al., 1985; Herrmann et al., 1984). There is 
however evidence that type I strains were replaced by type II RFLP genotypes during the 1980s 
(Capua et al., 1997a; Herrmann et al., 1984) which coincided with the intensification of the swine 
industry and the emergence of more virulent strains (Nauwynck et al., 2007; Pomeranz et al., 2005). 
Little is known about the genotypes that are still circulating in domestic swine. A recent study 
confirmed that most Italian domestic swine isolates are RFLP genotype II and cluster together in 
phylogenetic analysis, but some older domestic strains exhibiting a type I RFLP pattern were also 
observed (Sozzi et al., 2014). Genetic characterization by RFLP has furthermore shown that genotype 
I is predominant in domestic swine in the USA. For Southern America, a predominance of type I has 
been shown for Argentina, while in Brazil mainly genotype II strains are found. Genotype III and IV 
strains were historically circulating in Northern Europe and Asia, respectively (Herrmann et al., 1984), 
but appear to be no longer present.  
A comprehensive study of European PRV isolates from wild boar origin demonstrated that all 
belonged to genotype I, except one strain from France that was characterized as genotype II (Müller 
et al., 2010; Steinrigl et al., 2012). Also in the USA, only genotype I has so far been detected in the 
wild boar population (Hahn et al., 2010). 
2.3.2. Phylogenetic analysis by sequencing of the gC gene 
More recently partial DNA sequencing has been introduced in the investigation of Aujeszky’s disease 
and the gene encoding the glycoprotein C is most commonly used for genetic characterization of PRV 
strains (Goldberg et al., 2001). This membrane-associated glycoprotein is a non-essential component 
of the viral envelope and plays an important role in attachment of the virus to target cells via binding 
with heparan sulphate receptors (Karger et al., 1995; Mettenleiter et al., 1990; Spear & Longnecker, 
2003). Since the gC gene is a major target for cellular and humoral immunity in pigs (Kimman et al., 
1996; Mettenleiter, 1996; Mettenleiter et al., 1990), it is considered as a more variable part of the 
PRV genome, with 2-3 % variability between strains worldwide. Gene sequencing is conducted on a ± 
800 bp fragment of the 5’ non-coding and coding region of the gC gene, where much of the variation 
is concentrated (Goldberg et al., 2001).  
Phylogenetic analysis using the partial gC fragment has shown that PRV isolates circulating within 
wild boar in Europe are a genetically diverse population. Wild boar PRV strains differentiate in two 
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clades, designated as ‘A’ and ‘B’ that appear to overlap geographically in Central Europe (Müller et 
al., 2010; Steinrigl et al., 2012). Clade B consists of strains originating from southwestern Europe 
(southwestern Germany, France and Spain). With the exception of one isolate, which displayed a 
single amino-acid substitution, all sequences within this group were identical (Müller et al., 2010). 
Clade A on the other hand is genetically more diverse and made up of strains originating from 
eastern Europe (Austria, northeastern Germany, Hungary, Italy and Slovakia) (Müller et al., 2010; 
Steinrigl et al., 2012).  
Only limited information is available regarding this type of analysis for European strains originating 
from domestic swine. Most isolates originating from Italian domestic swine isolates were shown to 
form a separate lineage within cluster A (Sozzi et al., 2014). Furthermore, phylogenetic analysis of 
domestic swine isolates from the USA (Hahn et al., 2010), Argentina (Serena et al., 2010, 2011) and 
Brazil (Fonseca Jr. et al., 2010, 2012; Paes et al., 2013) has been performed. For these isolates, a good 
correlation between the RFLP genotype I and II and phylogenetic clustering was observed within 
clade A (Fonseca Jr. et al., 2010; Serena et al., 2011). 
3. PRV pathogenesis 
3.1. General PRV pathogenesis 
PRV enters the host’s body through the nasal and oral cavities. Primary replication occurs in 
epithelial cells of mainly the upper respiratory tract, which consists of the nasal cavity, the tonsils and 
the oropharynx. After initial local replication in epithelial cells, virus can cross the basement 
membrane and invade the underlying lamina propria (Kritas et al., 1994a; Pol et al., 1989; Sabó et al., 
1968, 1969; Wittmann et al., 1980). In the lamina propria, virus can 1) invade blood and lymph 
vessels resulting in a systemic spread, and 2) enter sensory nerve endings leading to neuroinvasion. 
Via blood and lymph, PRV can spread to internal organs, either as cell-free virus or cell-associated 
virus in leukocytes (Nauwynck & Pensaert, 1995b). Infection of sensory neurons innervating the 
infected epithelium, i.e. the trigeminal and olfactory nerves, enables the virus to invade the central 
nervous system (CNS). PRV can enter the trigeminal ganglion (TG) via retrograde transport through 
the trigeminal nerve and spread further into the sensory trigeminal nerve nuclei in the pons and 
medulla oblongata. From there on, virus can invade the thalamus, cerebellum and cerebral cortex via 
interneuronal transmission (Kritas et al., 1994a). Entry of PRV into the CNS may also occur via the 
olfactory route by infection of olfactory neurons located in the nasal cavity mucosa after which virus 
Chapter 1: General Introduction 
 
  
20 
  
can reach the second-order neurons located in the olfactory bulb (Kritas et al., 1994b). An important 
characteristic of alphaherpesviruses, including PRV, is that they can establish latency in the sensory 
ganglia. Latency is a dormant state of the virus and is a strategy to stay present in the host during its 
entire lifetime without being eliminated by the host’s immune system. Replication in the upper 
respiratory tract, the CNS, and the reproductive organs, is responsible for the respiratory, nervous 
and reproductive symptoms, respectively (Nauwynck et al., 2007) (Figure 4).  
 
Figure 4: Overview of neuropathogenesis of PRV. A schematic overview of the neuropathogenesis of PRV is 
shown. PRV enters the body though the nasal and oral cavity. After entry of nerve ending located in the nasal 
or olfactory mucosa, virus can invade the central nervous system. PRV can enter the trigeminal ganglion via 
retrograde transport through the trigeminal nerve and spread further into the sensory trigeminal nerve nuclei 
in the pons and medulla oblongata. From there on, virus can invade the thalamus, cerebellum and cerebral 
cortex via interneuronal transmission (Trigeminal route indicated in black). Entry of PRV into the central 
nervous system may also occur via the olfactory route by infection of olfactory neurons located in the nasal 
cavity mucosa after which virus can reach the second-order neurons located in the olfactory bulb (Olfactory 
route indicated in red). Furthermore, a schematic overview of the nasal (A) and olfactory (B) mucosa is shown 
(Figure adapted from Kritas et al., 1994a, b). 
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Whereas PRV transmission via the oronasal route is predominant in domestic pigs, venereal 
transmission has been suggested as the main route of transmission in free-living feral swine based on 
experimental transmission studies using natural infected feral pigs (Romero et al., 1997, 2001). In 
these feral swine, the sacral ganglion can therefore serve a site of latency next to the TG (Romero et 
al., 2003). Using a mathematical model, it has however been shown that preferential venereal 
transmission of PRV in feral swine populations may not account for observed seroprevalence and 
therefore, most likely both routes of transmission are important (Smith, 2012). 
In this part of the introduction, the anatomical structure of some important sites of PRV infection, 
together with the current knowledge on virus replication and immune response at these sites will be 
discussed. Specifically, this will be addressed for the nasal and olfactory mucosa, the TG and the CNS.  
3.2. The upper respiratory tract, primary site for replication of pseudorabies virus 
3.2.1. Anatomical structure 
The upper respiratory tract comprises a system of interconnected spaces: the nasal cavity, the 
paranasal sinuses and the nasopharynx. The nasal cavity is divided into a right and left half by the 
nasal septum. Three scroll-like structures, conchae or turbinates, project medially from each lateral 
wall of the nasal cavity: the dorsal, medial and ventral conchae. These mucosa-covered turbinates 
increase the inner surface of the nose, thereby increasing the area of contact between the nasal 
mucosa and the inhaled air. The nasal cavities consist of cutaneous (pars cutanae), respiratory (pars 
respiratoria) and olfactory areas (pars olfactoria). The pars respiratory forms the biggest part of the 
nasal cavity and is covered with respiratory mucosa. The pars olfactoria is responsible for smell and 
covered with olfactory mucus (Dyce et al., 1987; Marieb et al., 2005; Robert et al., 1975). 
3.2.1.1. Respiratory mucosa 
The upper respiratory tract is lined by the respiratory mucosa, which consists of a pseudostratified 
columnar ciliated epithelium supported by a loose collagenous layer, the lamina propria (Figure 4 A). 
A further supporting tissue layer called the submucosa separates the mucosa from the underlying 
structures. The major function of the respiratory mucosa is to filter and adjust the temperature and 
humidity of the inhaled air (Young et al., 2000). 
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A thin mucus layer protects the respiratory epithelium by entrapping foreign debris, bacteria and 
viruses, and clearing them from the airway, a process called mucociliary clearance (Petruson et al., 
1984). For optimal efficiency of ciliary action, the mucus requires the correct combination of viscosity 
and elasticity, a property conferred on the mucus primarily by high-molecular-weight mucous 
glycoproteins, called mucins (Houtmeyers et al., 1999; Sleigh et al., 1988). Mucins are produced by 
goblet cells in the respiratory epithelium (Rogers, 2002) and sero-mucous glands in the submucosa 
(Finkbeiner, 1999). The underlying pseudostratified columnar ciliated epithelium consists of four 
main cell types: ciliated epithelial cells, goblet cells, brush cells and basal cells (Martineau-Doizé & 
Caya, 1996). Ciliated epithelial cells are the predominant cell type in the nasal respiratory epithelium. 
This cell type has a large apical surface which contains fine projections, cilia, that extend into the 
nasal lumen and a small basal side towards the basement membrane. The coordinated beating of the 
cilia enables the mucociliary clearance (Petruson et al., 1984). Goblet or mucous cells are the 
principal secretory cells present in the epithelium of the upper airways. Their mucin secretions are 
the main property determinant of the mucus layer (Rogers, 2002). Brush cells are sparse but easily 
distinguishable by the presence of a brush of large thick apical microvilli. An adsorptive and/or 
secretory function is suggested for this cell type (Martineau-Doizé & Caya, 1996). Basal cells are small 
flattened cells adjacent to the basement membrane. They are poorly differentiated and have the 
capacity to proliferate and restore a fully differentiated epithelium (Martineau-Doizé & Caya, 1996). 
Between the epithelium and the underlying lamina propria, a non-cellular structure called the 
basement membrane provides structural support for the epithelium and constitutes a selective 
barrier to the passage of materials. The main constituents of the basement membrane are the 
glycosaminoglycan heparan sulphate, the fibrous protein collagen IV, and the structural glycoproteins 
fibronectin, laminin, and entactin (Young et al., 2000). The underlying lamina propria is a loose 
collagenous layer of supporting tissue. This layer contains sero-mucous tubuloalveolar glands which, 
together with the goblet cells in the epithelium, produce mucus. Also, a rich plexus of capillaries and 
thin-walled veins occupy the lamina propria. The main sensory innervation of the nasal mucosa is 
carried out by branches of the maxillary nerve, which represents the distal axons of pseudo-unipolar 
neurons of the TG. The nerve endings of these branches are distributed in the lamina propria but also 
reach between the epithelial cells of the nasal mucosa (Kritas et al., 1994a; Young et al., 2000).  
3.2.1.2. Olfactory mucosa 
The olfactory epithelium is a modified form of the respiratory epithelium and overlies the 
dorsocaudal part of the septum and the ethmoturbinate bones (Marieb et al., 2005; Pol et al., 1989; 
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 Young et al., 2000). This very tall, pseudostratified columnar epithelium contains three important 
cell types: olfactory receptor cells, ciliated supporting epithelial or sustentacular cells and basal cells 
(Figure 4 B). The olfactory receptor cells are true bipolar neurons with the cell bodies located in the 
olfactory epithelium. At the apical side, a single dendritic process extends from the cell body and 
terminates in a small swelling, the olfactory knob, which gives rise to several long modified cilia. 
These non-motile cilia are sites of interaction between odiferous substances and the receptor cells. 
At the basal side, each olfactory receptor cell forms a single non-myelinated axon. The axons cross 
the basement membrane and pass through the lamina propria where they form bundles, called fila 
olfactoria, which collectively constitute the olfactory nerve. The fila olfactoria pass via small holes 
through the cribriform plate of the ethmoid bone to reach the olfactory bulbs where they form 
synapses with neurons of the central olfactory nervous system. The supporting or sustentacular cells 
are elongated cells with a wide apical side with long microvilli and a small basal side towards the 
basement membrane. The functions of the sustentacular cells are poorly understood but they 
probably provide mechanical and physiological support for the receptor cells. Basal cells are also 
present in the olfactory epithelium and appear to serve as stem cells for both olfactory receptor and 
sustentacular cells. The olfactory epithelium is supported by loose connective tissue containing 
bundles of afferent nerve fibers, blood and lymphatic vessels, and numerous serous Bowman’s 
glands which produce the watery surface secretion in which odiferous substances are dissolved 
(Jenkins, 1978; Kritas et al., 1994b; van Riel et al., 2015; Young et al., 2000). In the lamina propria, the 
axons of the olfactory receptor cells are supported by a unique line of glial, Schwann cell-like cells, 
called olfactory ensheathing cell, which create continuous, fluid-filled perineural channels (van Riel et 
al., 2015). 
3.2.2. Viral replication and spread in the upper respiratory tract 
A first important but often overlooked barrier that virus particles have to overcome is the mucus 
layer coating the respiratory mucosa. It has been assumed that PRV penetrates easily through the 
mucociliary barrier. A recent study using a porcine ex vivo tracheal respiratory mucus model however 
showed that mobility of PRV through this mucus layer can be hindered due to a complex interplay of 
mucoadhesive interactions including electrostatic interaction (Yang et al., 2012). No data are yet 
available indicating that PRV mobility is also hindered in the mucus overlying the nasal mucosa, 
which is the common port of entry for PRV infection (Wittmann et al., 1982).  
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After crossing the mucociliary barrier, primary replication occurs in epithelial cells of mainly the 
upper respiratory tract, which consists of nasal cavity, tonsils and oropharynx, but also viral 
replication in the lower respiratory tract which consists of the trachea and lungs can occur (Kritas et 
al., 1994a, b; Miry & Pensaert, 1989; Pol et al., 1989; Sabó et al., 1968, 1969; Wittmann et al., 1980). 
The extent of replication at the different sites depends on the inoculation dose and on the route of 
inoculation. Replication in the lower parts of the respiratory tract is normally restricted, except when 
the virus is directly administered to these locations, via intratracheal or aerosol inoculation 
(Baskerville, 1971; Miry & Pensaert, 1989). While most respiratory viruses restrict their replication to 
epithelial cells, PRV can cross the basement membrane and get access to the underlying connective 
tissue. This invasive capacity may be considered as characteristic for alphaherpesviruses. After 
crossing the basement membrane, PRV can replicate in the underlying connective tissue of the 
lamina propria. Viral replication in epithelial and mucosal cells of the respiratory mucosa follows the 
general replication cycle as described in section 1.4. Replication in the mucosa and submucosa can 
cause blisters, ulcerations and respiratory problems. A similar plaque wise spread is also found in 
tonsils and lungs (Miry & Pensaert, 1989).  
 
Although the knowledge of virus penetration through the basement membrane is limited, some ex 
vivo studies in nasal explants have studied the underlying mechanisms. These studies have shown 
that gE appears to play a role in sorting virus particles to the basal side of respiratory epithelial cells 
towards and near the basement membrane barrier (Glorieux et al., 2009a). Furthermore, a trypsin-
like serine protease appears to be involved in PRV penetration of the basement membrane, possibly 
by local degradation of basement membrane barrier components. It is unknown whether the 
involved proteases are of cellular and/or viral origin (Glorieux et al., 2011).  
 
During invasion of the lamina propria of the respiratory mucosa, PRV can reach innervating blood 
vessels and nerve endings. Via infection of the endothelium of the widely distributed capillaries in 
the nasal mucosa, PRV can enter the bloodstream and can disseminate throughout the body to 
internal organs. Both cell-free and cell-associated viremia can be detected (Nauwynck en Pensaert, 
1995). Infection of nerve endings of the trigeminal and olfactory nerves that are present in the nasal 
and olfactory mucosa respectively, can result in spread to the CNS (Kritas et al., 1994a, b).  
 
The efficiency of replication at the nasal mucosa appears to be dependent on the viral strain. Studies 
using an ex vivo nasal explant model have indicated that there are differences in infection capacity 
and plaque formation in epithelial cells between PRV strains (Glorieux et al., 2009b). The virulent 
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NIA3 strain was able to efficiently infect epithelial and stromal cells within 24 hpi (Glorieux et al., 
2009b; Pol et al., 1991). Older and less virulent strains (Becker, NIA1, N374) showed a reduced 
capacity to infect nasal epithelial cells and/or a reduced plaque formation capacity (Glorieux et al., 
2009b). The non-virulent Bartha vaccine virus was restricted to epithelial cells, even at 48 hpi (Pol et 
al., 1991). Also in vivo studies suggested that the virulence of PRV is at least partly determined by the 
rate at which PRV is able to replicate and spread in the nasal and olfactory mucosa. Upon intranasal 
inoculation of 10-week-old pigs with the virulent NIA3 strain, virus antigens were already detected 16 
hpi in nasal epithelial cells as well as some stromal cells. At 24 hpi, the epithelial lesions had grown in 
size and number and viral antigens were detected in numerous stromal cells and in axons of the 
olfactory nerve. Viral antigens were also detected in tonsils and in the lungs. At 48 hpi, infection had 
completely invaded the lamina propria and viral antigens were detected in nerve cells and vascular 
walls. The Bartha strain on the other hand had only infected few cells of the epithelium by 16 hpi. 
The number of infected cells increased, but by 96 hpi, still no infected stromal cells were detected 
indicating that the Bartha strain was less capable of breaching the basement membrane (Pol et al., 
1989), in line with the findings in nasal explants (Pol et al., 1991).  
3.2.3. Local immune response at the upper respiratory tract after PRV infection 
Only limited information is available in literature regarding the PRV induced immune response at the 
initial site of replication, i.e. the upper respiratory tract. One study reported that replication of the 
NIA3 strain in the nasal mucosa causes accumulation of neutrophils and macrophages at 48hpi, while 
lymphoid cell infiltration is increasing from 72hpi. The ratio of infiltrating immune cells, however 
appears to depend on the viral strain. A mainly neutrophilic infiltration was observed after NIA3 
inoculation whereas, mainly infiltration of lymphocytes was observed after inoculation with the 
Bartha vaccine strain (Pol et al., 1989). Untill now, no studies have focussed on the local immune 
response at the olfactory mucosa after PRV infection.  
Furthermore, interferons appear to be of importance to inhibit primary replication at the primary site 
of replication. Interferon-α (IFN-α) can be detected in the nasal excretions of infected pigs between 2 
and 7 dpi. Animals with higher concentrations of IFN-α excrete less virus (Nauwynck and Pensaert, 
1995). In porcine nasal mucosa explants, it was demonstrated that IFN-α reduces virus replication in 
epithelial cells and protects fibroblasts from virulent PRV infection (Pol et al., 1991). A recent study 
indicated that treatment of axon endings of rat superior sacral ganglion neurons with IFN-β or IFN-γ 
in an in vitro compartmentalized three chamber model activated distinct mechanisms to restrict PRV 
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retrograde transport to the neuronal cell bodies without affecting the axonal transport of cellular 
organelles (Song et al., 2016). 
3.3. The trigeminal ganglion, site of PRV latency  
3.3.1. Anatomical structure 
The trigeminal nerve (cranial nerve V) is the largest of the cranial nerves with three divisions towards 
the facial area: the opthalmic nerve, the maxillary nerve and the mandibular nerve. The trigeminal 
nerves are the major general sensory nerves of the face and transmit afferent impulses from touch, 
temperature, and pain receptors. The opthalmic nerve conveys sensory information in part from the 
upper eyelid, the conjunctiva and the cornea of the eye, the nose and the nasal cavity mucosa. The 
maxillary nerve carries sensory information from the lower eyelid, the upper lip, the upper teeth, the 
palate, the cheek and the nasal cavity mucosa. The mandibular nerve carries sensory impulses in part 
from the lower lip, the lower teeth, the tongue and the chin. Besides sensory nerve fibers, the 
mandibular branch of the trigeminal nerve also contains some motor nerve fibers that innervate 
chewing muscles and are thus involved in motor functions as biting, chewing and swallowing 
(Jenkins, 1978; Marieb et al., 2005; Paxinos & Mai, 2004; Siegel & Sapru, 2006). 
The TG contains the cell bodies of the pseudo-unipolar sensory neurons of the trigeminal nerve. One 
branch of the neuron is directed to the periphery with nerve endings distributed in the lamina 
propria and between the epithelial cells of the nasal mucosa. The other branch connects the cell 
body to the CNS. This branch enters the brainstem at the level of the pons and connects the sensory 
neurons of the TG to the neurons of the main sensory nucleus and the spinal nucleus of the 
trigeminal nerve. They are respectively located in the pons and the medulla oblongata. Adjacent to 
this sensory root, a smaller motor root also enters the pons leading the motor nerve fibers to their 
cell bodies located in the trigeminal motor nucleus which lies near the main sensory trigeminal 
nucleus (Jenkins, 1978; Kritas et al., 1994a; Marieb et al., 2005; Paxinos & Mai, 2004; Siegel & Sapru, 
2006). 
3.3.2. Pseudorabies virus infection of trigeminal ganglion neurons 
After PRV entry in the axon endings that innervate the primary site of replication, PRV reaches the 
cell bodies of the TG neurons by retrograde transport. In vivo studies have shown that virulent wild- 
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type PRV strains are able to efficiently reach the cell bodies of trigeminal neurons, located in the TG, 
upon intranasal inoculation. By 2 days after inoculation of 3- to 5-week-old pigs with the virulent 
NIA3 strain virus antigens were detected in many first-order neurons of the TG (Mulder et al., 1996). 
Similar observations were done at 2 days after inoculation of 1-week-old piglets with the Kaplan 
strain (Kritas et al., 1994a, 1995). Besides neurons, also infected fibroblasts, satellite and Schwann 
cells were observed (Kritas et al., 1994a). 
The TG are of particular interest during PRV pathogenesis because they are characterized as the 
predominant site for the establishment of a latent infection (Gutekunst et al., 1980). Latency is a 
strategy of the virus to persist in the host during its entire lifetime without being eliminated by the 
host’s immune system. Although neurons of the TG are the predominant site, latent virus has also 
been shown in the tonsils, the CNS and the sacral ganglia (Beran et al., 1980; Romero et al., 2003; 
Sabó & Rajcáni, 1976; Wheeler & Osorio, 1991). After entry in TG neurons, either a productive 
infection is started with the formation of new infectious virus particles or the virus enters a latent 
state of infection where no new virus particles are produced. The general PRV productive replication 
cycle in neuronal cells is similar to that in non-neuronal cells, but some essential aspects are different 
and are described in section 3.3.2.1. Characteristics favouring a latent infection are described in 
section 3.3.2.2.  
3.3.2.1. Productive infection 
Although the general productive replication cycle of PRV in neuronal cells is similar to that in non-
neuronal cells (described in section 1.4) the virus has to overcome several hurdles due to the specific 
structure of neuronal cells that will be described in this section. 
As in somatic cells, PRV entry into neuronal cells is dependent on a stable binding mediated by the 
interaction of gD with its cellular receptor (Karger et al., 1995). Although several cellular entry 
receptors are described for PRV, nectin-1 has been suggested to serve as the predominant gD 
receptor on sensory neurons (Haarr et al., 2001; Ono et al., 2006; Simpson et al., 2005).  
The more complex structure of neuronal cells makes that nucleocapsids have to be transported over 
long distances (> 10 cm) to reach the nucleus where genome replication occurs. Transport to the 
neuronal nucleus is also dependent on transport along microtubules via the cellular motor protein 
dynein, but longer distances (> 10 cm) have to be covered by the nucleocapsid (Döhner et al., 2002; 
Granzow et al., 2005; Sodeik et al., 1997). Retrograde transport along microtubules towards the 
nucleus occurs at rates in excess of 1 µm/s (Antinone & Smith, 2010; Kristensson et al., 1986; Topp et 
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al., 1994). After reaching the nucleus in somatic cells, the tegument protein UL48 (VP16) forms a 
complex with host cell transcription factors in the nucleus, resulting in the expression of the 
immediate-early gene IE180 (Fuchs et al., 2002a; Stern et al., 1989). VP16 however dissociates from 
the virion after entry in the axon termini (Granzow et al., 2005; Luxton et al., 2005). Therefore, it is 
uncertain whether VP16 is able to perform this function in the context of a neuron considering the 
long distance these proteins have to travel to reach the nucleus after they have become dissociated 
from the capsid.  
The next steps of the replication cycle, i.e. viral transcription, replication and virion assembly are 
similar in neurons compared to somatic cells. Egress and subsequent release of infectious virus 
particles from the neuronal cell body occurs via exocytosis of virion-containing vesicles, similar to 
viral egress from non-neuronal cells (Miranda-Saksena et al., 2002). In neurons PRV virions do, 
however, not only spread from the cell body, but can also be released at the axon ending after 
anterograde transport (Antinone & Smith, 2010; Kramer & Enquist, 2013). Anterograde transport can 
be directed to the periphery, where the virus may cause recurrent disease, or to synaptically 
connected neurons of the peripheral nervous system (PNS) and CNS, an event that is associated with 
CNS symptoms. Just like retrograde transport, anterograde transport has been shown to rely on 
microtubule-based fast axonal transport, using kinesin motor proteins (Miranda-Saksena et al., 
2000). Questions still remain about the assembly state of viral particles during anterograde transport. 
Two models have been proposed, the “married model” and the “separate model”, each being 
supported by a set of well-documented data. In the traditional “married model” virion assembly and 
secondary envelopment occur in the cell body prior to axonal sorting and these enveloped virions are 
carried in transport vesicles from the cell body to axon termini. In contrast, under the “separate 
model” naked capsids and secondary membranes undergo axonal sorting and are transported 
separately. Final assembly occurs at or near sites of egress (Kratchmarov et al., 2012). An in vivo 
study in pigs has however indicated that anterograde transport to the nasal mucosa occurs in an 
infectious form, thereby supporting the “married model” (Kritas et al., 1995). 
3.3.2.2. Latent infection 
The latency-reactivation cycle can be divided into three major phases: 1) establishment of latency, 2) 
maintenance of latency and 3) reactivation from latency. During the phase of establishment, the viral 
genome enters the TG and is directed to a dormant state. Afterwards, the genome is kept in this 
dormant state during the maintenance phase of latency without the production of new virus 
particles. Over this period, transcription of viral lytic genes is repressed and the only transcript that is 
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detectable are the specific latency-associated transcripts (LATs). The viral genome can remain in this 
dormant state for a long time, but upon specific stimuli, it may be reactivated, which may lead to the 
production of new virus particles. 
Whether or not latency is induced in the TG is generally accepted to depend on a complex interplay 
between the neuronal environment, the virus and the immune system (Divito et al. 2006). Neurons 
are the predominant cell type in which latent alphaherpesvirus infections are induced and therefore 
must have properties that differentiate them from other cell types and create an environment 
favourable for latent infections. Several properties of neurons have been proposed to serve to this 
end. As already discussed above, the tegument protein VP16 is necessary for the initiation of 
transcription of the immediate-early gene IE180 (Fuchs et al., 2002a; Stern et al., 1989). VP16 forms a 
transcription initiation complex in the nucleus, together with the cellular proteins HCF and Oct-1. The 
formation of this transcription initiation complex is hampered in several ways in neurons. Since VP16 
is dissociated from the virion at the axon ending, only limited amounts are able to reach the nucleus 
(Kristie & Roizman, 1988; Roizman & Sears, 1987). Also, Oct-1 is low abundant in neurons and the 
differential distribution of the protein HCF in neuronal and non-neuronal cells hinders the interaction 
with VP16 (He et al., 1989; Kristie et al., 1999). Furthermore, sensory neurons are, in contrast to 
other cells, fully differentiated cells and therefore contain only low levels of proteins associated with 
DNA replication and in this way suppress lytic viral infection (Nichol et al., 1996).  
Neuronal properties are not sufficient to induce a latent state after PRV infection. Viral properties 
also contribute to the establishment of latency. The LAT gene is the only viral genomic region that is 
abundantly transcribed during latent PRV infection. The LAT gene is transcribed from the strand 
opposite to that encoding EP0 and IE180 (Cheung, 1991; Priola et al., 1990; Priola & Stevens, 1991), 
and LAT transcripts may therefore act as antisense RNA suppressing production of these lytic 
infection-associated viral transactivators. The LAT region is transcribed both during productive and 
latent infection, however, which set of transcripts is expressed during either of the stages remains 
unclear. The 4.6 kb intron is spliced from the transcript resulting in the 8.5 kb LTT (Cheung, 1991). 
Some of the smaller PRV LAT transcripts are possibly stable introns spliced from the LLT as is the case 
for HSV-1 (Farrell et al., 1991).  
In contrast to the LAT production during PRV infection, LAT expression during latent HSV-1 infection 
has been intensively studied. Although LAT expression is not necessary for establishment of a latent 
HSV-1 infection, it represses the viral lytic transcription during latency (Chen et al., 1997; Perng et al., 
1994, 1996). Several possible effects of LAT in maintaining or establishing latency have been 
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proposed. LAT appear to be capable of inhibiting apoptosis and thereby promote survival of infected 
neurons (Hamza et al., 2007; Perng et al., 2000). It was also proposed that LAT silence viral 
productive genes by inducing heterochromatin conformation in regions where promoters of lytic 
genes are located (Wang et al., 2005b). Furthermore, viral microRNAs (miRNAs) encoded by the LAT 
transcript are proposed to contribute to the establishment or maintenance of a latent infection by 
inhibition of productive infection and inhibition of apoptosis in neuronal cells (Perng & Jones, 2010). 
The difference in LAT transcripts that are expressed during the establishment of HSV-1 and PRV 
latency make that results obtained for HSV-1 not necessary hold true for PRV latent infection. 
Nonetheless, a recent study has suggested a role for PRV LAT miRNAs in regulating the host genome 
during latent PRV infection. The exact mechanisms however remain unclear (Mahjoub et al., 2015).  
The third important player in the equation that determines productive or latent PRV infection in TG 
neurons is the immune system, which will be described in more detail in the next subchapter. 
3.3.3. Local immune response at the trigeminal ganglion after PRV infection 
For HSV-1, the best characterized alphaherpesvirus, quite some evidence is available that besides the 
unique intrinsic properties of neurons, also the innate and adaptive immune response of the host 
play an important role in the establishment and maintenance of latency. Only very limited studies 
have been conducted to confirm this for PRV infection. Therefore, the next sections will focus most 
on studies using HSV-1, the best characterized alphaherpesvirus.  
3.3.3.1. Establishment of latency 
During the establishment of latency, it is primarily the innate immunity that is responsible for 
controlling early alphaherpesvirus infection in the TG. Several studies have shown the importance of 
immune cell infiltration and associated production of cytokines in the establishment of a latent 
alphaherpesvirus infection (Decman et al., 2005a; Egan et al., 2013; Held & Derfuss, 2011). 
Type I IFNs (IFN-α and IFN-β) are among the first immune effectors produced upon alphaherpesvirus 
infection. They are important to limit viral replication and spread during initial infection and 
reactivation by activating cells of the innate immune system and inducing an antiviral state in 
uninfected cells both at the periphery and in the TG. Type I IFNs are produced in mice TG after HSV-1 
corneal infection concurrent with HSV-1 transport to the ganglion (Decman et al., 2005a). Studies in 
transgenic mice expressing the IFN−α gene under control of an astrocyte specific promoter showed 
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that over-expression of IFN-α inhibited HSV-1 replication in the TG (Carr et al., 1998). Furthermore, 
primary mice TG cell cultures transduced with an adenoviral vector expressing IFN-β repressed HSV-1 
replication in a dose-dependent fashion (Al-khatib et al., 2003; Carr et al., 2003). For PRV, in vitro 
studies have reported that treatment of porcine TG neurons with IFN-α is sufficient to induce a 
quiescent PRV infection that shows strong similarities to in vivo latency. This suggests that IFN-α may 
represent a key immune component involved in efficient establishment of PRV latency in sensory 
neurons (De Regge et al., 2010). The IFN-induced latency-like quiescence was found to correlate with 
suppression of the immediate-early PRV IE180 levels in sensory neuronal cells by reducing its 
transcription relatively late in infection (Van Opdenbosch et al., 2011). 
Important immune cells that infiltrate the TG of HSV1-infected mice, concurrently with viral 
replication, are macrophages and γδ TCR+ T cells (Liu et al., 1996; Shimeld et al., 1995). Macrophages 
are professional antigen-presenting cells (APCs) that release proinflammatory cytokines and present 
viral peptides to cells of the adaptive immune response. Macrophages serve to limit viral replication 
until the adaptive immune system can be activated. The macrophages produce proinflammatory 
cytokines such as TNF-α, interleukin-6 (IL-6), RANTES (“regulated on activation, normal T cell 
expressed and secreted”), type I IFNs, and nitric oxide (NO) (Egan et al., 2013; Kodukula et al., 1999). 
Depleting macrophages, blocking NO production by inhibition of iNOS, or neutralizing TNF-α during 
the first 5 days after HSV-1 corneal infection in mice leads to increased viral replication and higher 
number of infected neurons in the TG (Kodukula et al., 1999). Placing IL-6 under control of an 
astrocyte specific promoter significantly reduced virus titers in the TG (Carr & Campbell, 1999).  
Several studies have shown the importance of γδ TCR+ T cells in the establishment of a latent HSV1 
infection in mouse, probably by their production of IFN-γ. IFN-γ not only possesses antiviral activity, 
but is also a potent activator of macrophages, inducing their production of NO and TNF-α (Heise & 
Virgin, 1995). Knock-out mice that lack γδ TCR+ T cells and mice that were depleted of γδ TCR+ T cells 
showed increased virus replication and spread resulting in higher mortality due to encephalitis. Also, 
most of the early IFN-γ production within the TG was eliminated (Kodukula et al., 1999; Sciammas et 
al., 1997). Taken together, these findings suggest that innate immunity is primarily responsible to 
suppress early HSV-1 replication in the TG following primary infection, driving the virus towards a 
latent state. 
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3.3.3.2. Maintenance of latency 
A persisting immune cell infiltration accompanied by cytokine and chemokine expression has been 
observed in latently HSV-1-infected TG in humans (Theil et al., 2003) and mice (Cantin et al., 1995; 
Halford et al., 1996; Shimeld et al., 1995).  
Immune infiltrates in humans latently infected with HSV-1 have been characterized to consist of 
macrophages and T cells, mainly belonging to the CD8+ subset, but also CD4+ T cells subset (Derfuss et 
al., 2007; Theil et al., 2003; Verjans et al., 2007). Infiltrated CD4+ T cells, virus specific and non-virus 
specific activated CD8+ T cells and macrophages were also found in TG of mice latently infected with 
HSV-1 while they were not detected in ganglia of uninfected mice (Khanna et al., 2003; van Lint et al., 
2005; Liu et al., 1996; Shimeld et al., 1995). It has been shown that the local CD8+ T cells can prevent 
HSV-1 reactivation in mouse TG ex vivo cultures in a dose-dependent, antigen-specific, and MHC-
restricted fashion (Khanna et al., 2003; Liu et al., 2000).  
The immune cell infiltrate is associated with an upregulation of cytokine and chemokine expression. 
In latently infected human TG, a significant induction of TNF-α and IFN-γ were observed (Theil et al., 
2003). Also in mice, a persistent expression of the T cell-associated cytokine mRNAs of IL-2, IL-10, 
TNF-α and IFN-γ were detected in latently infected TG (Halford et al., 1996). Furthermore, an 
increased expression of the T cell chemo-attractant RANTES was observed in latently infected TG 
both in mouse models (Cantin et al., 1995; Chen et al., 2000; Halford et al., 1996, 1997; Liu et al., 
1996) and in humans (Hüfner et al., 2006; Theil et al., 2003). These results further support an 
important role for T cells in maintaining HSV-1 in a latent state. 
The most important effectors of CD8+ T cells that promote latency are (i) IFN-γ and (ii) granzyme B. 
On the one hand, IFN-γ plays an important role in the inhibition of viral replication. Cells exposed to 
IFN-γ inhibit viral replication through the expression of antiviral genes which, among others, inhibit 
translation (Meurs et al., 1990). On the other hand, IFN-γ promotes the presentation of viral 
peptides. CD8+ T cells recognize infected cells through an interaction of their T cell receptor with an 
antigenic peptide bound to a MHC class I molecule that is presented on the surface of a target cell. 
Neurons normally do not express detectable MHC I molecules, but this expression is inducible by IFN 
(Neumann et al., 1995). Sensory neurons have been shown to express detectable MHC class I during 
acute HSV-1 infection (Pereira et al., 1994; Pereira & Simmons, 1999). Besides on neurons, MHC class 
I expression is also induced on Schwann and satellite cells after HSV-1 lytic infection in mouse TG 
(Pereira et al., 1994) and these cells could thereby function as antigen-presenting cells (van Velzen et 
al., 2009). Furthermore, IFN-γ also induces the expression of immunoproteosomal subunits (Belich et 
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al., 1994; Groettrup et al., 1996; Kelly et al., 1991) which can enhance processing of viral peptides for 
loading onto MHC class I (Sijts & Kloetzel, 2011).  
Next to the production of IFN-γ, antiviral CD8+ T cells exert their function through the release of 
perforin and granzymes A and B. Granzymes A and B are packaged in cytotoxic granules of cytotoxic T 
cells and NK cells together with perforin. Perforin is a pore forming cytolytic protein that binds to the 
cell membrane of the target cell allowing passive diffusion of granzymes into the target cell. The 
granzymes exert their function by activating caspase, which activates several substrates, including 
caspase-activated DNase to execute cell death. In contrast to most other cell types, the release of 
these molecules does not induce apoptosis in latently infected neurons (Knickelbein et al., 2008). 
Destruction of neurons during HSV-1 infection is only rarely seen in humans (Theil et al., 2003) and 
mice (Decman et al., 2005b; Esaki et al., 2010). In neurons, granzyme B is probably internalized by 
endocytosis where it is able to degrade the immediate-early HSV-1 protein ICP4, which is required for 
efficient viral gene expression (Knickelbein et al., 2008) and can thereby prevent the reactivation of 
HSV-1 from a latent state. Granzyme A was shown to possess a noncytolytic capacity to limit the 
spread of HSV-1 to other neurons, although the underlying mechanisms are still unknown (Pereira et 
al., 2000). 
3.4. The central nervous system 
3.4.1. Anatomical structure 
PRV can invade the CNS both via the trigeminal and via the olfactory route. The trigeminal pathway is 
currently best characterized and can be considered as the most important route of PRV 
neuroinvasion. It compromises passage via the TG, where latency is established. The current 
knowledge of PRV neuroinvasion to the CNS via both routes is limited and summarized below.  
3.4.1.1. Trigeminal route  
The pseudo-unipolar neurons of the trigeminal nerve have one branch connecting the cell body to 
the periphery and another one entering the brain stem at the level of the pons. The axons connect to 
the sensory neurons of the main sensory nucleus and the spinal nucleus of the trigeminal nerve, 
located in the pons and in the medulla oblongata respectively. The neurons of the main sensory and 
spinal nuclei of the trigeminal nerve are multipolar neurons, of which the axons form synapses with 
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neurons that have their cell bodies located in the thalamus and their axons directed to the 
cerebellum and the cerebrum (Jenkins, 1978; Kritas et al., 1994a; Marieb et al., 2005; Paxinos & Mai, 
2004; Siegel & Sapru, 2006). 
3.4.1.2. Olfactory route 
The axons of the olfactory receptor cells, which are located in the olfactory epithelium, combine to 
the fila olfactoria which collectively form the olfactory nerve (cranial nerve I). The fila olfactoria 
penetrate the cribriform plate of the ethmoid bone and enter the overlying olfactory bulb. In the 
olfactory bulb, the olfactory nerve axons make contact witch second order neurons in complex 
synaptic clusters called glomeruli. Three subsequent layers of second order neurons are present in 
the olfactory bulb: the brush neurons, the mitral neurons and the inner granular neurons. The axons 
of these neurons extend posteriorly as the olfactory tract which runs beneath the frontal lobe to 
enter the cerebral hemispheres. The olfactory information is sent to the limbic region, where smells 
elicit emotions, and to the piriform lobe of the cerebral cortex, which processes olfactory 
information into a conscious perception of odor. From the piriform lobe, information is further sent 
through a thalamic relay to the orbitofrontal cortex, where smells are analyzed and compared to 
others (Kritas et al., 1994b; Marieb et al., 2005; van Riel et al., 2015).  
3.4.2.  Viral replication and spread in the central nervous system 
3.4.2.1. Trigeminal route 
Upon intranasal inoculation of 1-week-old pigs with the Kaplan strain, virus antigens were already 
detected in trigeminal nerve fibers located in the lamina propria of the nasal mucosa at 48 h p.i. 
Furthermore, the Kaplan strain had already reached the trigeminal nerve cell bodies in the TG at that 
time point, and also infected fibroblasts, satellite and Schwann cells were detected. The first PRV 
positive neurons and glial cells in the trigeminal nuclei in the pons were detected at 48 h p.i. and the 
number of positive cells increased significantly by 5 d p.i.. At this time point, PRV had also reached 
the cerebellum and thalamus (Kritas et al., 1994a). 
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3.4.2.2.  Olfactory route 
After PRV infection of the olfactory receptor cells, located in the olfactory mucosa, virus particles can 
be transported anterogradely to the olfactory bulb via the olfactory nerve, thereby forming a direct 
connection between the nasal mucosa and the CNS (Marieb et al., 2005; van Riel et al., 2015). 
Replication can occur in the different parts of the olfactory pathway after PRV infection of its natural 
host (Kritas et al., 1994b; McFerran & Dow, 1965; Narita et al., 1991; Pol et al., 1989; Sabó et al., 
1969; Wittmann et al., 1980). Upon intranasal inoculation of 1-week-old pigs with the Kaplan strain, 
virus antigens were already detected at 48 h p.i. in both non-neuronal epithelial cells and olfactory 
receptor cells of the olfactory mucosa as well as in some stromal cells. Evidence for efficient invasion 
of all levels of the olfactory route was shown, since at this 48 h p.i. time point, virus antigens were 
already detected in the olfactory bulb glomeruli, brush, mistral and inner granular neurons as well as 
the higher parts of the olfactory route (Kritas et al., 1994b). 
3.4.3. Local immune response at in the central nervous system after PRV infection 
Until now, no studies have focused on studying the local immune response in the CNS after 
neuroinvasion via the trigeminal or the olfactory route.  
 
4. PRV virulence determinants 
Differences in the capacity of PRV strains to induce clinical disease have been observed, but the 
determinants of differences in virulence are not always clear.  
The most important PRV genes that are involved in neurovirulence and escape from the innate 
immune response and therefore potentially could account for differences in virulence between 
strains are described in the following section.  
4.1. Viral proteins involved in neuroinvasion and transneuronal spread 
Several viral proteins have shown to attribute to PRV neuroinvasion and transneuronal spread after 
in vitro infection of neurons from different species or in vivo infection of pigs or rodents. The gD, gE, 
gI and US9 proteins contribute to efficient neuroinvasion and transneuronal spread whereas the gB 
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and US3 proteins are important in determining the predominant route of neuroinvasion, i.e. the 
trigeminal or olfactory route. Next to these genes, a possible role in neurovirulence has been 
suggested for UL48 (VP16), UL7, UL16 and UL21 by mutant studies in mice. However, no further data 
involving neurovirulence in the natural host, the pig, is yet available (Klopfleisch et al., 2006).  
4.1.1. gB 
Glycoprotein gB has been shown to be important in determining the route of neuroinvasion (Gerdts 
et al., 2000; Mettenleiter, 2003). The gB protein is essential for entry into target cells, both during 
infection by free virions and during direct cell-to-cell spread. Since gB is an essential protein, gB-
negative virions are non-infectious. To study the function of gB, PRV gB was replaced by the 
homologous BHV-1 gB in the PRV reference strain Kaplan (Kopp & Mettenleiter, 1992). Infection with 
this mutant in pigs showed that the replacement of PRV gB by the homologues BHV-1 glycoprotein 
resulted in an alteration in the route of neuroinvasion. As described before, PRV can reach the CNS 
either by the trigeminal or the olfactory route. Whereas the parental PRV strain was primarily 
detected in the trigeminal pathway, the recombinant virus was primarily associated with the 
olfactory pathway demonstrating the importance of gB in determining the route of neuroinvasion 
(Gerdts et al., 2000). 
4.1.2. gD 
The gD protein is also essential for virus entry, rendering gD-negative virions non-infectious. Using a 
phenotypically complemented gD mutant (carrying gD in the viral envelope but not in the genome), it 
was shown that the loss of gD did not inhibit neuroinvasion of the NIA3 strain in 3- to 5- week-old 
piglets (Mulder et al., 1996). These results were confirmed by several in vitro studies (Babic et al., 
1993; Ch’ng et al., 2007; Ch’ng & Enquist, 2005a; Heffner et al., 1993) and indicate that transsynaptic 
spread of PRV in pigs can occur independently of gD. Spread of this mutant to the CNS was however 
slowed down, which could indicate a possible role in transsynaptic spread (Mulder et al., 1996). 
Using a homologous in vitro two-chamber system, it was reported that PRV induces, via its gD 
envelope protein, the formation of synaptic varicosities along the axon shaft of infected TG neurons. 
Nonneuronal cells that were juxtaposed to these virus-induced varicosities became preferentially 
infected with PRV, suggesting that varicosities may serve as axon exit sites for the virus (De Regge et 
al., 2006a). Impaired capacity of a phenotypically complemented gD mutant to induce varicosities 
during infection of TG neurons could provide a possible explanation for the reduced neuronal spread 
observed after infection in pigs.  
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4.1.3. gE and gI 
The glycoproteins gE and gI form a functional heterodimer and will therefore be discussed together. 
Infection of one-week-old piglets with a gE- and to lesser extent a gI-negative mutant, resulted in 
impaired transneuronal transfer of PRV (Kritas et al., 1994a, b, 1995). After infection with a gE-
negative mutant, no reduction in foci of infection were found in the nasal mucosa epithelium, but a 
reduced spread into the underlying connective tissue and a reduced infection capacity of the 
olfactory mucosa were observed. Furthermore, impaired neuroinvasion capacity for both the 
trigeminal and the olfactory route was observed since the gE-negative mutant was only able to reach 
the TG and the olfactory nerve axons, but no higher order neurons were infected (Kritas et al., 1994a, 
b, 1995). The gI-negative mutant was able to replicate in the nasal and olfactory mucosa in pigs to 
the same extent as the parental strain and efficiently reach the CNS via the trigeminal and olfactory 
route. The invasion of higher order neurons was however delayed compared to the parental strain, 
implying a role for the gI protein in neuronal spread (Kritas et al., 1994a, b, 1995). The reduced 
neuroinvasion of both mutants is associated with a impaired anterograde transport of newly formed 
particles and was also confirmed after in vivo infection of rats and in vitro infection of primary rat 
superior cervical ganglion neurons (Ch’ng & Enquist, 2005b; Husak et al., 2000; Kratchmarov et al., 
2013a). It is proposed that gE/gI are required for efficient KIF1A-mediated anterograde transport of 
viral particles because they indirectly facilitate or stabilize the interaction between US9 and KIF1A 
(see below) (Kratchmarov et al., 2013a). 
4.1.4. US3 
Fast induction of apoptosis of infected cells is a known defence mechanism to prevent anterograde 
transport of pathogens through olfactory receptor cells (Kanaya et al., 2014; Mori et al., 2002, 2004). 
For HSV-2, it was shown that US3 was able to suppress virus-induced apoptosis of olfactory receptor 
cells in the olfactory mucosa. In contrast to its parental strain, an US3-disrupted mutant of HSV-2 
induced apoptosis in olfactory receptor neurons and was therefore unable to efficiently spread to the 
olfactory bulb (Mori et al., 2006). Although an anti-apoptotic activity has also been attributed to the 
US3 orthologue of PRV (Van den Broeke et al., 2011; Chang et al., 2013; Geenen et al., 2005a), it is 
currently not known whether PRV US3 also inhibits virus-induced apoptosis of porcine olfactory 
receptor cells. An in vivo study using a US3-negative mutant showed reduced virulence compared to 
the parental NIA3 strain in 10-week-old pigs, but it was not specified whether this reduced virulence 
was associated with an impaired invasion of the olfactory bulb (Kimman et al., 1994). On the other 
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hand, primary porcine TG neurons are remarkably more resistant to PRV-induced cell death 
compared with other porcine cell types since no substantial apoptosis was observed in PRV-infected 
primary porcine TG neurons in vitro, even after infection with a US3-negative PRV strain (Geenen et 
al., 2005b).  
4.1.5. US9 
Next to the heterodimer gE/gI, also the US9 protein has been shown to be necessary for anterograde 
spread. PRV lacking US9 enters the PNS by retrograde axon transport but, following replication in 
neurons, is impaired in anterograde spread both in mice and in neuronal cell culture (Brideau et al., 
2000; Brittle et al., 2004; Klopfleisch et al., 2006). This defect was attributed to a decrease in viral 
particle sorting to axons, probably due to impaired interaction with a kinesin motor or cellular 
adaptor complex that facilitates axonal sorting and transport (Tomishima et al., 2001; Tomishima & 
Enquist, 2001). More recently it has been shown that US9 interacts with KIF1A, a microtubule-
dependent kinesin-3 motor involved in axonal sorting and transport (Kramer et al., 2012; 
Kratchmarov et al., 2013b) and probably functions in the in initial sorting of particles to axons and 
not in fast axonal transport of particles from the proximal axon to terminals (Daniel et al., 2015). 
4.2. Role of viral genes in evasion of the innate immune response 
Herpesviruses have developed different mechanism to evade the induced immune response. 
However, here we focused on evasion towards the innate immune response since we studied the 
involvement of the immune response shortly after PRV infection where the innate immune response 
appears to be the most important. Evasion mechanisms to counteract the IFN response and the 
antiviral activity of NK cells are described. 
4.2.1. IE180 
One of the most potent antiviral consequences of IFN on infected cells is phosphorylation and 
thereby inactivation of the translation factor eIF2α, resulting in a global inhibition of protein 
synthesis and shutdown of viral replication. PRV efficiently circumvents the IFN-mediated translation 
inhibition by interfering with phosphorylation of eIF2α via the immediate-early IE180 protein (Van 
Opdenbosch et al., 2011). IE180 suppresses phosphorylation levels of the eukaryotic translation 
initiation factor eIF2α via the cellular phosphatase PP1 (Van Opdenbosch et al., 2012).  
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4.2.2. EP0 
The PRV EP0 protein has been described to counteract the IFN-induced antiviral state in primary 
porcine fibroblasts, but not in non-host cells (Brukman & Enquist, 2006a). The exact mechanism is 
however unknown.  
4.2.3. gD 
Expression of PRV gD during infection or transfection led to degradation and consequent down-
regulation of CD112 (nectin-2), a ligand for the activating NK cell receptor DNAX accessory molecule 
1 (DNAM-1). CD112 downregulation resulted in a reduced ability of DNAM-1 to bind to the surface of 
both virus-infected and gD-transfected cells. Consequently, expression of gD suppressed NK cell-
mediated lysis of PRV-infected and gD-transfected cells (Grauwet et al., 2014) 
4.2.4. US3 
The PRV US3 protein kinase also suppresses NK cell-mediated lysis of PRV-infected cells. Expression 
of US3 modulates the exposure of specific phospholipids on the surface of infected cells, thereby 
triggering the binding of the inhibitory NK cell receptor CD300a. This provides increased CD300a-
mediated protection of infected cells against NK cell-mediated lysis (Grauwet et al., 2016). 
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Aujeszky’s disease is an important disease in domestic swine caused by the alphaherpesvirus 
pseudorabies virus (PRV). PRV infection is characterized by respiratory, reproductive, and 
neurological symptoms, leading to important economic losses in the pig industry. In several 
European countries, including Belgium, the virus was successfully eradicated from the domestic 
swine population. The virus remains however present in the wild boar population and thereby poses 
a possible risk for reintroduction of the virus into the currently unprotected domestic pig population. 
Furthermore, it has been observed that the wild boar population as well as the PRV seroprevalence 
within this population is increasing. This, in combination with an increasing popularity of farms with 
free-ranging facilities and the occurrence of some recent PRV reintroductions that were attributed to 
PRV circulating in wild boar, has led to a growing concern for a reintroduction of PRV into the 
domestic swine population. Unfortunately, the knowledge on PRV strains from wild boar and their 
associated threat to domestic pigs remains limited. Therefore, the general aim of this doctoral 
dissertation was to obtain more insights in the genetic relatedness, virulence and pathogenicity of 
PRV isolates circulating in Belgian wild boar compared to domestic swine. 
First, Belgian PRV strains from wild boar and domestic swine origin were genetically characterized by 
restriction fragment length polymorphism (RFLP) analysis and phylogenetic analysis of a partial 
sequence of the gC gene to get a better insight into the genetic relatedness between strains from 
both populations and to compare Belgian wild boar strains with those circulating in neighbouring 
countries (Chapter 3). 
PRV strains circulating within wild boar are assumed to be attenuated based on two in vivo studies. 
However, molecular characterisation studies have observed an important genetic diversity of PRV 
strain circulating within the wild boar population and therefore care should be taken when 
extrapolating these results to other wild boar strains. Furthermore, cell biological and molecular 
explanations for the observed differences in capacity to induce clinical disease between wild boar 
and domestic swine isolates are lacking. Therefore, we wanted to evaluate if differences in in vitro 
virulence between strains from domestic swine and wild boar exist that could help to explain the 
observed differences in in vivo virulence. The finding of such differences could lead to the use of in 
vitro models to assess the virulence of newly isolated wild boar strains and predict the potential 
consequences associated with a reintroduction of such a strain in the domestic swine population 
(Chapter 4). 
To further evaluate the possible impact of such a reintroduction, an in vivo infection study was 
performed. To evaluate the virulence of Belgian wild boar strains in domestic pigs, 15-week-old pigs 
were inoculated with either one of two different Belgian wild boar PRV isolates (BEL24043 and 
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BEL20075) or the NIA3 reference strain. Seen that for PRV strains from domestic swine origin it is 
known that the capacity to induce clinical symptoms is largely dependent on the age of the infected 
pig, we also assessed the virulence of one of both wild boar strains (BEL24043) and the NIA3 
reference strain in 2-week-old pigs. Next to the virulence of these wild boar strains, also the capacity 
to induce seroconversion, the extend of viral shedding and transmission capacity was assessed to 
evaluate the possible consequences of a possible reintroduction into domestic pigs (Chapter 5).  
After establishing that the severity of the induced clinical symptoms is largely dependent on the 
origin of the strain used for infection (domestic swine origin or wild boar origin) as well as the age of 
the infected pig, we wanted to evaluate if differences in the neuropathogenesis could be detected 
that could help to explain these differences in virulence. Therefore, an in vivo infection experiment 
was performed wherein domestic pigs of 2- and 15-week-old were inoculated with the PRV-reference 
strain NIA3 or the wild boar strain BEL24043. Virus spread and replication as well as the associated 
immune response were studied at important sites of the PRV (neuro)pathogenesis, i.e. the nasal 
mucosa, the trigeminal ganglion, the pons and the olfactory bulb, to assess whether potential 
explanations could be found for the observed age- and strain-dependent differences in clinical 
symptoms upon infection (Chapter 6). 
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Chapter 3 
Molecular characterization of Belgian pseudorabies virus 
isolates from domestic swine and wild boar 
 
 
 
 
 
 
 
 
 
Adapted from: 
Verpoest, S., Cay, A.B., Bertrand, O., Saulmont, M., De Regge, N., (2014). Isolation and 
characterization of pseudorabies virus from a wolf (Canis lupus) from Belgium. Eur J Wildl Res 60(1): 
149–153 
Verpoest, S., Cay, A.B., De Regge, N. (2014). Molecular characterization of Belgian pseudorabies 
virus isolates from domestic swine and wild boar. Vet Microbiol. 172(1-2):72-77  
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Abstract 
Aujeszky’s disease is an economically important disease in domestic swine caused by suid 
herpesvirus 1, also called pseudorabies virus (PRV). In several European countries, including Belgium, 
the virus has successfully been eradicated from the domestic swine population. The presence of PRV 
in the wild boar population however poses a risk for possible reintroduction of the virus into the 
domestic pig population. It is therefore important to assess the genetic relatedness between 
circulating strains and possible epidemiological links. In this study, nine historical Belgian domestic 
swine isolates that circulated before 1990 and five recent wild boar isolates obtained since 2006 
from Belgium and the Grand Duchy of Luxembourg were genetically characterized by restriction 
fragment length polymorphism (RFLP) analysis and phylogenetic analysis. While all wild boar isolates 
were characterized as type I RFLP genotypes, the RFLP patterns of the domestic swine isolates 
suggest that a shift from genotype I to genotype II might have occurred in the 1980s in the domestic 
population. By phylogenetic analysis, Belgian wild boar isolates belonging to both clade A and B were 
observed, while all domestic swine isolates clustered within clade A. The joint phylogenetic analysis 
of both wild boar and domestic swine strains showed that some isolates with identical sequences 
were present within both populations, raising the question whether these strains represent an 
increased risk for reintroduction of the virus into the domestic population.  
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1. Introduction 
Aujeszky’s disease is an economically important disease in domestic swine caused by suid 
herpesvirus 1, also called Aujeszky’s disease virus or pseudorabies virus (PRV). The virus belongs to 
the family Herpesviridae, subfamily Alphaherpesvirinae, genus Varicellovirus. PRV infection is 
characterized by respiratory, reproductive, and neurological symptoms which depend on the age of 
the pigs and the virulence of the strain (Pomeranz et al., 2005). 
In several European countries, including Belgium, the virus was successfully eradicated from the 
domestic swine population due to large-scale vaccination programs (Decision 2011/648/EU). The 
virus remains however present in the wild boar population (Czaplicki et al., 2006; Müller et al., 2011) 
and thereby poses a possible risk for reintroduction of the virus into the currently unprotected 
domestic pig population.  
Conventional restriction fragment length polymorphism (RFLP) analysis of genomic DNA has allowed 
differentiation of PRV isolates in four major types and several subtypes (Herrmann et al., 1984). In 
Europe, wild boar PRV strains are mainly genotype I (Müller et al., 2010), while in domestic swine 
both type I and II are found (Herrmann et al., 1984). Type III and type IV PRV strains are restricted to 
Northern Europe and Asia, respectively (Herrmann et al., 1984). More recently, phylogenetic analysis 
of a partial sequence of the glycoprotein C (gC) gene has been used for molecular typing (Goldberg et 
al., 2001) and showed that European wild boar isolates differentiate in two clades (Müller et al., 
2010). One clade consists of strains originating from eastern Europe, while the other clade is made 
up of strains originating from southwestern Europe, but both clades seem to overlap geographically 
in Central Europe (Müller et al., 2010). Only limited information is available for European domestic 
swine strains (Sozzi et al., 2014).  
In this study, we genetically characterized Belgian PRV strains from wild boar and domestic swine 
origin by RFLP analysis and phylogenetic analysis to get a better insight into the genetic relatedness 
between strains in both populations and to compare Belgian strains with strains circulating in 
neighbouring countries. 
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2. Materials and Methods 
2.1. Virus isolation and virus identification 
Brain or lung tissue from animals diagnosed with Aujeszky’s disease was used for virus isolation. A 
10% weight/volume suspension of tissue in phosphate buffered saline (PBS) was prepared by 
mechanical disruption using an ultraturrax and centrifuged at 1750 x g for 20 min. The supernatant 
was collected, filtered through a 0.45 µm filter and inoculated onto a confluent monolayer of PK15 
cells, grown on six-well plates. The inoculum was removed after 1 h at 37 °C. Cells were washed with 
PBS and MEM, supplemented with fetal calf serum (10%), penicillin (1000 U mL-1), gentamicin (50 µg 
mL-1) and fungizone (250 ng mL-1), was added to the cells and incubated at 37 °C. The cells were daily 
assessed for cytopathic effect typical for herpesvirus infection (Verpoest et al., 2014a). The 
supernatant of cell cultures with a cytopathic effect was collected and cells were fixed with 
methanol. Immunofluorescence staining using a PRV-specific fluorescein-conjugated antiserum was 
performed to confirm the presence of PRV (Nauwynck & Pensaert, 1995a).  
In total nine domestic swine isolates from the period between 1973 and 1989 were obtained from 
eight domestic swine and one bovine that got infected after being in close contact with pigs (Table 
1). Five PRV strains from wild boar origin were obtained between 2006 and 2011: one directly from a 
wild boar, and three from hunting dogs and one from a wolf that had been fed with wild boar offal 
(Cay & Letellier, 2009; Verpoest et al., 2014a). One of these wild boar isolates originated from a 
hunting dog from the Grand Duchy of Luxembourg. Brain tissue from the animal was sent to the 
Belgian reference laboratory for Aujeszky’s disease at CODA–CERVA for virus isolation and was 
therefore included in this study. Virus could be isolated from all animals, except from the wild boar. 
The latter could therefore only be examined by phylogenetic analysis and not by RFLP analysis. 
2.2. RFLP 
To determine the restriction fragment pattern, the PRV isolates were passaged once on ST cells 
followed by one freeze–thaw cycle. The cellular debris was removed by low speed centrifugation at 
1750 x g for 20 min. The supernatant was ultra-centrifuged at 100,000 x g and 4 °C for 90 min. The 
virus pellet was resuspended in PBS, followed by DNA extraction using the QiAmp DNA extraction kit 
(Qiagen, Germany). One µg of DNA was digested with 10 U BamHI (Roche, Switzerland) for 3 h at 37 
°C. The same procedure was applied to PRV reference strains Bartha and Kaplan. The digests were 
Chapter 3: Genetic characterization of PRV isolates from wild boar and domestic pigs 
 
 
52 
 
loaded on a 0.6 % agarose gel and run for 6 h at 50 V. Bands were visualized using a 0.5 µg mL-1 
ethidium bromide solution (Sigma-Aldrich, Belgium) (Müller et al., 2010; Steinrigl et al., 2012). 
2.3. Sequencing and phylogenetic analysis 
For sequencing purposes, a part of the gC sequence of the virus isolates was amplified with the 
DyNazyme Ext DNA polymerase (Thermo Fisher Scientific, USA) using previous published primers 
(Hahn et al., 2010; Müller et al., 2010). The amplicon of the expected size was excised from an 
agarose gel and DNA was purified using the Qiaquick Gel Extraction Protocol (Qiagen). Approximately 
5 ng of PCR product was used as template for sequencing using the PCR primers described above and 
the BigDye Terminator Sequencing Kit (Applied Biosystems, USA). Sequencing reactions were purified 
using the BigDye Xterminator reagent and ran on a 3130 Genetic Analyzer (Applied Biosystems). The 
obtained sequences were submitted to Genbank (accession numbers: KF415193 and KF779456 to 
KF779468; Table 1). The sequences of the Belgian isolates and previously described sequences 
obtained from wild boar and domestic swine from Europe (Müller et al., 2010; Sozzi et al., 2014; 
Steinrigl et al., 2012) were used for phylogenetic analysis. The sequences were aligned by ClustalW 
and all positions containing gaps and missing data were eliminated (complete deletion option) 
resulting in a final alignment of 639 bp that was used for further analysis. Neighbour joining analysis 
was performed, as implemented in MEGA5 (Tamura et al., 2011). The bootstrap test as percentage of 
replicate trees (500 replicates) in which the associated taxa cluster together and the composite 
maximum likelihood substitution model for calculating nucleotide distances were used. 
 
Table 1: Overview of Belgian PRV isolates from wild boar and domestic swine. 
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3. Results 
3.1. RFLP 
The restriction fragment pattern was obtained for nine Belgian isolates from domestic swine origin 
and four isolates from wild boar origin of which three originate from Belgium and one from the 
Grand Duchy of Luxembourg. The genotype of these isolates (Figure 1) was determined using the 
classification system for PRV isolates described by Herrmann et al. (1984) based on the BamHI 
induced RFLP patterns. All isolates from wild boar origin exhibited a RFLP pattern similar to that of 
the Kaplan reference strain and were thereby characterized as type Ip PRV strains (Table 1). 
However, some additional variation in the size of the band consisting out of fragment 5, 5’ and 6 can 
be observed. This is most likely the result of small molecular weight differences between strains in 
fragment 5 since it is located in the inverted repeat regions of the genome (Ben-Porat et al., 1979; 
Gielkens et al., 1985). The subtype Iw (5-10/5-12 double fusion) which is characterized by the 
appearance of two additional fragments above fragment 4, accompanied by the loss of fragments 5, 
10 and 12 (Lomniczi et al., 1989; Müller et al., 1998b, 2010; Steinrigl et al., 2012) was not found for 
any of the strains characterized in this study.  
Among the isolates from domestic swine, both type I and type II RFLP patterns were observed. Three 
domestic swine isolates were characterized as genotype I. Two of them, BEL50 and BEL2, exhibited 
the classical type I subtype Ip. The third genotype I isolate, BEL55, was characterized as an 
intermediate Ii RFLP genotype by the loss of the restriction site between fragment 5’ and 14 resulting 
in the presence of a combined fragment just below fragment 4. The other six domestic swine isolates 
belonged to genotype II. The classical RFLP pattern for type II PRV strains is characterized by the loss 
of fragment 2 and the appearance of two additional fragments, one just above and one just below 
fragment 4. This was observed for four domestic swine isolates, BEL62, BEL63, BEL69 and BEL71. For 
two of these isolates, BEL62 and BEL71, an additional variation was however found characterized by 
the loss of fragment 8. This variation is most likely the result of loss of the cleavage sites between 
fragment 8 and 8’ as well as 8 and 13 resulting in two extra fragments of which only one can be 
detected above fragment 4. The loss of the restriction site between the latter two fragments results 
in a fragment similar in size and therefore comigrating with fragment 7 (Lomniczi et al., 1989; 
Yamada et al., 1992). The remaining two isolates, BEL60 and BEL68 exhibited an intermediate pattern 
where the loss of fragment 2 resulted in only one additional fragment, just above fragment 4. 
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Figure 1: BamHI restriction fragment length polymorphism pattern of PRV reference strains Kaplan and 
Bartha and Belgian domestic swine and wild boar PRV isolates. Smartladder (Eurogentec, Belgium) and 1 kb 
Plus DNA ladder (Invitrogen, Belgium) were used as molecular markers. The respective restriction fragments 
are indicated on the right side. Lane 1: isolate BEL20070, Lane 2: isolate BEL20075, Lane 3: isolate LUX20484, 
Lane 4: isolate BEL24043, Lane 5: isolate BEL50, Lane 6: isolate BEL55, Lane7: isolate BEL2, Lane 8: isolate 
BEL60, Lane 9: isolate BEL62, Lane 10: isolate BEL63, Lane 11: isolate BEL68, Lane 12: isolate BEL69, Lane 13: 
isolate BEL71, Lane 14: PRV reference strain Bartha, Lane 15: PRV reference strain Kaplan.  
3.2. Sequencing and phylogenetic analysis 
Phylogenetic analysis was performed with the sequences obtained from the Belgian strains and 
previously described sequences from European PRV strains (Figure 2). This joint analysis of wild boar 
and domestic swine isolates showed that while wild boar isolates belong both to clade A and clade B 
(Müller et al., 2010), all domestic swine isolates are located within the genetically more diverse clade 
A. Three of the four Belgian wild boar strains and the isolate from the Grand Duchy of Luxembourg 
are located within clade B and cluster together with wild boar isolates from southwestern Germany, 
France and Spain. They are identical for the sequenced region apart from isolate BEL20075 that 
displays a single amino acid substitution that was already described for the French isolate FRA536. 
The remaining wild boar isolate, BEL10053, clusters with other wild boar isolates from Austria, 
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eastern Germany, Italy and Slovakia. Furthermore, the sequence of this isolate is identical to that of 
the Belgian domestic swine isolate BEL2 and the Slovakian wild boar isolate SVK558. 
All Belgian domestic swine isolates are located within clade A. Five strains, BEL60, BEL62, BEL68, 
BEL69, and BEL71 have an identical gC sequence and cluster together with other type II domestic 
swine isolates from Italy and the French isolate from wild boar origin, FRA527. The remaining type II 
isolate BEL63 appears to be less closely related to other genotype II domestic swine isolates and does 
not cluster with other known PRV isolates. Belgian type I domestic swine isolates did not cluster 
together. The isolate BEL50 has a sequence that is identical to the Kaplan reference strain. The 
isolate BEL55 clusters together with wild boar isolates from Austria and Germany and an Italian type I 
domestic swine strain. The remaining type I isolate BEL2 clusters together with wild boar isolates 
from Austria, eastern Germany, Italy and Slovakia, the Belgian wild boar isolate BEL10053 and the 
reference strain Bartha. Seen the possible importance of the observed identical sequences for the 
BEL2 isolate from a domestic pig and the Belgian wild boar isolate BEL10053, these results were 
confirmed by an independent reisolation and sequencing of both strains. 
4. Discussion 
Aujeszky’s disease had spread nearly globally around the 1980s and this coincided with the 
emergence of more virulent PRV strains and management changes in the swine industry (Pomeranz 
et al., 2005). For European domestic swine isolates, there is evidence that type I strains were 
replaced by type II RFLP genotypes during the 1980s (Capua et al., 1997a; Herrmann et al., 1984). For 
Belgian PRV isolates it is observed that two isolates from 1973 and 1976 exhibit a type I RFLP pattern, 
while most Belgian isolates from 1988 and 1989 are characterized as type II genotypes. The 
observation that these RFLP type II strains originate from at least three different Belgian provinces 
and belong to different subtypes suggest they are not epidemiologically linked, and could indicate 
that a shift to genotype II has also occurred for Belgian PRV strains. The rather limited number of 
samples tested, that all originate from the same time period, make however that this cannot be 
concluded with certainty at this moment. It remains also undetermined whether the type I isolate 
BEL2 from 1988 represents a type I PRV strain that was still circulating in the domestic swine 
population at that time or rather results from a reintroduction of PRV from wild boar into domestic 
swine. 
 
Chapter 3: Genetic characterization of PRV isolates from wild boar and domestic pigs 
 
 
56 
 
Since wild boars form a natural reservoir of the virus, it is important to monitor the prevalence and 
diversity of PRV in this population. European wild boar isolates cluster both within clade A and B 
(Müller et al., 2010), as is also found for the Belgian wild boar isolates. Three of the four Belgian 
isolates and the isolate from the Grand Duchy of Luxembourg cluster with wild boar isolates from 
southwestern Germany, France and Spain within clade B. In contrast, isolate BEL10053 is located 
within clade A, together with wild boar isolates from Austria, France, eastern Germany, Hungary, 
Italy and Slovakia. This confirms previous results showing that European wild boar isolates of both 
cluster A and B seem to overlap geographically in central Europe, since isolates belonging to both 
groups were found in Germany and France (Müller et al., 2010), and now in Belgium. Also the 
observed Ip RFLP pattern of all Belgian wild boar isolates is in line with previous findings that most 
European wild boar isolates belong to this subtype (Müller et al., 2010). Next to the Ip subtype, also 
the Iw has been frequently found in wild boar from Austria, eastern Germany and Hungary and an 
association with a PRV outbreak in domestic swine and cats from Hungary has been shown (Müller et 
al., 1998a, 2010; Steinrigl et al., 2012). This subtype was not observed for the Belgian wild boar 
isolates. Interestingly, the sequence of a Belgian wild boar isolate BEL10053 is identical to that of a 
Slovakian wild boar isolate. It remains puzzling to explain how a possible identical strain is present in 
these two geographically distinct countries without being detected in countries in between. Although 
a natural spread of the strain cannot be excluded, it seems plausible that this is the result of an 
importation of wild boar from one country to another at a certain moment in time. 
 
 
Figure 2. Phylogenetic tree of the European domestic swine and wild boar isolates constructed using the neighbour joining method. The 
bootstrap test (500 replicates) and the composite maximum likelihood substitution model were used. The Chinese strain Ea and Fa were 
used as outgroup. If multiple isolates showing identical gC sequences were found in Genbank, all were included in the analysis, but only 
one is displayed in the phylogenetic tree and the others are listed below.  (1) JQ768123.1/137181/Italy/2003/S; 
JQ768125.1/13814/Italy/2007/DD; JQ768127.1/12022/Italy/2000/S; JQ768130.1/285/Italy/2002/S; JQ768131.1/1317/It aly/2002/S; 
JQ768138.1/280666/Italy/2008/S; JQ768140.1/29652/Italy/2008/S; JQ768141.1/35155/Italy/2008/S; JQ768142.1/54/Italy/ 1984/S; 
JQ768143.1/2580/Italy/2000/S; JQ768144.1/4058/Italy/2000/S; JQ768145.1/11719/Italy/2000/S; JQ768146.1/8225/Italy/2001/S; 
JQ768147.1/ 15142/Italy/2001/S; JQ768148.1/13038/Italy/2001/S; JQ768150.1/14754/Italy/2001/S; JQ768151.1/5658/Italy/1988/S; 
JQ768152.1/36/Italy/1989/S; JQ768153.1/2441/Italy/1992/S; JQ768154.1/3718/Italy/1993/S; JQ768155.1/111/Italy/1994/S; 
JQ768156.1/736/Italy/1994/S; JQ768157.1/182/Italy/ 1994/S; JQ768158.1/426/Italy/1994/S; JQ768160.1/1369/Italy/1994/S; 
JQ768162.1/12455/Italy/1999/S. (2) JQ768128.1/261517/Italy/2004/S; JQ768129.1/32754/Italy/2003/S; JQ768136.1/4028/Italy/2001/ S; 
JQ768137.1/28617/Italy/2010/S; JQ768139.1/7145/Italy/2008/S; JQ768149.1/14096/ Italy/2001/S; JQ768161.1/361/Italy/1998/S; (3) 
JQ081288.1/2099-2210/Austria/2010/WB; JQ081291.1/2111-110/Austria/2010/HD; JQ081292.1/2111- 210/Austria/2010/HD; 
JQ081293.1/2216-10/Austria/2010/HD; (4) GQ259093.1/GER11ST/Germany/1996/WB; GQ259094.1/GER12BRB/Germany/1995/ 
WB;GQ259095.1/GER13BRB/Germany/1995/WB; GQ259096.1/GER15BRB/Germany/1996/WB; 
GQ259096.1/GER15BRB/Germany/1996/WB;GQ259117.1/GER612BRB/Germany/2003/WB; GQ259118.1/GER613SN/Germany/2005/WB; 
(5) GQ259091.1/ESP 2960/Spain/2004/WB; GQ259120.1/ ESP 2872/Spain/2000/WB; GQ259121.1/ESP 2873/Spain/-/WB; GQ259122.1/ESP 
2874/Spain/2005/WB; GQ259123.1/ESP 2882/Spain/2005/WB; GQ259124.1/ESP 2886/Spain/2005/WB; GQ259125.1/ESP 
2890/Spain/2004/WB; (6) GQ259103.1/GER551NRW/Germany/1999/WB; GQ259104.1/GER 552NRW/Germany/1999/WB; 
GQ259105.1/GER553RP/Germany/2000/HD; GQ259106.1/GER554RP/Germany/2000/HD; GQ259107.1/GER555RP/ Germany/2000/WB; 
GQ259108.1/GER556NRW/Germany/2000/WB; GQ259116.1/GER611RP/Germany/2003/HD; (7) GQ259100.1/FRA 537/France/ 1999/HD. 
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Based on the joint phylogenetic analysis of wild boar and domestic swine isolates, some interesting 
relatedness between strains originating from both populations could be observed. The sequence of 
the French isolate FRA527 originating from a hunting dog, which is the only isolate originating from 
European wild boars that is characterized as a type II RFLP genotype (Müller et al., 2010), is identical 
to that from Belgian and Italian type II domestic swine isolates. On the other hand, the Belgian 
domestic swine isolate BEL2 clusters together with wild boar isolates from eastern Europe and has an 
identical sequence as the wild boar isolates BEL10053 and SVK558, both directly obtained from 
infected wild boar tissue. The observation that some domestic swine and wild boar isolates cluster 
together or even have identical sequences for the gC fragment makes it tempting to speculate that 
spill-over between both population has occurred and that those strains could possibly pose a risk for 
a reintroduction of PRV into the domestic swine population. However, several arguments make that 
this hypothesis should be considered carefully. First of all, wild boar and domestic pig isolates were 
obtained in different time periods, making it impossible to establish a direct epidemiological link. 
Secondly, bootstrap values for the different lineages are low, indicating that the observed clustering 
needs to be interpreted with care. Low bootstrap values were also evident in other publications 
using this fragment for phylogenetic inference (Fonseca Jr. et al., 2010; Goldberg et al., 2001; Hahn et 
al., 2010; Müller et al., 2010; Steinrigl et al., 2012). However, the observation that some domestic 
swine and wild boar strains have identical gC sequences supports an overlap between PRV strains 
circulating in both populations. Thirdly, the region used for phylogenetic analysis represents only a 
small portion of the total genome that is not necessarily representative for the total genomic 
variation. This is illustrated by the observation that although some of the Belgian PRV strains have 
identical sequences for the gC fragment, different RFLP patterns can be observed. Finally, a limited 
number of experimental infection studies have shown that infection of domestic pigs with wild boar 
PRV strains results in only mild or nonclinical infection, indicating the attenuated nature of these 
strains (Hahn et al., 1997; Müller et al., 2001). It would be interesting to perform additional in vivo 
infection experiments to strengthen the hypothesis that this attenuated nature is a common 
characteristic of all wild boar strains. It is however important to keep in mind that not only strains 
capable of inducing clinical disease pose a risk upon reintroduction, but that also strains capable to 
induce seroconversion in the currently unprotected domestic pig population could already result in 
important economic consequences. 
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5. Conclusions 
Although PRV is eradicated from domestic swine in Belgium, the presence of the virus in the wild 
boar population poses a risk for reintroduction into the domestic population. Although an attenuated 
nature of wild boar isolates is assumed, the finding of identical sequences of the gC gene in both wild 
boar and domestic swine strains suggests that a spill-over between both populations might have 
occurred. Therefore, monitoring of the strain diversity in wild boars is necessary and further research 
on the virulence and the possible implications of a reintroduction of PRV from wild boar origin in the 
domestic swine population is advisable. 
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Abstract 
Pseudorabies virus is the causative agent of Aujeszky’s disease. Domestic pigs and wild boars are its 
natural hosts, and strains circulating within both populations differ in their capacity to induce clinical 
disease. Cell biological and molecular explanations for the observed differences in virulence are, 
however, lacking. Different virulence determinants that can be assessed in vitro were determined for 
five domestic swine strains, four wild boar strains and the NIA3 reference strain. Replication kinetics 
and plaque formation capacity in continuous swine testicular cells and different primary porcine cell 
lines were highly similar for isolates from both populations. Treatment of these cell lines with IFNα, 
IFNγ or a combination of both provoked similar plaque-reducing effects for all strains. In conclusion, 
our results indicate that isolates from domestic swine and wild boar differ neither in intrinsic 
replication and dissemination capacity nor in sensitivity to antiviral effects of IFNs. 
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1. Introduction 
Aujeszky’s disease is an economically important disease in domestic swine caused by suid 
herpesvirus 1, also called Aujeszky’s disease virus or pseudorabies virus (PRV). The virus belongs to 
the family Herpesviridae, subfamily Alphaherpesvirinae, genus Varicellovirus. Members of the family 
Suidae are the only natural hosts of the virus and infection is characterized by respiratory, 
reproductive and neurological symptoms. The severity of the symptoms depends on the age of the 
swine and the virulence of the strain (Pomeranz et al., 2005). Aujeszky’s disease occurred only 
sporadically before the 1960s, and pigs were considered to be only a reservoir for the virus. Since the 
early 1980s, an increase in clinical outbreaks has been reported, coinciding with the emergence of 
more virulent strains and the intensification of swine production (Nauwynck et al., 2007; Pomeranz 
et al., 2005). In view of the great economic impact of the virus, large-scale vaccination programs 
were set up, which led to the eradication of the virus in the domestic swine population in several 
European countries, including Belgium (Decision 2011/648/EU). PRV remains, however, present 
within the wild boar population (Czaplicki et al., 2006; Müller et al., 2011) and poses a risk for 
reintroduction of the virus in the currently unprotected domestic swine population. PRV strains 
circulating in wild boars are considered to be attenuated based on field observations and 
experimental infection studies (Hahn et al., 1997; Müller et al., 2001). The risk of transmission to 
domestic swine is considered low based on the limited number of observed reintroductions in 
countries free of Aujeszky’s disease (Pannwitz et al., 2012). The presence of genetic differences in the 
glycoprotein C (gC) segment of different wild boar PRV isolates and the high genetic resemblance 
between some isolates from wild boar and domestic swine (Müller et al., 2010; Verpoest et al., 
2014b) suggest, however, that one should be careful when generalizing the proposed attenuated 
nature of wild boar PRV strains. 
Cell biological and molecular explanations for the observed differences between wild boar and 
domestic swine isolates in their capacity to induce clinical disease are lacking. Therefore, we wanted 
to evaluate if differences in in vitro virulence between strains from domestic swine and wild boar 
exist that could help to explain the observed differences in in vivo virulence. If such differences 
would be found, this could lead to the use of in vitro models to assess the virulence of newly isolated 
strains from wild boar and predict the potential consequences associated with a reintroduction of 
such strains in the domestic swine population. 
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2. Materials and Methods 
2.1. Cells, viruses and interferons 
Continuous swine testicular (ST) cells were propagated in minimal essential medium (MEM), 
supplemented with fetal calf serum (10%), sodium pyruvate (1 mM), penicillin (2000 U mL-1) and 
gentamicin (250 µg mL-1). Primary porcine cells were established from kidney, lung, skin and 
testicular tissue from 7-14 day old piglets. Therefore, 1 g of tissue was digested in a 0.2 % solution of 
collagenase I in phosphate buffered saline (PBS) and dissociated cells were seeded in MEM, 
supplemented with fetal calf serum (10%), penicillin (1000 U mL-1), gentamicin (50 µg mL-1) and 
fungizone (250 ng mL-1). For the validation of the assays a wild-type PRV NIA3, an US3 null PRV and 
an US3null PRV rescue strain were used (Van Minnebruggen et al., 2003). For the comparison of wild 
boar and domestic swine strains, genetically characterized PRV isolates from domestic swine and 
wild boar origin from Belgium (Table 1) were used (Verpoest et al., 2014a). Commercially available 
recombinant porcine IFNα (PBL InterferonSource, USA) and recombinant porcine IFNγ (R&D systems, 
USA) were used in plaque reduction assays.  
2.2. One step growth curves 
The in vitro growth kinetics of each PRV isolate were analyzed by inoculating 80 % confluent 
monolayers of continuous ST or primary porcine cells grown in 24 well plates at a multiplicity of 
infection (MOI) of 10. Cells were incubated for 1 h at 4 °C to allow virus attachment. Thereafter the 
inoculum was removed, new medium was added, and temperature was shifted to 37 °C to allow viral 
entry. One hour post attachment (h p.a.), extracellular virus was inactivated by citric acid buffer 
treatment for 2 min. At 1, 4, 8, 12, 24 and 48 h p.a., cells and supernatant were collected. After one 
freeze-thaw cycle, cellular debris was removed by centrifugation and the obtained supernatant was 
titrated on ST cells (Klupp et al., 2000). Virus titres were calculated according to the method of Reed 
and Munch and expressed as the log10 median tissue culture infectious dose (TCID50) per mL. The 
detection limit of this assay was 102 TCID50 mL
-1. Average values and standard error of the mean 
(SEM) of three independent experiments were calculated.  
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2.3. Plaque size assays 
To compare the plaque formation capacity of the PRV isolates, a confluent monolayer of ST cells 
grown in 24 well plates was inoculated with 1000 TCID50 per well, resulting in approximately 50 
plaques/well. After one hour, the inoculum was washed away and medium containing 1% 
methylcellulose was added to the cells. At 36 hours post infection (h p.i.), cells were washed with 
PBS, fixed with methanol and immunofluorescence stainings using a PRV-specific fluorescein-
conjugated antiserum (Nauwynck & Pensaert, 1995a) were performed to visualize plaques. For each 
isolate, the average plaque diameter of 15 plaques was determined using Image J and average values 
and SEM of three independent experiments were calculated. 
2.4. Plaque reduction assay 
To compare the sensitivity of the PRV isolates to the antiviral effect induced by IFNs, plaque 
reduction experiments were performed. Experiments were conducted on confluent monolayers of 
continuous ST cells or primary porcine cells grown in 24 well plates. For each isolate, three wells 
were pretreated for 24 h either with IFNα, IFNγ, or a combination of both IFNs and three wells with 
non-treated cells were used as control. IFNα was used at a concentration of 100 U mL-1. IFNγ was 
used at a concentration of 50 ng mL-1, corresponding to approximately 1500 U mL-1, for continuous 
ST cells and primary kidney and lung cells and at a concentration of 5 ng mL-1, corresponding to 
approximately 150 U mL-1, for primary skin and testicular cells since a cytotoxic effect was observed 
in these tissues at higher concentrations. After pretreatment, 1000 TCID50 per well of the different 
strains, resulting approximately in 50 plaques/well, were added and after 1 h the inoculum was 
removed by washing twice with PBS. Fresh medium supplemented with the respective IFNs was 
added to the cells. Cells were fixed with methanol at 24 h p.i. and immunofluorescence stainings 
using a PRV-specific fluorescein-conjugated antiserum (Nauwynck & Pensaert, 1995a) were 
performed to visualize plaques. The number of plaques in each well was counted and plaque 
reduction was determined as the percentage reduction of the number of plaques in the treated wells 
compared to the untreated wells. Average percentages of plaque reduction and SEM of three 
independent experiments were calculated. 
Chapter 4: In vitro virulence of wild boar and domestic swine PRV strains 
 
 
67 
 
2.5. Statistical analysis 
Statistical analysis of data was carried out using SPSS software. Viral titers, plaque sizes and % plaque 
reduction between all individual strains were compared by one-way analysis of variance (ANOVA) 
and Bonferroni post hoc tests. Student t-tests were used to analyze whether an overall difference in 
virus replication, plaque size formation and plaque reduction exist between domestic swine and wild 
boar strains. Hereto, the average values of the three independent replicates of each strain were 
used. P values < 0.05 were considered to be significant. 
3. Results 
3.1. Validation of the capacity of one step growth curves and plaque reduction 
assays to detect differences between PRV strains 
The performance of both the one-step growth curve assay and the plaque reduction assay were first 
validated during preliminary experiments with PRV-NIA3 WT strain, isogenic PRV NIA3-US3 null strain 
and the rescue strain. PRV NIA3-US3 null is known to be associated with limited but significantly 
reduced growth kinetics and plaque formation (Klopfleisch et al., 2006; Van Minnebruggen et al., 
2003). A significant greater than tenfold reduction in viral titre at 24 and 48 h p.a. (Figure 1a) and a 
significant 20 % reduction of the plaque diameter (Table 1) were observed for the NIA-US3 null strain 
compared with the rescue strain and the NIA3 strain, indicating that these in vitro assays are suitable 
to detect differences in growth kinetics and plaque formation if present. 
3.2. In vitro growth kinetics 
When the replication kinetics of the different PRV strains under study were subsequently 
determined, similar one-step growth curves were observed for the different PRV isolates in all cell 
lines tested (Figure 1). Progeny virus was first detected 8 h p.a. and this was followed by a rapid 
increase of the viral titres, reaching a plateau level at 24 h p.a. On all cell types tested, the one-way 
ANOVA analysis showed that differences between the mean viral titres of individual strains were 
present at one or several time points. Two-by-two comparisons, however, only occasionally detected 
significant differences between individual strains. The domestic swine isolates BEL50, BEL71 and to a 
lesser extent BEL69 showed a faster production of infectious virus than other strains at some early 
time points, but this was not consistent for all cell types and time points tested. On ST 
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Figure 1. One-step growth kinetics of PRV isolates from wild boar and domestic swine on continuous ST cells 
and different primary porcine cell lines. One-step growth kinetics were determined for the NIA3 strain, the 
US3 null mutant and the US3 null rescue strain on continuous ST cells (A) and for PRV strains of both domestic 
swine and wild boar origin on continuous ST cells (B) and primary porcine cells obtained from kidney (C), lung 
(D), skin (E) and testicular (F) tissue. Cells were inoculated at an m.o.i. of 10 and at different time points post-
attachment, virus titres were determined on ST cells. Mean values of three independent assays (±SE) are 
shown. The detection limit of this assay was 102 TCID50 mL
-1 and is indicated by the horizontal line. Values of 
one-way ANOVAs with P < 0.05 and results of Bonferroni post-hoc tests performed at the different time points 
post-attachment are shown. Time points marked with an asterisk indicate that significant differences between 
strains were found in ANOVA. Further significant differences found by two-by-two comparisons in Bonferroni 
post-hoc tests are indicated by a number, and the following strains were involved: (I) NIA3, NIA3 null rescue 
versus NIA3-US3 null; (II) BEL 20070, NIA3 versus BEL2, BEL60 and BEL71 versus BEL60; (III) BEL50 versus BEL60; 
(IV) BEL50 versus BEL20075; (V) BEL50 versus NIA3; (VI) BEL50 versus BEL20075, LUX20484, BEL60, BEL69; (VII) 
NIA3, BEL50, BEL71 versus BEL24043. 
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cells, only the domestic swine isolate BEL50 and the wild boar isolate BEL20075 were significantly 
different from each other at 48 h p.a., while the final titres of the other strains did not differ more 
than 0.36(log TCID50 mL
-1). For the primary porcine cell lines, no significant differences were found 
between titres of the PRV isolates at 48 h p.a. and they did not differ more than 0.75(log TCID50 mL
-1) 
from each other. 
Interestingly, when the growth kinetics of wild boar strains were compared with those of domestic 
swine strains for the different time points, the mean titre for the wild boar isolates was significantly 
lower than that of the domestic swine isolates on primary lung cells at 24 h p.a. (P=0.010) and on 
primary testicular cells at 12 (P=0.029), 24 (P=0.011) and 48 (P=0.034) h p.a., but again, these 
differences were not consistent for all cell types or time points tested. 
3.3. Capacity of viral spreading to neighboring cells 
The capacity of the different PRV strains to spread to neighboring cells was analyzed by infecting ST 
cells at a low MOI and comparing plaque sizes at 36 h p.i. No significant differences were observed 
between the mean plaque diameters induced by the individual PRV isolates, indicating that all tested 
strains are equally capable of spreading to neighbouring cells in vitro (Table 1). Furthermore, no 
significant differences were observed when the overall plaque size of wild boar strains was compared 
with those of domestic swine strains. 
 
Table 1: Overview of the different PRV strains used, and plaque diameters obtained on ST cells 
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3.4. In vitro IFN-sensitivity 
Plaque reduction assays were performed on continuous ST cells and on primary porcine cells from 
kidney, lung, skin and testicular tissue to evaluate possible differences between individual strains in 
sensitivity to the antiviral effects induced by IFNs. IFN treatment of ST cells resulted in a reduction of 
plaque formation compared with non-treated cells for all PRV strains tested (Figure 2a). Treatment of 
the cells with IFNα led to a plaque reduction between 67.95 and 85.76 % depending on the strain, 
but differences between these strains were not significant. At the concentrations used, IFNγ 
treatment was less capable of reducing plaque formation than IFNα, and led to a reduction of 
between 6.20 and 51.51 %. Except for the difference in plaque reduction between the NIA3 
reference strain and the domestic swine isolate BEL60, no significant differences were, however, 
observed in the post-hoc tests. No synergism between IFNα and IFNγ treatment was found compared 
with IFNα treatment alone. Furthermore, none of the treatments resulted in significant differences in 
overall mean plaque reduction between wild boar strains and domestic swine strains. 
The plaque reduction experiments on primary porcine cells obtained from kidney, lung, skin and 
testicular tissue revealed comparable results (Figure 2b–e). On all primary porcine cells tested, the 
high IFNγ concentrations were less potent than IFNα in inhibiting plaque formation, and combined 
treatment with both IFNs resulted in plaque reductions that were slightly, but not significantly, 
higher than those obtained for IFNα treatment alone. Although the one-way ANOVA analysis 
indicated significant differences between strains for the combined treatment on primary porcine 
kidney cells, and for both IFNα and IFNγ treatment on primary testicular cells, no significant 
differences in mean plaque reduction between strains were detected using the Bonferroni post-hoc 
tests. Furthermore, when the overall sensitivity of wild boar strains was compared with that of 
domestic swine strains, the mean plaque reduction after IFNγ treatment was significantly lower 
(P=0.006) for the wild boar isolates than for the domestic swine isolates on primary testicular cells. 
This was, however, not the case on the other cell types tested. 
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Figure 2: Plaque reduction of PRV isolates from wild boar and domestic swine after IFN treatment of 
continuous ST cells and different primary porcine cell lines. The sensitivity of PRV strains of both domestic 
swine and wild boar origin to IFNs was compared by plaque reduction experiments on continuous ST cells (A) 
and primary porcine cells obtained from kidney (B), lung (C), skin (D) and testicular (E) tissue. Cells were 
pretreated for 24 h with either IFNα (100 U mL-1), IFNγ (50 ng mL-1 for ST and for kidney and lung primary 
porcine cells and 5 ng mL-1 for skin and testicular porcine cells) or a combination of both IFNs. Afterwards, cells 
were inoculated with the different strains to obtain approximately 50 plaques per well. Mean percentage 
plaque reductions of three independent experiments (±SE) are shown. Values of one-way ANOVA analyses for 
the different IFN treatments are shown for each cell line. If ANOVA indicated significant differences (P < 0.05), 
Bonferonni post- hoc tests were performed, and significant differences in these two-by-two comparisons are 
indicated by an asterisk [NIA3 and BEL60 in (A)]. 
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4. Discussion 
To evaluate if differences in in vivo virulence are also reflected in in vitro assays used to assess PRV 
replication and spreading capacity and sensitivity to IFN-induced antiviral mechanisms, four and five 
well characterized isolates of wild boar and domestic swine origins, respectively, and the PRV 
reference strain NIA3 were selected. Strains of wild boar origin were collected from a wolf and 
hunting dogs that were diagnosed with Aujeszky’s disease after being fed with offal of asymptomatic 
wild boar shot during hunting. Phylogenetic analysis of a part of the gC gene, performed in 
accordance with literature standards (Goldberg et al., 2001; Hahn et al., 2010; Müller et al., 2010), 
showed that these isolates cluster together with other wild boar isolates from south-western Europe 
in clade B and can therefore be considered as representative strains (Verpoest et al., 2014b). The 
virulence of two of these wild boar strains, BEL20075 and BEL24043, was tested in vivo in 2- and 15-
week-old domestic pigs, and indicated the attenuated nature of these strains in adult pigs (Verpoest 
et al., 2016a). Domestic swine strains were directly obtained from domestic swine that were 
euthanized after experiencing important clinical symptoms typical for Aujeszky’s disease. The strains 
clustered within the heterogeneous clade A, which contained all the domestic swine isolates so far, 
and also wild boar isolates from eastern Europe. 
In the first part of this study, the basic in vitro replication and spreading capacity of PRV isolates 
originating from both populations were compared by one-step growth curves and plaque size assays. 
The results indicate that the intrinsic replication and dissemination capacities of wild boar strains are 
not affected and that this probably does not account for the differences in in vivo virulence between 
strains from the two populations. Another possible virulence determinant that can be assessed in 
vitro is that of evasion mechanisms to counteract the IFN response. IFNs are known to limit 
peripheral replication of PRV in vivo as well as in vitro replication (Yao et al., 2007), and are also 
proposed to be involved in the induction or maintenance of PRV latency in trigeminal ganglia (Van 
Opdenbosch et al., 2011; De Regge et al., 2010). Several herpesviruses, including PRV, have evolved 
evasion mechanisms to counteract the IFN response (Brukman & Enquist, 2006a, b) and differences 
between PRV strains in these mechanisms may result in a different sensitivity to the antiviral effects 
of IFNs. 
Therefore, in the second part of the study, the sensitivity of strains from both populations to antiviral 
effects induced by IFNs was evaluated by plaque reduction experiments. Since only limited 
differences were observed between the replication kinetics and the plaque diameter of the five 
domestic swine PRV strains, only three of them (BEL50, BEL60, BEL71) were retained for further 
experiments analysing the sensitivity of these strains to IFN-induced antiviral effects by plaque 
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reduction experiments. Since these results did not reveal consistent differences between strains in 
their capacity to counteract the plaque-reducing effect of IFNs, differences in capacity to counteract 
the IFN response can probably not explain the attenuated nature of wild boar strains in vivo either. 
Based on the overall results of this study, no differences in intrinsic viral replication, spread to 
neighbouring cells, and sensitivity to the IFN-induced antiviral response were found. Therefore, these 
basic in vitro assays seem unsuitable as a screening tool to evaluate the in vivo virulence of PRV 
strains and to help in the prediction of possible consequences of a reintroduction of a wild boar 
strain into the domestic swine population. Further studies examining other processes like PRV 
crossing of the basement membrane, virus spread to the blood vessels and trigeminal nerves, and 
efficiency of replication and spread in the nervous system may possibly reveal underlying 
determinants of the in vivo virulence of strains from both populations. Some in vitro models to study 
the interactions of herpesviruses with the nasal mucosa (Glorieux et al., 2009b; Vandekerckhove et 
al., 2010) and replication and spread in trigeminal ganglion neurons (De Regge et al., 2006b) have 
been developed and could be useful for such studies. These models are, however, expensive, labour 
intensive and time demanding and are not suitable to routinely screen the virulence of a high 
number of strains. 
5. Acknowledgements 
We thank Professor H. Nauwynck from Ghent University for the kind gift of the continuous ST cell 
line. This study was funded by the Belgian Federal Public Service of Health, Food Chain Safety and 
Environment (RF11/6249) and the Federal Science Policy, BELSPO (BR/132/PI/melatin-PRV). 
 
 
  
 
 
 
 
 
 
 
 
 
  
  
 
75 
 
 
 
 
 
Chapter 5 
Age- and strain-dependent differences in the outcome of 
experimental infections of domestic pigs with wild boar 
pseudorabies virus isolates 
 
 
 
 
 
 
 
Adapted from:  
Verpoest, S., Cay, A.B., Van Campe, W., Mostin, L., Welby, S., Favoreel, H., De Regge, N., (2016).  
Age- and strain-dependent differences in the outcome of experimental infections of domestic pigs 
with wild boar pseudorabies virus isolates. J Gen Virol 97(2): 487-495  
  
 
 
 
 
Chapter 5: Wild boar PRV virulence and transmission 
 
 
77 
 
 
 
 
 
 
 
Abstract 
Although pseudorabies virus (PRV) has been eradicated in domestic swine in many countries, its 
presence in wild boars remains a threat for a reintroduction into the currently unprotected swine 
population. To assess the possible impact of such a reintroduction in a naive herd, an in vivo infection 
study using two genetically characterized wild boar PRV isolates (BEL24043 and BEL20075) 
representative for wild boar strains circulating in south-western and central Europe and the virulent 
NIA3 reference strain was performed in 2- and 15-week-old domestic pigs. Our study revealed an 
attenuated nature of both wild boar strains in 15-week-old pigs. In contrast, it showed the capacity 
of strain BEL24043 to induce severe clinical symptoms and mortality in young piglets, thereby 
confirming that the known age dependency of disease outcome after PRV infection also holds for 
wild boar isolates. Despite the absence of clinical disease in 15-week-old sows, both wild boar PRV 
strains were able to induce seroconversion, but to a different extent. Importantly, differences in 
infection and transmission capacity of both strains were observed in 15-week-old sows. Strain 
BEL24043 induced a more prolonged and disseminated infection than strain BEL20075 and was able 
to spread efficiently to contact animals, indicative of its capacity to induce a sustained infection. In 
conclusion, it was shown that a reintroduction of a wild boar isolate into the domestic swine 
population could have serious economic consequences due to the induction of clinical symptoms in 
piglets and by jeopardizing the PRV-negative status. 
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1. Introduction 
Pseudorabies virus (PRV; also known as Aujeszky’s disease virus or Suid herpesvirus 1), is the 
causative agent of Aujeszky’s disease. The virus belongs to the family Herpesviridae, subfamily 
Alphaherpesvirinae, genus Varicellovirus. Infection in its natural host, members of the family Suidae, 
is characterized by respiratory, reproductive and neurological symptoms. The severity of the 
symptoms depends on the virulence of the strain and the age of the pig. Morbidity and mortality 
associated with PRV infection are higher in younger pigs, and are typically associated with symptoms 
of the central nervous system, whereas older swine mostly exhibit symptoms of respiratory and 
reproductive disease (Pomeranz et al., 2005). As a result of the high economic impact of the virus, 
large-scale vaccination programs were set up which led to the eradication of the virus in domestic 
swine in several European countries, including Belgium, which has been officially PRV-free since 2011 
(Decision 2011/648/EU).  
Seroprevelance studies have, however, shown that the virus is still circulating within the wild boar 
population (Müller et al., 2011) which could pose a risk for a reintroduction of the virus into the 
currently unprotected domestic swine populations. Despite the fact that epidemiological studies 
suggest that such reintroductions do not occur frequently as PRV infection in domestic pigs and wild 
boar represent distinct infection cycles (Capua et al., 1997a, b; Müller et al., 1998a; Pannwitz et al., 
2012), some recent reintroductions in France and the USA have been attributed to PRV circulating in 
wild boars (ProMED archive number 20100923.3442) (Hahn et al., 2010). 
Only limited information on the virulence of wild boar PRV isolates is available from two 
experimental infection studies and some field observations (Hahn et al., 1997; Müller et al., 2001). 
These studies suggest an attenuated nature for PRV isolates of wild boar origin in adult pigs, but this 
has not yet been confirmed for young piglets. The existence of an important genetic diversity among 
European wild boar strains has been shown and therefore care should be taken when extrapolating 
these results to all wild boar isolates. Phylogenetic studies using a part of the glycoprotein C (gC) 
fragment have shown that PRV isolates from wild boar cluster in two clades, A and B. Clade A is a 
heterogeneous group consisting of wild boar isolates from eastern Europe, but also all known 
domestic swine isolates are located within this clade. Clade B consists of strains originating from 
south-western Europe and is further subdivided into two genetic variants differing in only one amino 
acid in the gC fragment (Müller et al., 2010; Verpoest et al., 2014b). 
As there is a growing concern for a reintroduction of the virus into the currently unprotected swine 
population, we performed an in vivo infection study in domestic pigs with isolates of wild boar origin 
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to evaluate the possible impact of such a reintroduction in a naive herd. In a first experiment, 15-
week-old domestic pigs were either inoculated with one of two different wild boar PRV isolates or 
the PRV-NIA3 reference strain to assess the virulence and the transmission capacity of these wild 
boar isolates in domestic swine. The wild boar isolates were genetically characterized in detail 
previously. They represent the two genetic variants of clade B and are therefore likely representative 
for wild boar strains circulating within south-western and central Europe. In a second experiment, 2-
week-old piglets were inoculated with one wild boar PRV isolate or the NIA3 strain to evaluate if 
morbidity and mortality were also age dependent, as has been observed for domestic swine isolates. 
2. Materials and Methods 
2.1. Animals and viruses  
The 15-week-old (n=36) and 2-week-old (n=18) Belgian Landrace sows were purchased from a 
commercial swine herd. The sows were in good condition and tested negative in serology for PRV 
and classical swine fever at the beginning of the experiment. The animals were housed in Biosafety 
Level 3 facilities on slatted floors (CODA-CERVA, Machelen, Belgium). Water was available ad libitum 
and pigs were fed once each day. The animals were randomly assigned to the different infection 
groups. Animal experiments were performed in accordance with the European Union and Belgian 
regulations on animal welfare in experimentation. The protocol was approved by the joined ethical 
committee of CODA-CERVA and the Scientific Institute of Public Health Belgium (procedure 
agreement 121017-02). 
Two Belgian PRV isolates from wild boar origin and the virulent PRV NIA3 reference strain were used. 
The wild boar isolates BEL24043 and BEL20075 were obtained from infected brain tissue of a wolf 
and a hunting dog, respectively, that had been fed with offal of asymptomatic wild boars shot during 
hunting. The wild boar strains have been genetically characterized previously (Verpoest et al., 
2014b). BEL24043 and BEL20075 belong to subgroup 1 and 2 of clade B strains, respectively. A 
second passage of the wild boar strains BEL24043 and BEL20075 and a third passage of the NIA3 
strain were used for inoculations. 
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2.2. Experimental design 
As the outcome of a PRV infection largely depends on the age of the pigs and the virulence of the 
strains, experiments were conducted in sows of two age categories (experiment 1 and experiment 2, 
respectively).  
In the first experiment, twinty-four 15-week-old sows were randomnly divided over 4 pens with 6 
sows each. The sows in the first pen were mock infected with PBS, the sows in the second pen were 
intransally inoculated (1 mL per nostril) with the virulent NIA3 reference strain, the pigs in the third 
pen were intranassly inoculated with the wild boar isolate BEL24043 and the pigs in the fourth pen 
were intranassaly inoculated with the wild boar isolate BEL20075. Due to the high costs of 
experimental infections in Biosafety Level 3 facilities only a limited number of groups and conditions 
could be tested. Therefore, the wild boar isolates were inoculated to a relatively high dose of 106 
TCID50 per animal to avoid the possibility that potential negative results would be due to an 
inoculation dose that was too low. For the NIA3 strain that was used as a positive control, this high 
dose was expected to result in premature lethal infection even in adult pigs (McFerran et al., 1979) 
and therefore a lower dose of 105 TCID50 per animal was used. To evaluate the transmission capacity 
of the wild boar isolates between domestic pigs, susceptible contact pigs that had been kept apart 
were introduced into the pens containing the pigs inoculated with the wild boar strains. For both the 
BEL24043 and the BEL20075 infection group, six contact pigs were added at 24 h p.i. No contact 
animals were included in the control and NIA3-infected group. The sows were monitored daily for 
clinical symptoms and rectal body temperature. Blood and nasal and genital swabs were collected at 
-4, 0, 1, 2, 3, 5, 7, 10, 14, 17, 21 and 28 days p.i.. Animals were euthanized and organs collected at 
the end of the experiment at 28 days p.i. or at intermediate time points when mandatory on ethical 
grounds. 
In the second experiment, six female 2-week-old piglets were intranasally inoculated (0.5 mL per 
nostril) with a final dose of 105 TCID50 per animal of either the NIA3 reference strain or with the wild 
boar isolate BEL24043. Six piglets were mock-inoculated with PBS and held as a negative control 
group. Piglets were monitored daily for clinical symptoms and rectal body temperature. Blood and 
nasal and genital swabs were collected at 0, 1, 3, 5, 7, 10, 14, 17 and 21 days p.i. Animals were 
euthanized and organs collected at the end of the experiment at 21 days p.i. or at intermediate time 
points when mandatory on ethical grounds. 
Blood was collected in serum tubes, and after centrifugation for 15 min at 2 000 x g serum was 
divided in aliquots and frozen at -70 °C. For both nasal and genital swabs, 2.5 mL minimal essential 
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medium (MEM), supplemented with penicillin (1000 U mL-1), gentamicin (50 µg mL-1) and fungizone 
(250 ng mL-1) was added per swab. The immerged swabs were shaken at high speed for 1 h at 4 °C 
before being divided in aliquots and frozen at -70 °C. 
2.3. VNT for detection of PRV-specific antibodies 
 The VNT was used to assess the presence of neutralizing antibodies against PRV in serum samples. 
Serum samples were decomplemented by heat for 30 min at 56 °C before testing. Afterwards, a two 
times dilution series (1/2 to 1/256) was made in duplicate in MEM for each serum sample in 
microtitre plates. Then, 50 µl PRV dilution containing 30–300 TCID50, as verified by back-titration of 
the virus dilution, was added to the serum dilution in microtitre plates and incubated for 1 h at 37 °C. 
Thereafter, 100 µl PK15 cell suspension in MEM, supplemented with 10 % FCS, penicillin (1000 U mL-
1), gentamicin (50 µg mL-1) and fungizone (250 ng mL-1), was added to each well and the microtitre 
plates were incubated for 4 days at 37 °C. Plates were then examined under a light microscope for 
the presence of plaques and the neutralizing titre of each serum sample was defined as the highest 
serial dilution that was capable of completely neutralizing the virus. VNT titers from 1/2 are 
considered positive. For each VNT, a negative, weak positive and strong positive reference serum 
was included, and VNTs were only validated if these samples showed the expected values. 
2.4. ELISA 
Serum samples were tested by an ELISA detecting antibodies directed against the gB glycoprotein 
(PrioCHECK PRV gB Antibody ELISA kit; Prionics) following the manufacturer’s instructions. For each 
sample, the sample/positive (S/P) percentage was calculated. Test results were considered negative 
if S/P<50 % and positive if S/P>50 %. 
2.5. qPCR 
Genomic DNA was extracted from the collected organs, serum samples, and vaginal and nasal swabs 
using a QIAamp DNA kit (Qiagen). The spin protocol ‘DNA Purification from Blood or Body Fluids’ was 
used to isolate DNA from serum samples, and nasal and vaginal swabs. For DNA extraction from all 
collected organs, except the tonsils, about 0.5 cm3 tissue was homogenized in 1 mL PBS by adding 
10–15 silicon carbide beads of 1 mm (Biospec Products) and high-speed shaking (4 min, 25 Hz) in a 
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TissueLyser (Qiagen). For homogenization of tonsil samples, about 0.5 cm3 tissue was homogenized 
in 1ml PBS by adding two stainless steel beads of 5 mm (Qiagen) and high-speed shaking (10 min, 30 
Hz) in a TissueLyser. After homogenization of the collected tissues the spin protocol ‘DNA Purification 
from Tissues’ was used to isolate DNA. The collected DNA was then tested for the presence of PRV by 
a qPCR detecting a fragment of the gB (gB-Forw: 5’-ACCACCGGCGCTACTTTAAG-3’; gB-Rev: 5’-
CCTCCAGCAGCGTCAGGTT-3’; gB-probe: FAM-5’-ACGATCAGCACGCGGGTGACC-3’-TAMRA) gene. 
Amplification was done using a FastStart TaqMan Probe Master kit (Roche) and reactions were run 
on a LightCycler 480 (Roche) under the following conditions: initial denaturation at 95 °C for 10 min, 
followed by 45 cycles of 15 s at 95 °C and 45 s at 60 °C, and a final step of 30 s at 40 °C (Verpoest et 
al., 2014a). 
2.6. Sequencing 
A part of the gC gene was sequenced following the protocol described previously (Verpoest et al., 
2014b). Viral DNA was amplified with DyNazyme Ext DNA polymerase (Thermo Fisher Scientific) using 
previously published primers (Hahn et al., 2010; Müller et al., 2010). Approximately 5 ng PCR product 
was used as template for sequencing using the PCR primers described above using a BigDye 
Terminator Sequencing kit (Applied Biosystems). Sequencing reactions were purified with BigDye 
Xterminator reagent and run on a 3130 Genetic Analyzer (Applied Biosystems). The sequences 
obtained from positive serum and swab samples were compared with the previously obtained 
sequences for the wild boar strains BEL24043 and BEL20075 (GenBank accession numbers KF415193 
and KF779458). 
2.7. Statistical analysis  
Fisher’s exact test was used to analyse whether statistically significant differences existed between 
the number of animals in the BEL24043 and BEL20075 group that were found to be positive in the 
different diagnostic tests. Student’s t-test was used to analyse whether differences in the period of 
viraemia and virus shedding existed between animals infected with the different isolates. This was 
done for both inoculated and contact animals. These tests were carried out using SPSS software 
(IBM, Armonk, NY, USA). P<0.05 was considered to be significant. 
Furthermore, a generalized linear mixed model was developed in SAS version 9.2 (SAS, Cary, NC, 
USA) to estimate the transmission rate β for each of the diagnostic tests and strains used. The 
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advantage of this longitudinal model in comparison with other methods used for the estimation of 
transmission parameters, such as the final size model or the transitional state model, is that this 
longitudinal model accounts for the time intervals between observations (van der Goot et al., 2003; 
Velthuis et al., 2007). The parameter log β was estimated by modelling the number of new infections 
upon contact, using the offset function ln(IΔt/N) and complementary log-log function. A back 
transformation of log β was required to obtain β. As the time intervals between sampling were >1 
day, we were unable to determine the exact infectious period, and therefore infectious periods of 1, 
5, 10 and 15 days were simulated. This enabled the calculation of the transmission ratio R0, indicating 
the mean number of secondary infections due to one infected individual, for the different infectious 
time periods (γ) given the strain and diagnostic test used based on the standard Susceptible–
Infectious–Recovered model and using the following formula: R0 = β∙γ. The 95% confidence intervals 
(CIs) were obtained for the parameter log β. The goodness of fit of the model was assessed with 
Akaike’s Information Criterion. The 95% CIs of the parameter R0 were calculated based on the 
following, taking into account the variance (Var) and the estimates (E) of each parameter: 
Var(β∙γ)=E(β)2Var(γ)+E(γ)2Var(β). 
3. Results 
3.1. PRV infection of 15-week-old sows  
3.1.1. Clinical symptoms 
Inoculation of 15-week-old pigs with the NIA3 reference strain quickly led to severe respiratory and 
neurological disease. Starting from 2 days post- inoculation (p.i.), a decrease in the general condition 
of the sows was observed, associated with a rise of rectal body temperature during acute infection 
(≥41 °C in all pigs), and reduced appetite and mobility. At 4 days p.i., the first neurological symptoms 
were observed. One pig exhibited excessive salivation, and another was trembling and showed 
paresis of the hind limbs. Over the next days, respiratory symptoms developed in all pigs and the 
neurological symptoms worsened. Two pigs had to be euthanized at 5 days p.i. and two pigs at 7 days 
p.i. as they developed the typical neurological symptoms associated with Aujeszky’s disease, such as 
scratching, lack of coordination, circling, seizures and paralysis. The remaining two animals were 
euthanized at 14 days p.i. as a result of persistent respiratory symptoms. 
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In contrast, no clinical symptoms were observed when pigs of the same age were inoculated with a 
10-fold higher dose of the wild boar isolates BEL24043 or BEL20075. The general condition of the 
animals, food consumption, mobility and rectal body temperature remained apparently unaffected 
throughout the experiment. The contact animals added to the BEL24043 and BEL20075 infection 
groups also remained unaffected during the entire experiment. 
3.1.2. Viraemia 
Serum samples of all 15-week-old sows inoculated with the different PRV strains and of all the 
contact pigs were tested for the presence of viral DNA by quantitative (q) PCR at several time points 
after inoculation (Figure 1a). All NIA3 and most BEL24043 (5/6) infected pigs became viraemic for at 
least 1 day between 3 and 7 days p.i. Importantly, two of the contact pigs present in the pen with the 
BEL24043-infected sows also developed viraemia, indicating that virus transmission had occurred. In 
contrast, the number of pigs that became viraemic in the BEL20075 group was clearly lower as only 
one serum sample of the inoculated and none of the contact animals became positive. This was, 
however, not significantly different when compared with the BEL24043 group (Fisher’s exact test: 
P=0.080 for inoculated animals and P=0.455 for contact animals). Virus concentrations found in the 
positive serum samples were low but comparable for all strains tested with high cycle threshold (Ct) 
values between 35 and 40 (data not shown). However, the BEL24043-inoculated pigs had a 
significantly (P=0.044) longer viraemia (1.2 days) compared with the BEL20075 infection group (0.2 
days). However, this was not the case when the mean viraemia was compared for the contact 
animals of both groups (P=0.145). 
3.1.3. Nasal and vaginal virus shedding 
qPCR results indicated that 15-week-old pigs already started to shed the NIA3 strain at the nasal and 
vaginal mucosa at 1 and 2 days p.i., respectively, and virus was shed until the day of euthanasia 
(Figure 1b, c). 
Infection with the wild boar isolate BEL24043 resulted in a prolonged nasal and vaginal virus 
excretion starting from 2 and 3 days p.i., respectively, and lasted until 17 days p.i. in some animals. 
Importantly, nasal and genital shedding by all contact animals in this pen evidenced efficient virus 
transmission. Contact animals were already found positive in nasal and genital swabs 2 days after 
introduction in the pen. Interestingly, the first positive vaginal swabs for both the inoculated and the 
contact sows were found at 3 days p.i. These positive vaginal swabs in contact animals were likely the 
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result of nose-to-vagina contact with pigs that nasally shed the virus. This is supported by the fact 
that the initial Ct values found in vaginal swabs of the contact animals were very high (data not 
shown) and only decreased later on. 
A completely different shedding pattern was observed in pigs inoculated with the wild boar isolate 
BEL20075. Only two nasal swabs from two different pigs were found to be positive for viral DNA by 
qPCR. Sequencing of the gC fragment present in those samples confirmed that the positive PCR signal 
resulted from infection with the BEL20075 strain and excluded the possibility that they resulted from 
contamination or transmission of the NIA3 or BEL24043 strain. Although, the number of inoculated 
animals that shed the virus nasally in the BEL20075 group was lower compared with the BEL24043 
group, this difference was again not statistically significant (P=0.061) in Fisher’s exact tests. The 
period of nasal shedding was, however, significantly longer for both the inoculated and contact 
 
Figure 1: qPCR analysis of (a) serum, (b) nasal and (c) genital swabs after inoculation of 15-week-old sows 
with different PRV strains. Six 15-week-old sows were intranasally inoculated with different PRV isolates: the 
virulent NIA3 reference strain, the wild boar isolate BEL24043 and the wild boar isolate BEL20075. At 1 day p.i., 
six susceptible contact sows were added to the pens with animals inoculated with the wild boar strains. The 
number of surviving pigs over time is indicated by the grey line, and the number of pigs that tested positive by 
qPCR in serum, nasal and genital swabs over time is indicated for every infection group (black bars) as well as 
their contact animals (grey bars). 
(a) 
(b) 
(c) 
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animals of the BEL24043 group (mean nasal shedding period of 10.7 and 11.8 days, respectively) 
compared with the BEL20075 group (mean nasal shedding period of 0.3 and 0 days, respectively) 
(P<0.001 for both the infected and contact animals). 
All genital swabs from the BEL20075 infection group remained negative, and no evidence for virus 
transmission to contact pigs was found for this virus strain based on qPCR analysis of both nasal and 
genital swabs. 
3.1.4. Antibody response: PRV-specific antibodies 
The development of PRV-specific antibodies was followed up over time by ELISA and virus 
neutralization tests (VNT) (Figure 2). In 15-week-old pigs, PRV-specific antibodies were detected by 
ELISA in all remaining NIA3-infected pigs at 7 days p.i., whilst VNT results only became positive at 10 
days p.i. In the BEL24043-infected group, antibodies were first detected at 10 days p.i. both by ELISA 
and VNT. An antibody response was also detected in the contact pigs of the BEL24043-infected group 
starting from 14 and 17 days p.i. by the use of ELISA and VNT, respectively. In contrast, no antibodies 
were detected by VNT in the serum samples of animals inoculated with the wild boar isolate 
BEL20075 nor in their contact animals. However, ELISA results revealed the presence of PRV-specific 
antibodies in three BEL20075-infected pigs and in one of their contact animals from 10 and 21 days 
p.i., respectively. This resulted in a significant higher number of VNT-positive animals in the 
BEL24043-infected and contact animals compared with the BEL20075 group (P=0.002 and 0.002, 
respectively). When the presence of antibodies was compared by ELISA, however, this difference was 
only significant for the contact animals (P=0.015), but not for the infected animals (P=0.182). 
3.1.5. Virus detection in organs collected at euthanasia by qPCR 
Important differences were found in the distribution of the strains over the different organs at the 
time of euthanasia. It should, however, be kept in mind that NIA3-infected animals were euthanized 
during acute infection, whilst pigs infected with the wild boar strains were euthanized at 28 days p.i. 
For NIA3-inoculated pigs, tonsil and brain samples of all pigs, and lung, kidney, liver and spleen of 
some pigs, tested positive. For the BEL24043-inoculated pigs, tonsils of all animals, and spleen and 
brainstem of one and two animals, respectively, were still positive at 28 days p.i. Transmission of the 
BEL24043 strain was evidenced by the detection of viral DNA in tonsils of five out of six contact 
animals. In contrast, none of the organs collected from BEL20075-inoculated pigs or their contact 
pigs tested positive. 
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Figure 2. Seroconversion of 15-week-old sows after inoculation with different PRV strains by (a) VNT and (b) 
ELISA. Six 15-week-old sows were intranasally inoculated with different PRV isolates: the virulent NIA3 
reference strain, the wild boar isolate BEL24043 and the wild boar isolate BEL20075. At 1 day p.i., six 
susceptible contact sows were added to the pens with animals inoculated with the wild boar strains. The 
number of surviving pigs over time is indicated by the grey line with square dots. (a) The number of pigs that 
tested positive by the VNT over time is indicated for the infected (black bars) and contact animals (grey bars). 
The black and grey line with circular dots shows the mean virus neutralization titre for both groups, 
respectively. (b) The number of ELISA-positive pigs is indicated for both the infected (black bars) and contact 
animals (grey bars). 
3.1.6. Transmission ratios for wild boar PRV isolates 
For both wild boar strains, the transmission rate β was calculated based on the results obtained with 
the different diagnostic tests. The transmission rate β enables the calculation of the reproductive 
ratio R0 that indicates the mean number of secondary infections due to one infected individual, 
depending on the infectious period. As time intervals between sampling points were irregular in this 
study, no exact calculation of the infectious period could be done. Therefore, we calculated the 
reproductive ratios for hypothetical infectious periods of 1, 5, 10 and 15 days (Table 1). 
However, based on the mean period of nasal shedding detected by qPCR, we can estimate the 
infectious period. For the wild boar isolate BEL24043, our study indicated that nasal shedding lasted 
for a mean of 10.7 and 11.8 days for the inoculated and contact animals, respectively. Therefore, 
based on an infectious period of a minimum 10 days, a reproductive ratio R0>1 was found for all 
diagnostic tests used, indicating that introduction of the BEL24043 strain in a domestic swine 
population would result in a sustained infection (Table 1). However, results were only significantly 
(a) 
(b) 
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different for the reproductive ratio R0 based on ELISA and nasal swabs. The statistical analysis shows 
that the reproductive ratio associated with qPCR results found in genital swabs was not reliable as 
the first positive swabs in the inoculated and the contact sows were both found at 3 days p.i., as 
described above. Seeing that the differences in reproductive ratios were dependent on the 
diagnostic test used, it was decided to also determine an overall reproductive ratio, taking into 
account all tests. Thereby, an animal was considered positive once it had scored positive in one of 
the tests. The transmission ratio simulated for an infectious period of 10 days and its 95% confidence 
intervals were far above unity, confirming that a reintroduction of this strain would result in a 
sustained infection. 
 
Table 1. Transmission parameters for the wild boar isolates BEL24043 and BEL20075 in domestic pigs. Six 15-
week-old sows were intranasally inoculated with the wild boar PRV isolates BEL24043 and BEL20075. At 1 day 
p.i., six susceptible contact sows were added to the pens. The transmission rate ϐ [95 % confidence interval 
(CI)] was estimated using a generalized linear mixed model for the different diagnostic tests to detect virus 
transmission to contact animals. As time intervals between sampling periods were .1 day, the reproductive rate 
R0 (95 % CI) was simulated for different infectious periods of 1, 5, 10 and 15 days. For the wild boar strain 
BEL20075 it was impossible to calculate transmission parameters for VNT, and virus detection in serum, nasal 
and genital swabs, as no transmission of the virus could be observed based on these diagnostic tests. 
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As no transmission of the wild boar strain BEL20075 to contact animals was observed based on the 
VNT and qPCR analysis of serum, nasal and genital swabs, no transmission parameters could be 
calculated based on these tests. Transmission was only detected by ELISA where one of the contact 
animals became positive. Based on nasal shedding as detected by qPCR, it could be assumed that 
virus shedding occurs for a maximum of 1 day for both the inoculated and the contact animals. This 
corresponds to a reproductive ratio R0 of 0.10. This is <1, indicating that a reintroduction of this 
strain will probably not lead to a sustained infection in the population. 
3.2. PRV infection of 2-week-old piglets 
Inoculation of 2-week-old piglets with the NIA3 reference strain led to general depression of all 
piglets, associated with severe diarrhoea and vomiting. The animals exhibited complete exhaustion 
and were unable to stand up, so that neurological symptoms could only be observed to a limited 
extent. All piglets were euthanized at 3 or 4 days p.i. Interestingly, infection with the wild boar isolate 
BEL24043 also induced respiratory and neurological disease in 2-week-old piglets. The symptoms 
were, however, less severe than after NIA3 infection and only one piglet had to be euthanized at 6 
days p.i. based on ethical grounds. 
Four of the six piglets infected with NIA3 were found to be viraemic by qPCR for at least 1 day at 3 
and 4 days p.i. (Table 2). After inoculation with the BEL24043 strain, only serum from two piglets 
tested positive at 7 and 10 days p.i., respectively. The NIA3-infected piglets had to be euthanized 
before the antibody response developed. In the BEL24043-infected piglets, neutralizing antibodies 
were detected from 10 days p.i. by the VNT. Virus excretion occurred both at the nasal and genital 
mucosa after infection with both strains. Analysis of the organs collected at euthanasia showed that 
NIA3 had spread to the tonsils, lung and brain of all piglets, and also to the kidney, spleen and liver of 
most of them. As the general condition of BEL24043-infected piglets improved from 5 days p.i. 
onwards, we decided to euthanize the remaining piglets at 7 (piglets 2 and 3), 10 (piglet 4), 14 (piglet 
5) and 21 (piglet 6) days p.i. to study the spread of the virus to the organs over time. qPCR showed 
that the BEL24043 strain had spread to the brain of all piglets, but that the spread to the other 
organs had occurred to a lesser extent than in NIA3-infected piglets. BEL24043 was found in three 
lungs, two tonsils and one kidney, but not in liver and spleen.  
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Table 2. Inoculation of 2-week-old piglets with different PRV strains. Six 2-week-old piglets were intranasally 
inoculated with the virulent NIA3 reference strain or the wild boar isolate BEL24043. The presence of viral DNA 
detected by qPCR in serum samples, nasal and genital swabs over time is shown, together with the results of 
the VNTs. Furthermore, the results of virus detection by qPCR in different organs collected at the moment of 
euthanasia are indicated.  
4. Discussion 
Based on previous experimental infection studies and field observations, an attenuated nature of 
wild boar strains has been assumed (Hahn et al., 1997; Müller et al., 2001). Our study partly confirms 
these results, as no clinical symptoms were observed after inoculation of 15-week-old domestic pigs 
with two different Belgian wild boar strains using a relatively high inoculation dose. As it is known 
that mortality and morbidity associated with PRV infection are age dependent, and more severe 
symptoms are expected in younger piglets, we also infected 2-week-old piglets with one of the wild 
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boar PRV strains. This infection induced a fast deterioration of their general condition and severe 
neurological symptoms. This interesting observation indicates that the known age dependency for 
symptoms upon infection with PRV strains circulating in domestic pigs also holds true for wild boar 
PRV isolates. This had been suggested previously by Hahn et al. (1997). Importantly, however, in 
contrast to an infection with the NIA3 strain, most piglets recovered after some days. In addition to 
the induction of respiratory and neurological symptoms in young piglets, it cannot be excluded that 
wild boar PRV isolates might also be able to induce reproductive disorders as described for strains 
from domestic pigs (Pomeranz et al., 2005), but this was not evaluated in this study. 
Apart from the potential direct production losses due to induced clinical disease, it is important to 
underline the observation that wild boar PRV strains are able to induce seroconversion of domestic 
pigs, as has also been shown in previous infection studies (Hahn et al., 1997; Müller et al., 2001). This 
could compromise the Aujeszky’s disease-free state of a country and lead to important economic 
consequences. Efficient monitoring seems crucial for the early detection of a potential reintroduction 
as the absence of clinical symptoms after infection with the wild boar PRV strains, as observed in this 
study, could allow the virus to spread unnoticed within the population. This is further emphasized by 
the fact that one of our tested isolates was capable of inducing a sustained infection upon 
introduction into a population of naive domestic pigs. It seems advisable that monitoring should 
especially focus on farms with free-ranging facilities, associated with an elevated risk of contact 
between wild boars and domestic pigs. 
Our results indicate that qPCR analysis of nasal swabs represents the most efficient method for PRV 
detection during an acute outbreak, allowing more sensitive virus detection over a longer time 
period than PCR analysis in serum samples. This, in combination with the serological screening of 
serum samples by ELISA, seems to be the most efficient way to rapidly detect a reintroduction of a 
wild boar strain in the domestic population. It had already been shown that ELISA is more sensitive 
than the VNT to detect PRV-specific antibodies (Müller et al., 2001) and this was further confirmed in 
this study. However, individual sampling of animals remains labour intensive and the use of group 
sampling methods, such as saliva collection based on ropes, for the detection of both virus and 
antibodies could provide an easier and cheaper method for surveillance and screening against PRV, 
but still needs to be validated for this virus. 
An important difference in infection and transmission capacity between both wild boar strains was 
observed. BEL24043 caused amore prolonged and disseminated infection in inoculated animals and 
spread more efficiently to contact pigs than the BEL20075 strain. This difference in virulence was 
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somewhat surprising as both strains belong to clade B in the PRV phylogeny, and are supposed to be 
representative for strains circulating within south-western and central Europe (Verpoest et al., 
2014b). The reason for these differences remains unknown and future sequencing studies will be 
required to reveal if genomic differences in regions outside the gC region exist that could provide an 
explanation for the reduced virulence of the BEL20075 strain. Furthermore, if cannot be excluded 
that the less efficient infection observed for the BEL20075 strain could be due to the choice of an 
intranasal infection route as it has been suggested that transmission of feral isolates can also occur 
through the venereal route (Romero et al., 1997, 2001), as opposed to domestic swine strains where 
transmission usually occurs by the oropharyngeal route after direct contact of infected and 
susceptible animals, and the ingestion or aspiration of infected aerosols, secretions and excretions 
(Pomeranz et al., 2005). Our results with the BEL24043 strain, however, clearly show that 
transmission of wild boar PRV isolates between domestic pigs can occur efficiently via the 
oropharyngeal and respiratory route. Interestingly, despite the apparent differences in in vivo 
virulence between both wild boar isolates, no differences were found in their in vitro growth and 
plaque-forming characteristics, and their sensitivity to type I and II IFNs (Verpoest et al., 2016b). 
The observed differences in virulence between both wild boar isolates belonging to clade B suggest 
that it might also be interesting to evaluate the virulence of strains belonging to clade A (Verpoest et 
al., 2014b) as those are genetically more diverse and cluster together with strains originating from 
domestic swine. 
5. Conclusion 
In conclusion, to the best of our knowledge this is the first study to show the attenuated nature of 
two genetically characterized isolates representative for strains circulating in south-western and 
central Europe in adult domestic pigs. Despite the absence of clinical symptoms upon inoculation, 
clear differences in virulence were observed between both strains. One strain was capable of 
inducing seroconversion and was efficiently transmitted to contact animals. Furthermore, the same 
isolate was capable of inducing severe clinical symptoms upon inoculation in 2-week-old piglets, 
thereby confirming that the known age dependency on the outcome of infection with PRV isolates 
from domestic pigs also holds true for wild boar strains. This had not been shown before for strains 
circulating in this population. Despite the fact that reports of PRV transmission from wild boars to the 
domestic population are rare, the current report thus indicates that a potential reintroduction could 
have serious economic consequences. 
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Abstract  
Pseudorabies virus (PRV) is the causative agent of Aujeszky’s disease. Infection in its natural host, the 
pig, causes respiratory, reproductive and neurological symptoms. Morbidity and mortality associated 
with PRV infection are dependent on the age of the pig and the virulence of the strain. During this 
study domestic pigs of 2- and 15-week-old were inoculated with the PRV strain NIA3 or the wild boar 
strain BEL24043. The presence of viral DNA and mRNA and the cytokine-related mRNA expression 
were analysed to provide more insight into the general PRV pathogenesis and to provide possible 
explanations for the observed age- and strain-dependent differences in virulence.  
Besides confirmation of the general knowledge on PRV pathogenesis by qPCR analysis of viral DNA in 
different organs, several new findings sorted from the detailed study of viral and cytokine mRNA 
expression at important sites of neuropathogenesis. First, only limited viral and cytokine associated 
mRNA expression was found in the nasal mucosa after infection of 2- and 15-week-old pigs with 
either strain, which might indicate that other sites of primary replication are favoured. Secondly, 
extensive viral replication associated with a robust expression of cytokine mRNA was detected in the 
olfactory bulb of pigs of both age categories after NIA3 infection, which seems to be linked with the 
neurological symptoms observed in pigs of both age categories.  
A potential explanation for the differences in clinical symptoms and mortality in 2-week-old-piglets 
and 15-week-old pigs can be found in the observation that upon infection with the NIA3 strain, viral 
replication was more extensive and more consistent in 2-week-old pigs compared to 15-week-old 
pigs in the TG and pons on the one hand and in the olfactory bulb on the other hand.  
Last, interesting differences in pathogenesis were found when comparing the NIA3 strain and the 
wild boar strain, which was shown to be attenuated in adult pigs, but induces important clinical 
disease in young piglets. The capacity of the wild boar strain to spread systemically to visceral organs 
was impaired in pigs of both age categories. Furthermore, whereas neuroinvasion was hindered in 
15-week-old pigs, very efficient spread to the CNS via both the trigeminal and the olfactory route was 
observed in all 2-week-old piglets inoculated with the wild boar strain. The underlying mechanisms 
for these strain-dependent differences in capacity for systemic and/or neuroinvasion remain 
however unclear.  
Chapter 6: Age- and strain-dependent differeences in PRV neuropathogenesis 
 
 
98 
 
1. Introduction 
Pseudorabies virus (PRV), also called suid herpesvirus 1 or Aujeskzy’s disease virus, is the causative 
agent of the economically important Aujeskzy’s disease in swine. PRV belongs to the family 
Herpesviridae, subfamily Alpaherpesvirinae, genus Varicellovirus. Members of the family Sus scrofa 
are the natural host and reservoir of the virus. 
The current knowledge on PRV pathogenesis in its natural host, the pig, is mostly based on studies 
performed in the 70’ to 90’s of the twentieth century that mainly used virus isolations and 
immunohistochemistry (IHC) stainings for virus detection. It is generally accepted that PRV infection 
starts with local replication in epithelial cells of the nasal and oral cavities, whereafter the virus can 
cross the basement membrane and invade the underlying lamina propria (Kritas et al., 1994a; Pol et 
al., 1989; Sabó et al., 1968, 1969; Wittmann et al., 1980). Via blood and lymph, PRV can spread to 
internal organs, either as cell-free virus or cell-associated virus in leukocytes (Nauwynck & Pensaert, 
1995b). Infection of sensory neurons innervating the infected epithelium, i.e. the trigeminal and 
olfactory nerves, enables the virus to invade the central nervous system (CNS). PRV can enter the 
trigeminal ganglion (TG) via retrograde transport through the trigeminal nerve and spread further 
into the sensory trigeminal nerve nuclei in the pons and medulla oblongata. From there on, virus can 
invade the thalamus, cerebellum and cerebral cortex via interneuronal transmission (Kritas et al., 
1994a). Entry of PRV into the CNS may also occur via the olfactory route by infection of olfactory 
neurons located in the nasal cavity mucosa after which virus can reach the second-order neurons 
located in the olfactory bulb (Kritas et al., 1994b). Replication in the upper respiratory tract, the CNS, 
and the reproductive organs, is responsible for the respiratory, nervous and reproductive symptoms, 
respectively (Nauwynck et al., 2007). 
A key characteristic of PRV infection is that the virus can go into a dormant state, called latency. PRV 
latency is predominantly established in neurons of the TG (Gutekunst et al., 1980). During productive 
infection, viral genes are transcribed in a temporally ordered sequence consisting of three major 
classes of transcripts (immediate-early, early, and late genes) (Ben-Porat & Kaplan, 1985; Pomeranz 
et al., 2005). Latency on the other hand is characterized by the presence of the viral genome as an 
episome in the cell without the production of infectious virus particles. The only transcripts that are 
detectable during latency are the specific latency-associated transcripts (LATs) (Cheung, 1991). Upon 
reactivation, which is often correlated with physical stress, new virus particles may be produced in 
neurons and transported back to the periphery, causing recurrent spread and transmission to contact 
animals (van Oirschot & Gielkens, 1984). Whether or not latency is established in the TG is generally 
accepted to depend on a complex interplay between the neuronal environment, the virus and the 
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immune system (Divito et al. 2006). Latency induction and maintenance of HSV-1 is rather well 
studied. Studies in mice have suggested that the innate immune response is primarily responsible for 
controlling early HSV-1 replication in the TG following primary infection. On the other hand, the 
adaptive immune response with in particular CD8+ T cells, is involved in the maintenance of latency 
(Allen et al., 2011; Egan et al., 2013). For PRV, little is known about the mechanisms involved in the 
establishment and maintenance of latency. An in vitro study in primary porcine TG neurons has 
reported that treatment of porcine TG neurons with IFN-α is sufficient to induce a quiescent PRV 
infection that shows strong similarities to in vivo latency (De Regge et al., 2010). Furthermore, a 
recent study indicated that treatment of axon endings of rat superior sacral ganglion neurons in an in 
vitro compartmentalized three chamber model with IFN-β or IFN-γ restricted PRV retrograde 
transport to the cell bodies (Song et al., 2016). This suggests that IFNs may represent a key immune 
component involved in efficient establishment and maintenance of PRV latency in sensory neurons. 
The main factors that can influence the clinical outcome of PRV infection are the age of the infected 
pig and the virulence of the PRV strain by which they are infected.  
The severity of the clinical symptoms after PRV is inversely related with the age of the piglets. 
Morbidity and mortality associated with PRV infection are higher in younger pigs, and typically 
associated with symptoms of the CNS. Older swine mostly exhibit symptoms of respiratory and 
reproductive disease. The cause of high mortality in piglets had historically been attributed to viral 
encephalitis (Pomeranz et al., 2005). Furthermore, the virulence of the PRV strain by which the pigs 
are infected greatly influences the clinical outcome of infection. The virulence of PRV strains that 
circulated in domestic pigs had increased significantly in the 1960-80s. Because of its important 
economic impact, eradication campaigns against PRV were set up and have led to the eradication of 
the disease in several European countries. Next to domestic pigs, wild boar also represent a natural 
host and reservoir of the virus. Strains circulating in this population are generally assumed to be less 
virulent than isolates that circulated in domestic swine. Recently, we showed that although a Belgian 
wild boar strain was attenuated in adult pigs, it was capable to induce important respiratory and 
neurological disease in 2-week-old piglets (Verpoest et al., 2016a). The cell biological and molecular 
basis for these differences in virulence between strains of domestic pigs and wild boar remains 
however unknown.  
To study the neuropathogenesis of PRV in its natural host, an in vivo infection experiment was 
performed wherein domestic pigs of 2- and 15-week-old were inoculated with the PRV-reference 
strain NIA3 or the wild boar strain BEL24043. Virus spread and replication were studied using qPCR, 
qRT-PCR and immunofluorescence stainings. It was further evaluated whether local cytokine 
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production correlated with observed virus replication and spread and whether potential explanations 
could be found for the observed age- and strain-dependent differences in clinical symptoms upon 
infection. 
2. Materials and Methods 
2.1. Animals and viruses 
Thirty-seven 15-week-old and thirty-six 2-week-old Belgian Landrace sows were purchased from a 
commercial swine herd. The sows were in good condition and tested negative in serology for PRV 
and classical swine fever at the beginning of the experiment. The animals were housed in BSL3 
facilities on slatted floors (CODA-CERVA, Machelen). Water was available ad libitum and pigs were 
fed once each day. The animals were randomly assigned to the control or infection group. Animal 
experiments were performed in accordance with the EU and Belgian regulations on animal welfare in 
experimentation. The protocol was approved by the joined ethical committee of CODA-CERVA and 
the Scientific Institute of Public Health Belgium (procedure agreement no. 121017-02).  
The virulent PRV NIA3 reference strain and a Belgian wild boar isolate BEL24043 were used. The wild 
boar isolate was obtained from infected brain tissue of a wolf that had been fed with offal of 
asymptomatic wild boars shot during hunting. The wild boar strain has been genetically characterized 
previously (Verpoest et al., 2014b) and was found to be attenuated in adult pigs, but could still 
induce important clinical disease in young piglets (Verpoest et al., 2016a). A second passage of the 
wild boar strains BEL24043 and a third passage of the NIA3 strain were used. 
2.2. Experimental design 
In the first experiment, nine 15-week-old sows were mock infected with PBS, fourteen sows were 
intranasally inoculated (1 mL/nostril) with the PRV reference strain NIA3 and fourteen sows were 
intranasally inoculated with the wild boar strain BEL24043 via a small nebulizer with a final infectious 
dose of 105 TCID50/animal. The sows were monitored daily for clinical symptoms and rectal body 
temperature. Euthanasia of one pre-defined pig of the control group and two pre-defined pigs of the 
NIA3-inoculated and the BEL24043-inoculated group was foreseen at 1, 2, 3, 5, 7, 14 and 28 days p.i.. 
Two additional pigs of the control group were euthanized at 0 days p.i.. During the experiment, 
animals were euthanized at the intended date or when necessary based on ethical grounds. At 
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euthanasia, blood and several tissues (nasal mucosa, tonsils, lung, kidney, liver, spleen, olfactory 
bulb, TG, pons, cerebellum and cerebrum) were collected using new disposable scalpels and forceps 
per tissue sample to eliminate the risk of cross contamination.  
In the second experiment, twelve and sixteen female 2-week-old piglets were intranasally inoculated 
via a small nebulizer (0.5 mL/nostril) with a final infectious dose of 105 TCID50/animal of the NIA3 
reference strain and the wild boar strain BEL24043, respectively. Eight piglets were mock-inoculated 
with PBS and held as a negative control group. Piglets were monitored daily for clinical symptoms 
and rectal body temperature. Euthanasia of one pre-defined pig of the control group and two pre-
defined pigs of the NIA3-inoculated group was foreseen at 1, 2, 3, 4, 5 and 7 days p.i.. Two additional 
pigs of the control group were euthanized at 0 days p.i. Seen the expected low virulence of the 
BEL24043 strain, extra piglets were foreseen to euthanize at 14 and 21 days p.i.. During the 
experiment, animals were euthanized at the intended date or when necessary based on ethical 
grounds. Same samples as for 15-week-old pigs were collected at the moment of euthanasia.  
2.3. Sample preparation and DNA extraction  
For all collected organs, except tonsils, about 0.5 cm³ of tissue was homogenized in 1 mL phosphate 
buffered saline (PBS) by adding 10–15 silicon carbide beads of 1 mm (Biospec Products Inc) and high 
speed shaking (4 min, 25 Hz) in a TissueLyser (Qiagen). For homogenization of tonsil samples, about 
0.5 cm³ of tissue was homogenized in 1 mL PBS by adding 2 stainless steel beads of 5 mm (Qiagen) 
and high speed shaking (10 min, 30 Hz) in a TissueLyser. For the 2-week-old piglets, homogenization 
of samples was done in only 0.5 mL of PBS because of the limited amount of sample available. 
Genomic DNA was extracted from the homogenized tissues using the QiAmp DNA kit (Qiagen) 
following manufacturer’s instructions. 
2.4. RNA extraction and cDNA synthesis 
Extraction of total RNA from the homogenized tissue preparations was done by the RNeasy Mini kit 
(Qiagen) following manufacturer's instructions. Extracted total RNA was treated with Turbo DNase 
(Ambion) following manufacturer's instructions in a 50 µL reaction to eliminate contaminating DNA. 
Subsequently DNase treated RNA samples were converted to cDNA using the M-MLV reverse 
transcriptase system (Life Technologies). For each reaction, a mix of 4 μl RNA , 4 μl 5× first strand 
buffer, 2 μl 0.1 M DTT, 1 μl 10 nM dNTP mix (Roche, Basel, Switzerland), 0.2 μl 10× hexanucleotide 
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mix (Roche, Basel, Switzerland), 0.5 μl M-MLV RT and 8.3 μl H2O was prepared and incubated at 37 °C 
for 60 min, followed by inactivation at 95 °C for 10 min. 
2.5. Preamplification 
A preamplification step of the cDNA was done using the TaqMan PreAmp Master Mix (Applied 
Biosystems) following manufacturer’s instructions to increase the amount of available material. A 
mix of primers (Table 1) for the selected reference genes, cytokines and viral genes (except IE180 and 
EP0) was made to a final concentration of 0.18 µM per primer. A separate mix containing only the 
reverse primers for the IE180 and EP0 gene was made since these genes mostly overlap with the 
oppositely transcribed large latency transcript (LLT). Preamplification reaction conditions involved 
the amplification of 12.5 μl cDNA in a 50 μl reaction consisting of 25 μl TaqMan PreAmp Master Mix 
and 12.5 μl pooled assay mix. Pre-amplification consisted of 14 cycles on a Thermocycler (Biometra) 
with the following program: denaturation at 95°C for 10 min and 14 cycles of amplification (15 sec at 
95°C, 4 min at 60°C). The preamplified products were diluted at a ratio 1:10 and used as templates 
for the real-time qPCR analysis. 
The preamplification uniformity of the different target sequences was checked according to the 
manufacturer’s protocol. Reference samples for the different tissues (nasal mucosa, TG and CNS 
tissues) were tested in duplicate before and after preamplification for the different reference genes, 
viral genes and cytokines. Subsequently, PreAmp uniformity values related to the reference genes 
ACTB, GADPH, PPIA, UBC were calculated. Therefore, the normalized Ct values were calculated for 
the different target genes before (cDNA) and after preamplification (PreAmp) according to the 
following formulas: ΔCt [cDNA] = average Ct [cDNA target gene] - average Ct [cDNA reference gene] 
and ΔCt PreAmp = average Ct [PreAmp target gene] - average Ct [PreAmp reference gene], 
respectively. The ΔΔCt was determined by the difference of the two ΔCts: ΔΔCt = ΔCt [PreAmp] - ΔCt 
[cDNA]. A ΔΔCt close to zero indicates ideal PreAmp uniformity and a range of PreAmp uniformity 
values between -1.5 and +1.5 is acceptable. The mean PreAmp uniformity for the investigated gene 
assays in nasal mucosa tissue related to the reference genes ACTB, GADPH, PPIA and UBC was -0.38 ± 
0.47, 0.48 ± 0.47, 0.24 ± 0.47 and 0.64 ± 0.47, respectively. The mean PreAmp uniformity for the 
investigated gene assays in TG tissue related to the reference genes ACTB, GADPH, PPIA and UBC was 
-0.39 ± 0.96, 0.25 ± 0.65, 0.71 ± 0.96 and 0.95 ± 0.96, respectively. The mean PreAmp uniformity for 
the investigated gene assays in CNS tissue related to the reference genes ACTB, GADPH, PPIA and 
UBC was -0.53 ± 0.76, 0.40 ± 0.62, 0.58 ± 0.76 and 0.57 ± 0.76, respectively. Depending on the tissue 
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tested and reference gene used, the individual PreAmp uniformity values for the gE and IL1α assay 
slightly exceeded 1.5 but were accepted for this study. 
2.6. Quantitative real-time PCR (qPCR) assay design and analysis 
Primer and probes for seven porcine reference genes (ACTB, B2M, GADPH, HPRT1, PPIA, SDHA and 
UBC), eleven cytokines (IFN-α, IFN-β, IFN-γ, TNF-α, IL1α, IL1β, IL2, IL4, IL6, IL8 and IL10) and six PRV 
genes (IE180, EP0, gB, gC, gE, LAT intron) were either selected from previous studies (Calzada-Nova 
et al., 2011; Duvigneau et al., 2005; Erkens et al., 2006; Petrov et al., 2014) or designed using the 
Primer Quest tool (Integrated DNA Technologies, Belgium). Porcine sequences available in the NCBI 
databases were used to design qPCR assays, taking into account the amplicon specificity of the 
primers (Blast). The synthesis of oligonucleotides was carried out by IDT. All probes were labelled 
with 6-Carboxyfluorecein (FAM). Sequences and corresponding references are shown in table 1. A 
dilution series of a reference sample was tested for each gene to acquire PCR efficiencies and 
associated standard errors using the qBasePlus software (Biogazelle).  
The real-time PCR reactions were performed in a final volume of 20 μl, containing 5 μl DNA or cDNA, 
10 μl FastStart TaqMan Probe Master Mix 2x (Roche), 1 μl probe (final concentration 0.25 μM), 1 μl 
of a mix containing the forward and reverse primer (both primers at a final concentration 0.9 μM) 
and 3 µL H2O. The following real-time RT-PCR temperature cycle was applied: denaturation by a hot 
start at 95°C for 10 min, followed by 45 cycles of denaturation at 95°C for 15 sec and 
annealing/extension at 60°C for 45 sec. All experiments were performed in duplicate on a LightCycler 
480 Real-Time PCR system (Roche, Basel, Switzerland). In all qPCR analyses performed, negative 
extraction controls and negative and positive amplification controls were included and tests were 
only validated when all controls were satisfactory.  
2.7. Construction of a standard curve for qPCR for the glycoprotein B (gB) assay 
A gB DNA standard curve was constructed for absolute quantification of viral DNA present in the 
different tissues. A plasmid containing part of the gB sequence was 10-fold serially diluted resulting 
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Tabel 1: Primer and probes. Primer and probes for seven porcine reference genes, eleven cytokines and six PRV genes were either selected from previous studies or 
designed using the Primer Quest tool.   
Reference genes 
Abbreviation Gene Forward primer Reverse primer Taqman probe Reference 
ACTB 
 
β-actin AGCGCAAGTACTCCGTGTG CGGACTCGTCGTACTCCTGCTT TCGCTGTCCACCTTCCAGCAGATGT (Petrov et al., 2014) 
B2M 
 
β-2-microglobulin AAACGGAAAGCCAAATTACC ATCCACAGCGTTAGGAGTGA AGAAGATGAACGCGGAGCAGTCAG 
Primers: (Erkens et al., 2006) 
Probe: Primerquest 
GADPH 
 
glyceraldehyde-3-phosphate-
dehydrogenase 
ACATGGCCTCCAAGGAGTAAGA GATCGAGTTGGGGCTGTGACT CCACCAACCCCAGCAAGAGCACGC (Petrov et al., 2014) 
HPRT1 
 
hypoxanthine 
phosphoribosyltransferase 1 
GTGATAGATCCATTCCTATGACTGTAGA TGAGAGATCATCTCCACCAATTACTT ATCGCCCGTTGACTGGTCATTACAGTAGCT (Duvigneau et al., 2005) 
PPIA 
 
peptylpropyl isomerase A of 
cyclophilin A 
TGCTTTCACAGAATAATTCCAGGATTTA GACTTGCCACCAGTGCCATTA TGCCAGGGTGGTGACTTCACACGCC (Duvigneau et al., 2005) 
SDHA 
 
succinate dehydrogenase complex, 
subunit A, flavoprotein 
GAACCGAAGATGGCAAGA CAGGAGATCCAAGGCAAA CTGCACACGTTGTACGGAAGGTCT 
Primers: (Erkens et al., 2006) 
Probe: Primerquest 
UBC 
 
ubiquitin C GCGCACCCTGTCTGACTACA AGATCTGCATCCCACCTCTGA AGTCCACCCTGCACCTGGTCCTCC (Calzada-Nova et al., 2011) 
Cytokines 
Abbreviation Gene Forward primer Reverse primer Taqman probe Reference 
IFNα 
 
interferon alpha TGGTGCATGAGATGCTCCA GCCGAGCCCTCTGTGCT CAGACCTTCCAGCTCT (Petrov et al., 2014) 
IFNβ 
 
interferon beta AGCAGATCTTCGGCATTCTC GTCATCCATCTGCCCATCAA TAGCACTGGCTGGAATGAAACCGT PrimerQuest 
IFNγ 
 
interferon gamma CGATCCTAAAGGACTATTTTAATGCAA TTTTGTCACTCTCCTCTTTCCAAT ACCTCAGATGTACCTAATGGTGGACCTCTT (Duvigneau et al., 2005) 
TNFα 
 
tumor necrosis factor alpha AACCTCAGATAAGCCCGTCG ACCACCAGCTGGTTGTCTTT CCAATGCCCTCCTGGCCAACG (Petrov et al., 2014) 
IL1α 
 
interleukin 1 alpha GTGCTCAAAACGAAGACGAACC CATATTGCCATGCTTTTCCCAGAA TGCTGAAGGAGCTGCCTGAGACACCC (Duvigneau et al., 2005) 
IL1β 
 
interleukin 1 beta GTGCTGGCTGGCCCACA GAACACCACTTCTCTCTTCA CTCTCCACCTCCTCAAAGGG (Petrov et al., 2014) 
IL2 
 
interleukin 2 TGCTGATCTCTCCAGGATGC CCTCCAGAGCTTTGAGTTCTTCTACTA AAGCAGGCTACAGAATTGAAACACCTT (Petrov et al., 2014) 
IL4 
 
interleukin 4 GTCTGCTTACTGGCATGTACCA GCTCCATGCACGAGTTCTTTCT CCACGGACACAAGTGCGACATCACCTTAC (Petrov et al., 2014) 
IL6 
 
interleukin 6 CTGGCAGAAAACAACCTGAACC TGATTCTCATCAAGCAGGTCTCC TGGCAGAAAAAGACGGATGC (Petrov et al., 2014) 
IL8 
 
interleukin 8 AAGCTTGTCAATGGAAAAGAG CTGTTGTTGTTGCTTCTCAG TCTGCCTGGACCCCAAGGAAAAGT (Petrov et al., 2014) 
IL10 
 
interleukin 10 CGGCGCTGTCATCAATTTCTG CCCCTCTCTTGGAGCTTGCTA AGGCACTCTTCACCTCCTCCACGGC (Duvigneau et al., 2005) 
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Viral genes 
Abbreviation Gene Forward primer Reverse primer Taqman probe Reference 
IE180 
 
immediate-early 180 GAAGCGGGCGAGAGAAAT GGGATTTCGCGAACTT TCGCGAGGACCATTTGCATGC PrimerQuest 
EP0 
 
early protein 0 TTTGACATATCGGCGCAGT AGAGTGTGCCTCGGACT ATGAGCCACCAGGGTGTGAACTAT PrimerQuest 
gB 
 
glycoprotein B ACCACCGGCGCTACTTTAAG CCTCCAGCAGCGTCAGGTT ACGATCAGCACGCGGGTGACC PrimerQuest 
gC 
 
glycoprotein C CTTCGAGGTCCGCTTCTAC TTGGCGGAGCTGAAGAG CCGAGTACTTTGACGAGCCC PrimerQuest 
gE 
 
glycoprotein E GCTTCCACTCGCAGCTCTTCT GATGCAGGGCTCGTACACGTA CCGCGCGTGGTCTCGGACA PrimerQuest 
LAT intron 
intron of latency associated 
transcript 
CTTCTTCACACGGAGGACAC AAGCCACGCTGATACTCTTG ATGGGCAGCAGATGGTACGGTC PrimerQuest 
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in a dilution series from 5 × 109 to 5 × 10−1 copies/μl. All dilutions were tested in the qPCR described 
above. Three independent replicates were run, mean values of each dilution were calculated and a 
standard curve was constructed by plotting the Ct values against the log of the input DNA copy 
number.  
2.8. geNorm analysis and relative quantification 
A pilot study was set up to identify the best set of reference genes to be used for normalization of 
qPCR data (Hellemans & Vandesompele, 2014). Ten, fifteen or eleven representative samples of 
nasal mucosa, TG or CNS tissue samples, respectively, were selected and analyzed for seven porcine 
reference genes. The obtained data were analyzed using the geNorm application available in 
qBasePlus software (Biogazelle). The geNorm application ranks genes according to their stability and 
determines the optimal number of reference genes required for the calculation of a reliable 
normalization factor. This pilot study determined the most suitable and required number of 
reference genes for the different tissues: UBC and GADPH for nasal mucosa samples, ACTB, GADPH 
and PPIA for TG samples, and UBC and PPIA for CNS samples. 
The quantification and normalization of results were based on the calculation of target Ct values and 
reference gene Ct values in qBasePlus software (Biogazelle). All samples were run in duplicate for the 
target and reference genes. Relative expression levels were normalized with respect to the selected 
reference genes, and to technical and experimental errors. Relative expression quantification 
analysis relied on the qBase method (Hellemans et al., 2007). Individual cytokine levels for all animals 
were expressed relative to the average of the control group (separately for 2- and 15- week old 
animals). Viral gene levels were expressed relative to the lowest positive sample for each age 
category. 
2.9. Enzyme-linked immunosorbent assay (ELISA) 
Serum samples collected at the day of euthanasia were tested by an ELISA detecting antibodies 
directed against the gB glycoprotein (PrioCHECK PRV gB Antibody ELISA kit; Prionics) following the 
manufacturer’s instructions. For each sample, the sample/positive (S/P) percentage was calculated. 
Test results were considered negative if S/P < 50 % and positive if S/P > 50 %. 
Chapter 6: Age- and strain-depenent differences in PRV neuropathogenesis 
 
 
107 
 
2.10. Immunofluorescence staining 
During sample collection at the moment of euthanasia, parts of the nasal mucosa, TG, pons and 
olfactory bulb were embedded in methocel (Fluka) and frozen at −70 °C. Cryosections of 5 µm were 
made from tissues of selected animals based on qRT-PCR results and fixed in methanol (−20 °C, 
100%, 25 min). PRV-infected cells were visualized by 1 h incubation of the cryosections with a 
combination of mouse monoclonal anti-gB and -gD antibodies (1:100 in PBS) followed by 1 h 
incubation with FITC-labelled goat anti-mouse antibodies (1:200). Additionally, all cryosections were 
incubated for 15 min with Hoechst 33342 (Invitrogen). Cryosections were washed three times with 
PBS after the different incubation steps. Finally, cryosections were mounted with glycerin-DABCO. 
Images of the immunofluorescence stained cryosections were acquired using a Leica TCS SPE 
confocal microscope (Leica Microsystems GmbH, Heidelberg, Germany). 408 nm and 488 laser lines 
were used to excite Hoechst counterstaining and FITC fluorochromes, respectively. 
3. Results 
3.1. Clinical symptoms 
3.1.1. NIA3 strain reference strain 
Intranasal inoculation of 2-week-old piglets with the NIA3 reference strain resulted in important 
clinical disease and high mortality rapidly after inoculation. Starting from 2 days p.i., an increase in 
rectal body temperature (between 40 and 41.3 °C) and general depression of all piglets, associated 
with severe diarrhea and vomiting, was observed. The symptoms worsened at 3 and 4 days p.i.. 
Piglets exhibited complete exhaustion and were unable to stand up making that respiratory (nasal 
discharge, coughing, heavy breathing) and neurological (circling, scratching, trembling, paresis) 
symptoms could only be observed to a limited extent. Next to the foreseen euthanasia of two piglets 
at 1, 2, 3 and 4 days p.i., extra piglets were euthanized at 2 (1 piglet), 3 (1 piglet) and 4 (2 piglets) 
days p.i. based on ethical grounds. 
Also 15-week-old sows showed important respiratory and neurological symptoms after inoculation 
with the NIA3 PRV-reference strain. Morbidity and mortality were however lower compared to the 
young piglets. The general condition of the sows started to decrease from 2 days p.i. and was 
associated with a loss of appetite and lethargy. On day 3, their condition worsened, accompanied by 
a rise in rectal temperature which exceeded 41 °C for all pigs over the next days. Both respiratory and 
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neurological symptoms were observed from 4 days p.i. which became more severe over the next 
days. Most pigs developed the typical neurological symptoms associated with Aujeszky’s disease, 
such as scratching, lack of coordination, circling, seizures and paralysis between 4 and 7 days p.i.. 
Respiratory symptoms, including dyspnoea, nasal discharge, sneezing, coughing, and respiratory 
distress were also observed. As planned, two pre-defined sows were euthanized on 1, 2, 3, 5, 7 days 
p.i.. Furthermore, one pig died overnight between 5 and 6 days p.i. (N09) and one additional pig was 
euthanized at 6 days p.i. (N10) as a consequence of severe neurological symptoms. Therefore, only 
two pigs remained that were foreseen to be euthanized on 14 and 28 days p.i.. It was decided to 
euthanize both pigs at 14 days p.i. to have duplicate data at that time point. 
3.1.2. Wild boar strain BEL24043 
Inoculation of 2-week-old piglets with the wild boar strain induced important respiratory and 
neurological disease. Starting from 4 days p.i., the piglets showed a slight increase in body 
temperature (± 0.5 °C), a reduced appetite and were lethargic. Between 5 and 9 days p.i. all piglets 
experienced respiratory and/or neurological symptoms. Two predefined piglets were euthanatized as 
foreseen on 1, 2, 3, 4, 5 and 7 days p.i.. One additional piglet (W11) had to be euthanized at 5 days 
p.i. based on ethical grounds. For the remaining three piglets it was decided to euthanize one pig at 
10, 14 and 21 days p.i. to better follow up pathogenesis at these later time points. The symptoms 
observed after inoculation with the wild boar strain were, however, less severe than after NIA3 
infection and mortality was much lower.  
On the other hand, no clinical symptoms were observed in 15-week-old pigs inoculated with the wild 
boar isolate. The general condition of the animals, food consumption, mobility and rectal body 
temperature remained apparently unaffected throughout the experiment.  
3.2. Pseudorabies virus DNA detection in the nervous system and visceral organs 
3.2.1. NIA3 strain reference strain 
Analysis of the presence of viral DNA by qPCR in the different tissues collected at the day of 
euthanasia indicated that the NIA3 strain quickly disseminated throughout the body of both 2- and 
15-week-old sows after intranasal inoculation (Figure 1 and S1).  
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At 24 hours p.i., viral DNA was already detected in the nasal mucosa, tonsils and lung of 2-week-old 
piglets. Importantly, virus had also already reached the TG at that time point, indicating efficient 
infection and retrograde transport through the trigeminal nerve in these young piglets. At 48 hours 
p.i., viral concentrations remained similar in nasal mucosa and tonsils. Virus was no longer detected 
in lung tissue but had further disseminated to other peripheral organs (liver and/or spleen) in two 
out of three euthanized piglets. In the TG, viral DNA copies had increased 300-fold and virus had also 
invaded the CNS where it was detected in the pons and/or the olfactory bulb. At 3 and 4 days p.i., an 
additional 100-fold increase in the concentration of viral DNA was observed in the nasal mucosa, and 
peripheral organs (lung, kidney, spleen and/or liver) of most piglets were positive for viral DNA at 
those time points. Furthermore, an extended invasion of the CNS was observed. The virus had by this 
time also reached the cerebellum and cerebrum. 
A similar dissemination pattern of the NIA3 strain was found in 15-week-old pigs, with the exception 
that the spread to the TG, CNS and peripheral organs showed a delay of 24 hours. The most striking 
difference in viral dissemination between pigs of both age categories was observed at the level of the 
nasal mucosa. Viral DNA was detected in all inoculated 2-week-old piglets between 1 to 4 days p.i., 
whereas only half of the 15-week-old pigs were positive between 1 and 6 days p.i. and at 7 and 14 
days p.i., viral DNA was no longer detected. Despite the low replication at the nasal mucosa and the 
delayed spread, the tonsils of both 15-week-old sows euthanized at 24 hours p.i. tested positive for 
viral DNA. At 48 hours p.i., PRV had reached the TG and had already invaded the CNS, where it was 
detected in the pons and/or cerebellum. At day 3, a 15 fold and 500 fold increase in viral DNA 
concentrations was detected in the TG and the pons, respectively. Virus was also present in the 
olfactory bulb of one of both sows euthanized at that time point. However, it was only at 5 days p.i. 
that virus had invaded the cerebrum. Between 5 and 7 days p.i. the virus was detected in the 
peripheral organs. Viral DNA was however never detected in the kidneys. Starting from 7 days p.i., 
viral DNA concentrations in all positive organs started to decrease. At 14 days p.i., virus remained 
detectable in the different nervous tissues, although concentrations had decreased compared to 
those observed during the acute phase of infection. By that time virus was no longer detected in 
peripheral organs and only tonsils remained positive. 
3.2.2. Wild boar strain BEL24043 
Analysis of the presence of viral DNA by qPCR in the different tissues collected at the day of 
euthanasia indicated that the wild boar strain quickly invaded the PNS and CNS of 2-week-old piglets 
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 Figure 1:  Distribution of viral DNA in different tissues. Several tissues were collected from 2- and 15-week-old domestic pigs at different time points after intranasal 
inoculation with the NIA3 reference strain or the BEL24043 strain and tested by qPCR directed against glycoprotein gB. Viral DNA concentrations for different primary and 
secondary sites of replication for 2- and 15-week-old pigs (a,c  and e, g respectively) and for peripheral and central nervous system tissues for 2- and 15-week-old pigs (b,d 
and f,h respectively) are shown. 
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after intranasal inoculation (Figure 1 and S1). At 24 hours p.i., viral DNA was already detected in the 
nasal mucosa and lungs of both and in the tonsils of one of both piglets. Virus had also reached the 
TG at that time point, indicating efficient neuroinvasion. At 48 hours p.i., virus was still detected in 
the nasal mucosa and tonsils, but was no longer detectable in lung tissue. In addition to the TG, virus 
had also invaded the CNS where it was detected in the pons, cerebellum and/or olfactory bulb. Both 
at 3 and 4 days p.i., there was important variation between the pigs euthanized with one of both pigs 
being positive in the TG and pons, while the other pig was positive for all brain tissues tested. 
Between 5 and 21 days p.i. brain tissues of all piglets remained positive for viral DNA. These results 
show that the pattern of neuroinvasion in 2-week-old piglets was quite similar after inoculation with 
the NIA3 and the wild boar strain.In contrast, an important difference between the wild boar strain 
and NIA3 was observed when comparing viral dissemination to the visceral organs. For the NIA3 
strain, viral DNA was detected in visceral organs between 2 and 4 days p.i.. After inoculation of the 
wild boar strain however, no viral DNA was detected in the organs of piglets, except for renal tissue 
of a piglet at 5 and 7 days p.i.. 
In 15-week-old pigs, important differences were observed both in spread to the central nervous 
system and visceral organs after inoculation with the NIA3 and the wild boar strain (Figure 1 and S1). 
Only in three animals, tissues positive for viral DNA were found at the moment of euthanasia. One 
animal euthanized at 2 days p.i. was positive in lung tissue. The other two sows were positive for viral 
DNA in tonsils, TG, pons and one of both also in the cerebellum.  
3.3. Viral and cytokine mRNA expression at distinctive sites involved in 
neuropathogenesis 
Viral and cytokine mRNA expression was studied at four relevant sites involved in PRV 
neuropathogenesis: the nasal mucosa, the TG, the brainstem (pons) and the olfactory bulb.  
3.3.1. Nasal mucosa 
3.3.1.1. NIA3 strain reference strain 
Although we described above that an important difference was observed in the presence of viral 
DNA in the nasal mucosa between 2- and 15-week-old pigs after NIA3 inoculation, the PRV-
associated mRNA expression pattern in nasal mucosa was similar in pigs of both age-categories and 
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Figure 2: Nasal mucosa. Domestic pigs of 2- and 15-weeks old were intranasally inoculated with the NIA3 strain 
or the BEL24043 wild boar strain and euthanized at different time points post infection. Viral mRNA expression 
in the nasal mucosa was studied by RT-qPCR assays directed against several PRV genes in 2- and 15-week-old 
pigs (a and d, respectively). Viral gene levels were expressed relative to the lowest positive sample for each age 
category. Cytokine-related mRNA expression in the nasal mucosa was tested by RT-qPCR assays directed 
against several cytokines for 2- and 15-week-old pigs (b, c and e, f, respectively). Individual cytokine levels for 
all animals are expressed relative to the average cytokine expression in the control group (separately for 2- and 
15- week old animals).  
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 was surprisingly low over the entire study period (Figure 2 a and d). Viral mRNA was only detected in 
those animals that showed the highest DNA-concentrations. Viral mRNA expression was limited to 
one or more glycoproteins, except one 2- and one 15-week-old pig that also expressed the LAT 
intron. Expression of IE180 and EP0 was never detected. The low extent of viral mRNA expression 
was in line with the limited number of PRV plaques we could find during analysis of 
immunofluorescent stainings. In 15-week-old pigs, no plaques were detected despite the fact that 
150 sections/pig were analysed of pig N01, N02, N03, N04 (euthanized at 1 and 2 days p.i.). Only 
when sections were made from 2-week-old piglet N08, that expressed the highest viral mRNA levels, 
a small PRV plaque was found (Figure 3 a). 
In the nasal mucosa only limited evidence was found for changes in cytokine expression after 
infection of pigs of both age categories with the NIA3 strain (Figure 2 b, c, e and f). No clear 
upregulation of cytokines was observed in the nasal mucosa of 2-week-old piglets. Only in the 15-
week-old pig N06 euthanized at 3 days p.i., an increase in cytokine mRNA of IL-6 (40 fold), IL-8 (22 
fold) and TNF-a (22 fold) was found. This was also the pig in which the highest viral replication was 
detected. 
3.3.1.2. Wild boar strain BEL24043 
As described for the NIA3 strain, viral mRNA expression in the nasal mucosa of 2-week-old piglets 
was also surprisingly low and limited after infection with the wild boar strain (Figure 2 a). Expression 
of IE180, EP0 and LAT intron was never detected. In 15-week-old pigs, no viral mRNA was detected at 
all, correlating with the absence of viral DNA in the nasal mucosa (Figure 2 d).  
No clear upregulation of cytokine mRNA expression was observed in the nasal mucosa after 
inoculation of 2-week-old piglets with the wild boar strain (Figure 2 b and c). In some 15-week-old 
pigs inoculated with the wild boar strain, a modest increase in cytokine mRNA was found for IL-6 
(Figure 2 e and f). This was however in pigs in which no viral DNA or mRNA was detected 
3.3.2. Trigeminal ganglion 
3.3.2.1. NIA3 strain reference strain 
In 2-week-old piglets, viral replication was evidenced by detection of viral mRNA by RT-qPCR analysis 
in the TG starting from 2 days p.i., thus 24 hours after virus had invaded the TG (Figure 4 a). Highest 
viral mRNA levels were found on 3 and 4 days p.i. and they were comparable for all piglets 
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euthanized at those time points. Viral mRNA of the three glycoproteins and the LAT intron was 
observed, but mRNA of immediate early and early genes was not detected. In 15-week-old sows, viral 
DNA was first detected in the TG starting from 2 days p.i., correlating with the observed gC mRNA 
expression found in one pig at that time point (Figure 4 d). Viral replication in the TG was evidenced 
by more extended late viral gene expression from 3 days p.i. in the TG of all pigs, except pig N05. Late 
viral mRNA expression was however less pronounced and less consistent compared to 2-week-old 
piglets (mostly only detection of mRNA of one or more of the glycoprotein genes). This could indicate 
that viral replication is at least partly inhibited in the 15-week-old pigs during the early stages of 
infection. At 14 days p.i. viral gene expression was no longer detected in the TG, except from LAT 
intron expression in one of both sows. As for 2-week-old pigs, no expression of IE180 or EP0 genes 
was observed in the TG of 15-week-old pigs. Despite the late viral mRNA expression in 2-week-old 
 
Figure 3: PRV immunofluorescence straining. Immunofluorescence images of nasal mucosa (a) and olfactory 
bulb (b) of the NIA3-inoculated piglet N08 euthanized at 3 days p.i.. PRV antigens (green) were stained with a 
combination of mouse monoclonal anti-gB and -gD antibodies (1:100 in PBS) followed by an incubation step 
with FITC-labelled goat anti-mouse antibodies (1:200). Nuclei (blue) were counterstained with Hoechst 33342. 
Images were taken with a 63 x objective.  
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piglet N08, we were not successful in detecting any PRV positive cell in its TG by immunofluorescence 
staining. 
After inoculation of 2-week-old piglets, an upregulation of cytokine-related mRNA expression of IFN-
β, IFN-γ, TNF-α, IL6, IL10 and to a lesser extent IL8 and IL1-α was observed in the TG (Figure 4 b and 
c). A moderate increase of TNF-α (average of 10 fold), IFN-β (average of 5 fold), IL10 (average of 4 
fold) and IL1-α (average of 5 fold) was observed already at 2 days p.i.. By the next day, the mRNA 
concentrations of TNF-α (average of 32 fold), IFN-β (average of 42 fold) and IL10 (average of 14 fold) 
had increased notably. Furthermore, also an upregulation of IFN-γ (average of 22 fold), IL6 (average 
of 23 fold) and IL8 (average of 6 fold) was observed. From 4 days p.i. concentrations of the 
upregulated cytokines started decreasing again. Interestingly, in contrast with 2-week-old pigs, 
cytokine upregulation in 15-week-old swine was clearly less pronounced and limited to a maximum 
10 fold increase of IL6, IL8 and IL10 around 3 and 5 days p.i. (Figure 4 e and f).  
3.3.2.2. Wild boar strain BEL24043 
Viral mRNA was first detected in the TG at 48 hours p.i., i.e. 24 hours after PRV DNA detection, of 2-
week-old pigs inoculated with the wild boar strain. Viral mRNA was detected in all piglets euthanized 
between 2 and 5 days p.i., and in one piglet euthanized at 14 days p.i. (Figure 4 a). The latter showed 
that depending on the animal, viral replication was not easily suppressed. Compared to the NIA3 
strain, viral mRNA expression seemed to be somewhat less consistent since viral mRNA of all late 
genes studied was not detected in all piglets and LAT intron mRNA was only found in about half of 
the mRNA-positive piglets. Between 6 and 21 day p.i. viral gene expression was no longer detected in 
the TG, except for the piglet euthanized at 14 days p.i.. In contrast, viral mRNA was not detected at 
all in the TG of 15-week-old pigs after inoculation with the wild boar isolate (Figure 4 d). 
After inoculation of 2-week-old piglets with the wild boar strain a moderate upregulation of cytokine 
related mRNA was observed especially for those animals where viral mRNA expression was 
detectable. Particularly in these animals, an mRNA upregulation of IL6 (maximum increase of 23 
fold), IFN-γ (maximum increase of 19 fold) TNF-α (maximum increase of 13 fold), and IL10 (maximum 
increase of 11 fold) was observed. No clear upregulation of cytokine-related mRNA was observed in 
15-week-old pigs after inoculation with the wild boar isolate (Figure 4 e and f). 
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Figure 4: Trigeminal ganglion. Domestic pigs of 2- and 15-weeks old were intranasally inoculated with the NIA3 
strain or the BEL24043 wild boar strain and euthanized at different time points post infection. Viral mRNA 
expression in the trigeminal ganglion was studied by RT-qPCR assays directed against several PRV genes in 2- 
and 15-week-old pigs (a and d, respectively). Viral gene levels were expressed relative to the lowest positive 
sample for each age category. Cytokine-related mRNA expression in the trigeminal ganglion was tested by RT-
qPCR assays directed against several cytokines for 2- and 15-week-old pigs (b, c and e, f, respectively). 
Individual cytokine levels for all animals are expressed relative to the average cytokine expression in the 
control group (separately for 2- and 15- week old animals).  
Chapter 6: Age- and strain-depenent differences in PRV neuropathogenesis 
 
 
117 
 
3.3.3. Brainstem 
3.3.3.1. NIA3 strain reference strain 
Detection of PRV DNA had shown that PRV was able to spread efficiently to the CNS and had invaded 
the brainstem already by 2 days p.i. in pigs of both age-categories. Although viral DNA concentrations 
were comparable in 2- and 15-week-old pigs in the first 4 days p.i., viral mRNA expression was 
remarkably lower in the 15-week-old sows (Figure 5 a and d). Where mRNA of all late viral genes and 
LAT intron was extensively found in all 2-week-old pigs at 4 days p.i. and already in 1 pig at 2 and 3 
days p.i., only limited PRV-related mRNA expression was found in five 15-week-old animals between 
3 and 6 days p.i.. In three of these pigs, expression was restricted to gC, indicating an inhibition of 
late viral mRNA expression in the pons of 15-week-old pigs. As for the TG, we could not confirm the 
presence of viral glycoproteins by immunofluorescence stainings in the pons of piglet N08 that was 
however positive for viral mRNA in qRT-PCR. 
The viral mRNA expression in the pons of 2-week-old piglets seemed to be associated with an 
upregulation of cytokine-related mRNA expression of IFN-β and TNF-α (Figure 5 b and c). At 2 days 
p.i. an increase in TNF-α (average of 6 fold) was observed. Expression continued to rise by the next 
day (average of 18 fold) and an upregulation of IFN-β (average of 8 fold) mRNA was observed at that 
time point and expression of both cytokines remained elevated by 4 days p.i.. Cytokine upregulation 
in 15-week-old swine was again less clear and no clear trend could be observed (Figure 5 e and f). 
3.3.3.2. Wild boar strain BEL24043 
Viral mRNA was detected in the pons of 2-week-old piglets inoculated with the wild boar strain for 
one of both piglets at 3 and 4 day p.i. and for all piglets between 5 and 7 days p.i. (Figure 5 a). 
Compared to infection with the NIA3 strain, viral expression was less consistent with only in about 
half of the mRNA-positive viral piglets the LAT intron being detectable. On the other hand, no viral 
mRNA expression was observed at all after inoculation of 15-week-old pigs with the wild boar isolate 
(Figure 5 d). 
After inoculation of 2-week-old piglets with the wild boar strain, an upregulation of cytokine-related 
mRNA expression of TNF-α was observed during the entire period of the experiment (with a 
maximum increase of 36 fold at 5 days p.i.) and an increase at 5 p.i. of IFN-β (maximum increase of 
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Figure 5: Pons. Domestic pigs of 2- and 15-weeks old were intranasally inoculated with the NIA3 strain or the 
BEL24043 wild boar strain and euthanized at different time points post infection. Viral mRNA expression in the 
pons was studied by RT-qPCR assays directed against several PRV genes in 2- and 15-week-old pigs (a and d, 
respectively). Viral gene levels were expressed relative to the lowest positive sample for each age category. 
Cytokine-related mRNA expression in the pons was tested by RT-qPCR assays directed against several cytokines 
for 2- and 15-week-old pigs (b, c and e, f, respectively). Individual cytokine levels for all animals are expressed 
relative to the average cytokine expression in the control group (separately for 2- and 15- week old animals).  
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16 fold), IL1-α (maximum increase of 13 fold) and IL10 (maximum increase of 9 fold) (Figure 5 b and 
c). On the other hand, no clear upregulation of cytokine-related mRNA was observed after 
inoculation of 15-week-old pigs with the wild boar strain (Figure 5 e and f). 
3.3.4. Olfactory bulb 
3.3.4.1. NIA3 strain reference strain 
The results described above showed that immediate early and early viral gene mRNA was never 
detected in nasal mucosa, trigeminal ganglia and brainstem, and late viral mRNA expression was 
always lower and less consistent in 15-week-old pigs than in 2-week-old pigs. The results obtained in 
the olfactory bulb were clearly different. Viral mRNA expression was considerably higher in the 
olfactory bulb of both 2- and 15-week-old sows compared to the other tissues that were analyzed 
and it was the only tissue in which IE180 and EP0 mRNA expression could be detected (Figure 6 a and 
d). Two out of three 2-week-old piglets was already positive for viral mRNA associated with 
glycoprotein genes and/or the LAT intron at 2 days p.i.. At 3 and 4 days p.i., mRNA concentrations 
had increased, associated with a consistent mRNA expression profile of immediate early, early and 
late genes. Also the LAT intron was expressed in high concentrations. For 15-week-old pigs, DNA 
detection had shown that PRV invaded the olfactory bulb between 3 days and 5 days p.i. Viral mRNA 
was only detected for the first time at 5 days p.i.. By day 6, viral replication had increased and clear 
expression of immediate early, early and late genes was observed. Also the LAT intron was detected 
in considerable concentrations. Interestingly, viral mRNA concentrations decreased already by day 7 
p.i.. At 14 day p.i. PRV-related mRNA was no longer detected. Viral replication in the olfactory bulb 
was confirmed by immunofluorescence stainings of the olfactory bulb of piglet N08 (Figure 3b). Viral 
glycoproteins could easily be detected in the cytoplasm of cells and were visible over the entire 
section. 
Compared to all previously discussed tissues, more pronounced cytokine mRNA expression was 
observed in the olfactory bulb of both 2- and 15-week-old pigs during the first days after NIA3 
infection (Figure 6 b, c, e and f), and the expression was higher in 2-week-old than 15-week-old pigs. 
The extensive upregulation of cytokine-related mRNA correlated with the expression of late viral 
genes. At 3 and 4 days p.i. of 2-week-old pigs a strong upregulation of IFN-β (maximum average 
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Figure 6: Olfactory bulb. Domestic pigs of 2- and 15-weeks old were intranasally inoculated with the NIA3 
strain or the BEL24043 wild boar strain and euthanized at different time points post infection. Viral mRNA 
expression in the olfactory bulb was studied by RT-qPCR assays directed against several PRV genes in 2- and 15-
week-old pigs (a and d, respectively). Viral gene levels were expressed relative to the lowest positive sample for 
each age category. Cytokine-related mRNA expression in the olfactory bulb was tested by RT-qPCR assays 
directed against several cytokines for 2- and 15-week-old pigs (b, c and e, f, respectively). Individual cytokine 
levels for all animals are expressed relative to the average cytokine expression in the control group (separately 
for 2- and 15- week old animals).  
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 increase of 131 fold), IFN-γ (maximum average increase of 223 fold), TNF-α (maximum average 
increase of 26 fold), IL1-α (maximum average increase of 26 fold), IL6 (maximum average increase of 
92 fold), IL8 (maximum average increase of 102 fold) and IL10 (maximum average increase of 10 fold) 
was observed in the olfactory bulb. Also in 15-week-old pigs, cytokine upregulation correlated with 
viral replication in the olfactory bulb. An increase in cytokine-related mRNA expression was observed 
starting from 5 days p.i.. For most upregulated cytokines, a maximum increase was observed at 6 
days p.i. At this time point an increase in mRNA expression of IFN-γ (average increase of 69 fold), IL6 
(average increase of 32 fold), IL8 (average increase of 21 fold), TNF-α (average increase of 7 fold) 
increase of 6 fold) was observed. Cytokine-related mRNA expression went down again by 7 days p.i. 
and reached levels similar to the control animals by 14 days p.i..  
3.3.4.2. Wild boar strain BEL20403 
After inoculation of 2-week-old pigs with the wild boar strain, viral mRNA associated with 
glycoproteins and the LAT intron was already observed on 2 and 3 days p.i., for those animals that 
were also positive for viral DNA in the olfactory bulb. Starting from 4 days p.i., viral replication 
increased, with more consistent expression of viral mRNA. However, whereas mRNA expression of 
IE180 and EP0 was consistently detected in the olfactory bulb at 3 and 4 day p.i. after NIA3 infection, 
only two piglets inoculated with the wild boar strain expressed immediate-early and early gene 
mRNA expression. Starting from 7 days p.i. viral mRNA concentrations started to decrease and were 
limited to mRNA expression of one or more glycoproteins. Consistent with the absence of viral DNA 
in the olfactory bulb of 15-week-old pigs, no viral mRNA expression could be observed in pigs of this 
age after inoculation with the wild boar isolate (Figure 6 d). 
Similar as observed for the NIA3 strain, a robust increase in cytokine-related mRNA was detected 
after inoculation of 2-week-old pigs with the wild boar strain, although it seemed to start 1 day later 
(Figure 6 b and c). An important observation was made at 5 days p.i. in piglet W11 that experienced 
severe neurological symptoms and had to be euthanized based on ethical grounds. In this piglet, 
cytokine related mRNA expression was more pronounced compared to the expression of the other 
animals euthanized at 4 and 5 day p.i. with a massive increase in IFN-γ (increase of 487 fold), IFN-β 
(increase of 81 fold), TNF-α (increase of 14 fold), IL1-α (increase of 58 fold), IL6 (increase of 184 fold), 
IL8 (increase of 271 fold) and IL10 (increase of 34 fold). However, also for the other animals 
euthanized at 4 and 5 days p.i. that were positive for viral mRNA, a strong upregulation of IFN-β 
(maximum average increase of 35 fold), IFN-γ (maximum average increase of 161 fold), TNF-α 
(maximum average increase of 12 fold), IL1-α (maximum average increase of 15 fold), IL6 (maximum 
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average increase of 51 fold), IL8 (maximum average increase of 25 fold) and IL10 (maximum average 
increase of 8 fold) was observed in the olfactory bulb of the young piglets. Starting from 7 day p.i. 
cytokine-related mRNA concentrations started to decrease again, returning to baseline levels at 14 
and 21 day p.i.. Again, no changes in cytokine-related mRNA expression were observed in the 
olfactory bulb of 15-week-old pigs after inoculation with the wild boar isolate (Figure 6 e and f). 
3.4. Detection of PRV-specific antibodies by ELISA 
Since almost no viral DNA or mRNA positive samples were found in 15-week-old pigs after 
inoculation with the wild boar strain BEL24043, we verified if infection with this wild boar isolate had 
nevertheless taken place by testing the presence of PRV specific antibodies in blood samples 
collected at the day of euthanasia via an ELISA directed against glycoprotein gB. Logically, no PRV-
specific antibodies were detected in pigs euthanized between 1 and 5 days p.i.. However, in the pigs 
euthanized at 7, 14 and 28 days p.i., each time one of both animals (W09, W12, W14) had 
seroconverted, indicating that infection had taken place. For one of these ELISA-positive animals 
(W12), viral DNA was detected in the tonsils, TG and pons. For the other two positive animals (W09, 
W14), no viral DNA or mRNA was detected at the day of euthanasia in any tissue.  
4. Discussion  
The current knowledge on the pathogenesis of PRV in pigs mostly comes from studies performed in 
the last decades of the twentieth century that used virus isolations and immunohistochemistry (IHC) 
stainings for virus detection. Since more sensitive techniques like PCR are now routinely used, we 
reassessed the PRV pathogenesis using those techniques. In general, our results confirmed previous 
observations. PRV was first detected at the nasal mucosa and tonsils which are known places of 
primary replication of the virus. PRV enters into the trigeminal nerve quickly after infection and 
reaches the TG from where it can further invade the CNS. Viral replication at the respiratory mucosa 
is likely required before dissemination of PRV to the visceral organs, since virus only reached the 
organs several days after infection. Our results also confirmed the importance of the olfactory route 
as an alternative route of neuroinvasion. Despite the confirmation of the general knowledge on PRV 
pathogenesis, several new interesting findings sorted from the detailed study of viral and cytokine 
mRNA expression at important sites of neuropathogenesis.  
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A first interesting observation was made at the level of the nasal mucosa. Unexpectedly, only limited 
viral mRNA expression was detected in pigs of both age categories after infection with the NIA3 
strains as well as the wild boar strain. Viral DNA was however detected in considerable amounts in 2-
week-old piglets after both NIA3 and BEL24043 infection and in half of the 15-week-old pigs after 
NIA3 infection. These results are in contrast with previous in vivo studies where viral antigens were 
observed in the epithelium and the underlying mucosa shortly after infection (Kritas et al., 1994a; Pol 
et al., 1989). Most probably, this discrepancy can be explained by differences in inoculation dose, 
inoculation route, viral strains used and age of the pigs in the different studies. Compared to 
previous infection experiments where pigs were inoculated with the NIA3 strain at 1.25x108 pfu/pig 
and the Kaplan strain at 107 TCID50/pig (Kritas et al., 1994a; Pol et al., 1989), we used a much lower 
inoculation dose of 105 TCID50/pig. The most plausible hypothesis seems that nasal mucosa did not 
serve as initial place of extensive viral replication in our experiment and that the detected DNA 
comes from virus that was produced at another replication site. In this respect, the olfactory mucosa, 
tonsils and oropharynx have already been described as alternative sites of primary replication (Kritas 
et al., 1994a, b; Miry & Pensaert, 1989; Pol et al., 1989; Sabó et al., 1968, 1969; Wittmann et al., 
1980) and might be favoured by our used method of aerosol inoculation (Baskerville et al., 1971; 
Miry & Pensaert, 1989).  
Although only limited evidence was found for viral replication in the nasal mucosa, PRV was able to 
quickly reach the TG in pigs of both age categories after NIA3 infection. This rapid spread to the TG 
suggests that PRV does not need to replicate extensively in the respiratory epithelium and may not 
need to breach the basement membrane to get access to TG neurons. It therefore supports the 
presence of nerve endings in the respiratory epithelium that can be accessed directly. The 
observation that PRV only reached the peripheral organs at later time points supports the need to 
cross the basement membrane to get access to blood and lymph. When however studying the viral 
and cytokine-related mRNA expression at the TG of NIA3 infected animals, an important difference in 
viral replication as well as the associated cytokine response was observed between animals of both 
age categories. In 2-week-old piglets, important viral replication was found starting from 2 days after 
NIA3 infection which was associated with an increased expression of particularly IFN-β, TNF-α, IL6, 
IL10 and IFN-γ mRNA in the TG after PRV infection. Although speculative at this point, this suggests 
an infiltration of mainly macrophages and γδ TCR+ T cells (and/or NK cells), which would be in line 
with observations done after corneal HSV-1 infection of mice (Kodukula et al., 1999; Sciammas et al., 
1997). Those authors suggested that the γδ TCR+ T cells probably exert a function in the 
establishment of latency by the production of IFN-γ. IFN-γ not only possesses antiviral activity, but is 
also a potent activator of macrophages which in turn produce proinflammatory cytokines such as 
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TNF-α, interleukin-6 (IL-6), RANTES (“regulated on activation, normal T cell expressed and secreted”), 
type I interferons, and nitric oxide (NO) (Egan et al., 2013; Heise & Virgin, 1995; Kodukula et al., 
1999).  
In contrast, viral mRNA expression was less pronounced and less consistent in the TG of 15-week-old 
pigs compared to 2-week-old piglets. This difference in viral replication furthermore correlated with a 
different expression pattern of cytokine-related mRNA between pigs of both age-categories. While a 
strong upregulation of especially pro-inflammatory cytokines was observed in 2-week-old piglets, 
almost no changes in cytokine mRNAs were detected in 15-week-old pigs. This suggests that cytokine 
production, and the related immune cell infiltration, are probably less important than previously 
assumed in controlling PRV infection in the TG shortly after infection in older pigs. This could indicate 
that factors linked to neuronal morphology and cell biology as well as viral properties play a more 
prominent role in the induction of latency in adult pigs, but appear not sufficient in young piglets. 
Several neuronal and viral properties that could favour the induction of a latent HSV-1 infection in 
the TG include among others a lower abundance of viral and cellular transcription factors in the 
nucleus of sensory neurons and the capacity of LAT transcript to repress the viral lytic transcription 
(reviewed by Divito et al., 2006; Held & Derfuss, 2011). Also recent in vitro results showing that 
cytokine responses at axon endings are sufficient to limit virus spread towards the cell body (Song et 
al., 2016) are consistent with the hypothesis that the immune response in the TG itself may be of 
lesser importance for latency induction. The fact that PRV DNA was present in the TG of both 15-
week-old pigs euthanized at 14 days p.i. in the absence of detectable viral mRNA expression of all 
immediate early, early and late genes in all tissues studied however indicates that latency was 
established at the end of the study (14 days p.i.) in the TG. Furthermore, the LAT intron could be 
detected in the TG of one of both pigs. As expected, this LAT intron was also expressed during 
productive infection. Future studies on the material collected during this study may allow to analyse 
which parts of the LAT region are transcribed during productive versus latent PRV infections. In 
contrast to HSV-1, where only the intron spliced from the LLT is expressed during latency (Farrell et 
al., 1991), for PRV it remains to be clarified which set of transcripts is expressed during either of both 
stages.  
Next to the observed differences in viral and cytokine related mRNA expression at the TG of NIA3 
infected animals, a more pronounced viral replication and associated cytokine response were also 
observed in the brainstem in young piglets compared to the older sows. The cytokine expression 
after alphaherpesvirus infection in the brainstem has however been less well studied. After infection 
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of 2-week-old piglets with the NIA3 strain, an upregulation of mainly TNF-α and IFN-β was observed 
which is probably the result of activation of microglia cells, the resident macrophages of the CNS. 
The finding that both the viral replication as well as the associated immune response were more 
pronounced in the TG and the brainstem of young piglets, combined with the more severe clinical 
symptoms observed in the 2-week-old piglets is in line with the assumption that the high morbidity 
and mortality in young piglets upon PRV infection are linked to viral encephalitis (Pomeranz et al., 
2005), and suggest that the observed symptoms are the result of neuronal damage caused by a 
combination of viral replication and immune-mediated pathology. 
Another interesting result, besides the limited replication at the nasal mucosa and the differences 
between viral and cytokine mRNA expression in the TG and brainstem of 2- and 15-week-old pigs 
after NIA3 infection, were the observations done at the olfactory bulb. After infection with the NIA3 
strain, extensive viral replication was detected in the olfactory bulb in pigs of both age categories, 
which was significantly higher compared to the viral replication in the other neuronal tissues (TG and 
brainstem). This extensive viral replication in the olfactory bulb further correlated with a robust 
expression of cytokine mRNA. The cytokine expression was most pronounced in 2-week-old pigs and 
included upregulation of IFN-γ, IFN-β, IL6, IL8 and to a lesser extent TNF-α, IL1α and IL10. The 
cytokine expression in 15-week-old pigs was somewhat less pronounced but still showed a more than 
50 fold increase in IFN-γ and IL6 mRNA expression. Little is currently known about the immune cells 
responsible for cytokine production in the olfactory bulb, but the high increase in IFN-γ suggests an 
infiltration of T- or NK-cells into the inflamed area. Although hypothetical, the high viral replication 
and associated immune response in the olfactory bulb seem to be linked with the neurological 
symptoms observed in pigs of both age categories, more so than the viral replication and cytokine 
expression in the TG and brainstem. In this respect, it is important to note that the 15-week-old pig 
that spontaneously died at 5 days p.i., N09, and the one that was euthanized due to the severe 
neurological symptoms at 6 days p.i., N10, were among those with the highest IFN-γ expression in 
the olfactory bulb. As such, our data may suggest that infection of the olfactory bulb may play a 
significant role in severe PRV pathology.  
As described above, a potential explanation for the age-dependent differences in clinical symptoms 
and mortality could be found in the observation that upon infection with the NIA3 strain, viral 
replication was more extensive and more consistent in 2-week-old pigs compared to 15-week-old 
pigs in the TG and pons on the one hand and in the olfactory bulb on the other hand. During this 
study, we however also tried to elucidate if differences in viral and cytokine-related mRNA could also 
provide explanations for the observed strain-dependent differences in clinical symptoms between 
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the NIA3 reference strain and the wild boar strain BEL2043. Wild boar strains are considered to be 
attenuated compared to strains circulating in domestic pigs. This was confirmed before for the wild 
boar strain BEL24043. Despite absence of clinical symptoms in 15-week-old pigs, this strain was 
capable to induce important respiratory and neurological disease in 2-week-old piglets. The severity 
of clinical symptoms and mortality were however lower compared to NIA3 infection (Verpoest et al., 
2016a).  
A first important difference between NIA3 and the wild boar strain was found at the level of viral 
dissemination to visceral organs. Viral DNA was detected rather quickly upon NIA3 inoculation 
(between 2 and 4 days in young piglets and between 3 and 7 days for 15-week-old pigs) in the 
kidney, spleen and liver. In contrast, viral DNA was only detected in renal tissue of 2 piglets after 
infection with the wild boar strain. In the other piglets as well as in 15-week-old pigs, no viral DNA 
was detected in any of the visceral organs tested at the day of euthanasia. This could indicate that 
the wild boar strain may be less capable of reaching lymph and blood vessels. A first potential 
explanation could be that the wild boar strain is more hindered in its mobility through the mucus 
layer to reach the epithelial cells (Yang et al., 2012) than NIA3. A second explanation could be a 
reduced capacity of the wild boar strain to replicate at the primary site of infection. This however 
seems unlikely since only low replication at the nasal mucosa was found for both strains in both 2- 
and 15-week-old pigs. A third plausible explanation could be that genetic differences exist between 
both strains in their capacity to cross the basement membrane. Ex vivo studies in nasal explants have 
shown that the viral gE protein appears to play a role in sorting virus particles to the basal side of 
respiratory epithelial cells towards and near the basement membrane barrier (Glorieux et al., 2009a) 
and a trypsin-like serine protease appears to be involved in PRV penetration of the basement 
membrane (Glorieux et al., 2011). These ex vivo nasal explants could provide an interesting tool to 
further evaluate the (possibly reduced) capacity of the wild boar PRV strains to invade the host via 
the nasal mucosa. Despite the fact that it remains unclear why the wild boar strain is less efficient in 
its spread to the visceral organs, this observation could contribute to the explanation of why the 
mortality in 2-week-old pigs is lower when infected with the wild boar strain compared to the NIA3 
strain. Next to a reduced capacity to reaching lymph and blood vessels, a reduced capacity to infect 
the endothelium or blood cells on the one hand or reduced infection and spreading capacity in the 
visceral organs on the other hand could also contribute to the observed reduced capacity to reach 
visceral organs. 
Interestingly, after inoculation of 15-week-old pigs with the wild boar strain, no viral mRNA and only 
limited viral DNA was detected in the brain tissues. This limited neuroinvasion capacity of the wild 
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boar strain is in contrast with the NIA3 strain that efficiently spread to the PNS and CNS and suggests 
that the wild boar isolate may be blocked at the site of inoculation. Next to a hindered capacity to 
infect and cross the nasal mucosa as described above another/additional potential explanation could 
be that the wild boar strain is blocked at the level of entry or transport in axons. The exact reason 
can however not be deduced from our results. No clear evidence of an involvement of the local 
immune response at the nasal mucosa was found since no obvious induction of cytokine expression 
was observed in 15-week-old pigs with either virus strain. 
Only for two animals, neuroinvasion could be evidenced at the moment of their euthanasia. Viral 
DNA was detected in the TG and pons of both animals and the virus even reached the cerebellum in 
one of both animals. The absence of viral mRNA detection in those animals could indicate that virus 
can efficiently spread in and between neurons once it is capable to get access without the need of 
extensive viral replication in the nucleus of neurons of the TG or the second order neurons leading 
into the central nervous system. Interestingly, the same animals were also positive in the tonsils, 
opening the question of the importance of this primary site of replication for PRV 
neuropathogenesis. Whether or not a latent infection of the wild boar strain is induced in these 
animals remains unclear. We did not detect any expression of the LAT intron but as described above, 
it is not clear which set of LAT transcripts are expressed during PRV latency (Cheung, 1989, 1991). It is 
possible that the LAT intron is not (abundantly) expressed during latency and is therefore not 
observed or that LAT are only expressed in a limited part of the latently infected neurons, as has 
been shown for HSV-1 (Wang et al., 2005a). 
While evidence for neuroninvasion in 15-week-old pigs was limited to two animals and appeared to 
only occur via the trigeminal route, very efficient spread to the central nervous system via both the 
trigeminal and the olfactory route was observed in all 2-week-old piglets inoculated with the wild 
boar strain. A first question related to this observation is why clinical symptoms and mortality are 
reduced for the wild boar isolate compared to NIA3 upon infection in 2-week-old pigs. In the TG and 
brainstem, viral replication and cytokine mRNA expression seemed comparable to that observed 
after NIA3 infection, although late viral gene expression was somewhat less consistent. A more clear 
difference in level of viral replication between both strains was found in the olfactory bulb. While 
high NIA3 replication was supported by the detection of IE180 and EP0 mRNA in all piglets between 3 
and 4 day p.i. with NIA3, this was only the case in 2 out of 7 wild boar PRV infected piglets in the 
same period (between 2 and 5 days p.i.). Interestingly, IE180 and EP0 expression were detected in 
the only piglet (W11) infected with the wild boar strain that showed severe neurological symptoms 
and had to be euthanized. It was also this piglet in which the most extensive induction of a IFN-β, 
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IFN-γ, IL1-α, IL6, IL8 and IL10 mRNA was found. This observation supports the previously formulated 
hypothesis that virus- and immune-related damage induced in the olfactory bulb could be an 
important trigger for neurological disease upon PRV infection.  
A second question is why the wild boar strain is capable to enter the trigeminal and olfactory nerves 
in 2-week-old pigs but not, or less efficiently, in 15-week-old pigs. One possible explanation would be 
a different local immune response in pigs of both age categories, since it is known that the immune 
system is still developing in suckling piglets (Annamalai et al., 2015). No clear differences in cytokine 
response at the nasal mucosa could however be detected between pigs of both age categories with 
the wild boar strain. Another possible explanation could be that the immature neurons of the 
trigeminal nerve in young piglets are more prone to infection than those in adult pigs. A recent study 
showed that the myelination process in the maxillary division of the trigeminal nerve continues after 
birth, at least up to 5 weeks of age. Not only an increase in myelin sheath thickness, but also a 
reduction in the distances between myelin layers and an increase in the number of myelin layers 
around the axons was observed with increasing age of the pigs (Papageorgiou et al., 2016). Such 
development difference in the brain of these young pigs could possibly explain the increased 
neuroinvasion compared to adult pigs. The fact that the NIA3 strain is however capable to efficiently 
invade these mature neurons indicates that potentially also genetic differences in viral proteins 
involved in neuronal entry or transport in the wild boar strain could render this virus strain less 
efficient in invading mature neurons.  
The results obtained with the attenuated wild boar strain comply with previous in vivo studies using 
some attenuated strains from domestic pig origin. NIA1 was isolated from Northern Ireland in 1962 
and while it induced encephalitis in young piglets under 4 weeks old and reproductive disorders in 
pregnant sows, older animals did not show clinical signs. Importantly, viral dissemination via lymph 
and blood and replication in internal organs was also very restricted (McFerran & Dow, 1962). Also 
after inoculation of 7-week-old pigs with the low virulent Belgian strain NS374 only a restricted 
replication in the respiratory tract and no viremia was detected. Futhermore, in the CNS virus could 
only be demonstrated in the brainstem (Nauwynck et al., 2007). The observed pathogenesis also 
resembles the situation observed after infection of with a gE or gI deleted strain showing a reduced 
neuroinvasion with virus only reaching the TG and olfactory nerve axons but not higher order 
neurons due to impaired anterograde transport of newly formed particles (Kritas et al., 1994a, b, 
1995). In contrast, infection with the virulent NIA3 strain and the virulent Belgian 75V19 strain 
induces respiratory, reproductive and neurological symptoms. Infection is associated with a more 
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clear viremia and virus was able to replicate in different regions of the CNS (McFerran et al., 1979; 
Nauwynck et al., 2007; Pol et al., 1989).  
Therefore, these findings confirmed the attenuated nature of the wild boar strain BEL24043 in adult 
pigs. Probably, a block at the nasal mucosa is responsible for the absence of systemic spread to the 
visceral organs and a reduced capacity to invade the nervous system, although the mechanism is 
unknown. In young piglets, this strain is however capable to induce clinical symptoms and mortality, 
although less severe compared to the NIA3 strain. The absence of viral spread to visceral organs also 
in young piglets appears to confirm a possible block of the virus at the level of the nasal mucosa. The 
wild boar strain was however able to efficiently invade the central nervous system in young piglets 
but appears to be less capable of replicating and spreading within particular regions of the central 
nervous system, notably the olfactory bulb, and cause neurological disease compared to the NIA3 
strain. 
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6. Supplementary Figures 
Supplementary figure S1:  Distribution of viral DNA in different tissues. Several tissues were collected from 2- 
and 15-week-old domestic pigs at different time points after intranasal inoculation with the NIA3 reference 
strain or the BEL24043 strain and tested by qPCR directed against glycoprotein gB. Viral DNA concentrations for 
different primary and secondary sites of replication as wella peripheral and central nervous system tissues for 
2- and 15-week-old pigs are shown. 
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Aujeszky’s disease is an economically important disease, caused by the alphaherpesvirus 
pseudorabies virus (PRV). The natural host and reservoir of PRV are members of the family Sus 
scrofa. The pathogenesis of PRV in pigs is characterized by the following features. PRV enters the 
host’s body through the nasal and oral cavities. After initial local replication in epithelial cells, virus 
can cross the basement membrane and invade the underlying lamina propria (Kritas et al., 1994a; Pol 
et al., 1989; Sabó et al., 1968, 1969; Wittmann et al., 1980). In the lamina propria, virus can 1) invade 
blood and lymph vessels resulting in a systemic spread, and 2) enter sensory nerve endings leading to 
neuroinvasion. Via blood and lymph, PRV can spread to internal organs. Infection of sensory neurons 
innervating the infected epithelium, i.e. the trigeminal and olfactory nerves, enables the virus to 
invade the central nervous system (CNS). PRV can enter the trigeminal ganglion (TG) via retrograde 
transport through the trigeminal nerve and spread further into the CNS. Entry of PRV into the CNS 
may also occur via the olfactory route by infection of olfactory neurons located in the nasal cavity 
mucosa after which virus can reach the second-order neurons located in the olfactory bulb (Kritas et 
al., 1994b). Replication in the upper respiratory tract, the CNS, and the reproductive organs, is 
responsible for the respiratory, nervous and reproductive symptoms, respectively (Nauwynck et al., 
2007).  
The current knowledge on PRV pathogenesis in pigs, as described above, is mostly obtained from 
studies performed in the 1970-1990s that mainly used virus isolation and immunohistochemistry 
(IHC) stainings for virus detection. Since more sensitive techniques like PCR are now routinely used, 
some of the general aspects of the pathogenesis of PRV in pigs were reassessed using those 
techniques. This led on the one hand to a confirmation of the general knowledge on PRV 
pathogenesis, and on the other hand to several novel findings from the detailed study of viral DNA 
and mRNA and cytokine mRNA expression at important sites of neuropathogenesis. 
A first important finding was made at the level of the nasal mucosa. Although viral DNA was detected 
in the nasal mucosa of all 2-week-old and half of the 15-week-old pigs, only limited viral mRNA 
expression indicative of viral replication was detected. The presence of low viral- and cytokine-
related mRNA in the nasal mucosa was however a rather unexpected finding and in contrast with 
previous in vivo studies where viral antigens were observed in the respiratory epithelium and mucosa 
(Kritas et al., 1994a; Pol et al., 1989). A plausible hypothesis seems that nasal mucosa did not serve 
as initial place of extensive viral replication in our experiment or that viral replication preferentially 
occurs in parts of the nasal mucosa other than the respiratory mucosa overlying the septum that was 
collected here. Alos, other tissues have been described as alternative sites of primary replication, e.g. 
the olfactory mucosa, tonsils, oropharynx and lower respiratory epithelium (Kritas et al., 1994a, b; 
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Miry & Pensaert, 1989; Pol et al., 1989; Sabó et al., 1968, 1969; Wittmann et al., 1980) and it could 
be interesting to further analyze viral replication by RT qPCR in these tissues. Especially the tonsils 
seem of particular interest since all 2- and 15-week-old pigs were positive for viral DNA in this tissue 
after infection with the PRV strain NIA3. However, the presence of high viral genome copies detected 
in the nasal mucosa in combination with the observed nasal shedding after infection (as described in 
chapter 5), raises the question how this viral DNA reaches the nasal mucosa without detectable viral 
replication. As described above, viral DNA could retained in the nasal mucosa after shedding from 
other sites of primary replication (or other sites of the nasal mucosa). Another possible explanation is 
however, that the detection of viral and/or cytokine-related mRNA expression is influenced by 
inhibitors present in the nasal mucosa leading to a lower sensitivity compared to the other tissues 
tested. Influence of inhibitors on the qPCR reaction itself would probably also be reflected by lower 
values for viral genome copies, but still the preparation process, i.e. RNA extraction and cDNA 
synthesis, could be influenced. Therefore, it would be interesting to test for the presence of 
inhibitors during this preparation process by comparing the obtained Cq values after spiking a mRNA 
samples into a broyat of the nasal mucosa as well as a broyat of neural tissue and water. 
 
A second important observation was made at the level of the olfactory bulb. As an alternative route 
of neuroinvasion, PRV can reach the CNS via the olfactory route (Kritas et al., 1994b). In our study, 
extensive viral replication, which was associated with a robust expression of cytokine mRNA, was 
detected in the olfactory bulb in pigs of both age categories after NIA3 infection. Although 
hypothetical, the high viral replication and associated cytokine response in the olfactory bulb may be 
linked with the neurological symptoms observed in pigs of both age categories, suggesting that 
infection of the olfactory bulb may play a significant role in severe PRV pathology. In this respect, it is 
important to note that the two 15-week-old pigs that experienced the most severe neurological 
symptoms were among those with the highest viral and cytokine related mRNA expression in the 
olfactory bulb. To examine whether or not virus- and immune-related damage induced in the 
olfactory bulb could be an important trigger for neurological disease after PRV infection, it would be 
interesting to infect pigs with mutant strains that are impaired in their spread via the olfactory route 
or/and the trigeminal route. Therefore, repeating our experiment with a NIA3 US3null mutant or a 
mutant strain of NIA3 where gB is replaced by the homologous BHV-1 glycoprotein may provide 
interesting information. Indeed, for HSV-2, it was shown that an US3-disrupted mutant induced 
apoptosis in olfactory receptor neurons and was therefore unable to efficiently spread to the 
olfactory bulb in mice, resulting in reduced virulence (Mori et al., 2006). Interestingly, for PRV, an in 
vivo study using a NIA3 US3null mutant showed reduced virulence compared to the parental strain in 
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10-week-old pigs, but it was not specified whether this reduced virulence was associated with an 
impaired invasion of the olfactory bulb (Kimman et al., 1994). Gerdts et al., (2000) demonstrated that 
replacement of PRV gB of the Kaplan strain by the homologous BHV-1 glycoprotein resulted in an 
altered route of neuroinvasion after infection of 4-week-old pigs, which then mainly occurred via the 
olfactory route. This is interesting related to our results, since this was associated a dramatic increase 
in neurovirulence.  
 
A third important observation was made at the level of in the TG. The establishment of a dormant 
state, called latency, is a key characteristic of PRV infection and occurs predominantly in neurons of 
the TG (Gutekunst et al., 1980). Latency is characterized by the presence of the viral genome as an 
episome in the cell without the production of infectious virus particles. The only transcripts that are 
detectable during latency are the latency-associated transcripts (LATs) (Cheung, 1991). For PRV, it is 
however not known which sets of LAT transcripts are expressed during PRV productive and latent 
infection (Cheung, 1989, 1991). Our study showed that PRV DNA was present in the TG of both 15-
week-old pigs euthanized at 14 days p.i. in the absence of detectable viral mRNA expression of all 
analyzed immediate early, early and late genes in all tissues studied, indicating that latency was 
established in the TG at the end of the study. Furthermore, the LAT intron could be detected in the 
TG of one of both pigs. This LAT intron was however also detected during productive infection, 
making it difficult to say if expression of this intron is specific for latency. Therefore, future studies on 
the material collected during this study may allow to analyse which parts of the LAT region are 
transcribed during productive versus latent PRV infections.  
 
It is generally accepted that the induction of latency depends on a complex interplay between the 
neuronal environment, the virus and the immune system (Divito et al., 2006; Held & Derfuss, 2011). 
By studying the cytokine mRNA expression in the TG we wanted to evaluate if evidence could be 
found for a role of the immune response in controlling PRV infection in the TG shortly after infection. 
No clear upregulation of cytokine-associated mRNA was however observed in the TG of the 15-week-
old pigs after NIA3 infection. In contrast with our results, in vitro studies have however suggested 
that IFN-α, IFN-β and IFN-γ are involved in the establishment and maintenance of latency (De Regge 
et al., 2010; Song et al., 2016). It should be taken into account that local and limited increases in 
cytokine expression that are not detected in the current set-up could be sufficient to induce a 
biological significant effect. Furthermore, other cytokines and chemokines than the ones tested here 
could be involved in the induction of latency.  
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Next to the general pathogenesis of PRV, important questions remain about how certain factors like 
the age of the infected animal influence the course of the pathogenesis and the clinical outcome. 
Morbidity and mortality associated with PRV infection are known to be higher in younger pigs, and 
are typically associated with symptoms of the CNS, whereas older swine mostly exhibit symptoms of 
respiratory and reproductive disease. Therefore, the pathogenesis of PRV infection was not only 
studied in 15-week-old, but also in 2-week-old domestic pigs after inoculation with the PRV-
reference strain NIA3 to evaluate whether differences in virus replication and spread and the 
associated immune response could provide possible explanations for the observed age-dependent 
differences in clinical symptoms.  
Although infection of pigs of 2- and 15-week-old with the NIA3 strain resulted in important 
respiratory and neurological symptoms, the associated morbidity and mortality were lower in the 
older pigs. A potential explanation for the differences in clinical symptoms and mortality in 2-week-
old-piglets and 15-week-old pigs can be found in the observation that upon infection with the NIA3 
strain, viral replication was more extensive and more consistent in 2-week-old pigs compared to 15-
week-old pigs in the TG and pons on the one hand and in the olfactory bulb on the other hand. Also, 
the associated immune response at the respective sites was more pronounced in these young piglets. 
In the TG of 2-week-old piglets, an increase in mRNA expression of particularly IFN-β, IFN-γ, TNF-α, 
IL6 and IL10 could be detected, which may be suggestive for an infiltration of mainly macrophages 
and γδ TCR+ T cells and/or NK cells. In the pons of these animals, an upregulation of IFN-β and TNF-α 
mRNA expression was found which could result from the activation of microglia cells. No clear 
change in cytokine associated mRNA expression was however found in the TG and pons of 15-week-
old pigs. In contrast, the cytokine-related mRNA expression in the olfactory bulb was upregulated in 
pigs of both age categories. In young piglets, this was associated with an mRNA upregulation of IFN-γ, 
IFN-β, IL6, IL8 and to a lesser extent TNF-α, IL1α and IL10. The cytokine expression in 15-week-old 
pigs was somewhat less pronounced but still showed a more than 50 fold increase in IFN-γ and IL6 
mRNA expression. Little is currently known about the immune cells responsible for cytokine 
production in the olfactory bulb, but the high increase in IFN-γ suggests an infiltration of T- or NK-
cells into the inflamed area.  
Since, as discussed above, the increased presence of cytokines suggests the activation and infiltration 
of macrophages and T-cells, we performed a preliminary IHC staining experiment on these sites (data 
not shown). Both for a 2- and 15-week-old pig, cryosections were made from the TG, pons and 
olfactory bulb of a mock-infected and an NIA3-infected pig. CD3-specific antibodies were used to 
detect T-cells and MAC387 antibodies to detect activated macrophages. In the TG of 15-week-old pig, 
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a modest increase in T-cells and activated macrophages was detected at 6 days p.i. compared to the 
control pig. We were not able to detect such a difference in the 2-week-old pigs, since both T-cells 
and macrophages were already present in high quantities in the control piglet. This however seems 
to confirm our hypothesis that the increase in cytokine related mRNA expression in the TG may be 
the result of an infiltration of mainly macrophages and γδ TCR+ T cells. However, other immune cells, 
such as NK cells, can also be involved. In the brainstem of both 2- and 15-week-old pigs at 4 and 6 
days p.i., respectively, no change in the number of T-cells was observed but an increase in activated 
macrophages was detected. This could correspond to the observed increase in TNF-α mRNA 
expression. In the olfactory bulb, we expected a more pronounced infiltration of immune cells in 2-
week-old compared to 15-week-old pigs based on the RT-qPCR analysis of cytokine related genes. 
IHC straining showed an increase in T-cells in both age categories which was however more 
pronounced in 15-week-old pigs compared to 2-week-old pigs. Also a modest increase in activated 
macrophages was detected in these 15-week-old pigs. These results are however obtained from a 
limited number of samples and immune cells tested and should be analysed in more detail to get a 
clear view on the immune cell infiltration.  
In summary, our results suggest that the observed neurological symptoms in 2-week-old piglets are 
the result of neuronal damage caused by viral replication, together with an immune-mediated 
pathological damage to TG and pons on the one hand and the olfactory bulb on the other hand, 
which is in line with the assumption that the high morbidity and mortality in young piglets upon PRV 
infection are linked to viral encephalitis (Pomeranz et al., 2005). Since we suggest that neuronal 
damage in the olfactory bulb could play an important role in severe neurological pathology after PRV 
infection, as described above, the difference in viral replication and associated immune response 
between 2- and 15-week-old pigs in the olfactory bulb could be of particular interest. 
The results described above were obtained after infection with the NIA3 strain, a virulent strain that 
was isolated from domestic swine in 1971 from Northern Ireland. From the 1960-70s onwards, an 
increase in the virulence of PRV strains was observed associated with more severe outbreaks and a 
change in clinical symptoms. However, also PRV strains from domestic swine origin that differ in their 
virulence and capacity to induce clinical disease exist (Nauwynck et al., 2007). This is also reflected by 
important genetic variability that can be detected by phylogenetic and RLFP analysis (Christensen & 
Sorensen, 1991; Gielkens et al., 1985; Sozzi et al., 2014; Verpoest et al., 2014b). Therefore, the 
enclosure of a Belgian clade A strain could have been an interesting option, as the NIA3 strain is not 
necessarily representative for domestic swine strains because of its high virulence. Because of the 
high cost of performing experimental infection studies using pigs in Biosafety Level 3 facilities, only a 
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limited number of conditions could be tested. The NIA3 strain is a well characterized strain by genetic 
as well as in vitro and in vivo studies, whereas the knowledge regarding the domestic swine strains 
used in our studies is rather limited, and was therefore included in our studies. Futher studies using 
other domestic swine strains, like the Belgian domestic swine strains for which genetic characteristics 
as well as intrinsic replication and dissemination characteristics were evaluated in this doctoral 
dissertation could be interesting. Furthermore, the enclosure of other domestic strains with a more 
moderate virulence, such as NS374 and 75V19, for which the virulence and pathogenesis (Nauwynck 
et al., 2007) as well as the replication characteristics in porcine respiratory nasal mucosa explants 
(Glorieux et al., 2009b) are well described, could be an interesting option.  
Because of the important economic impact of Aujeszky’s disease, PRV has however been eradicated 
from domestic pigs in several European countries after the implementation of large scale vaccination 
programs. As the presence of the virus in the wild boar population poses a possible risk for a 
reintroduction of PRV into the domestic swine population, there is an increasing interest in PRV 
strains circulating within the wild boar population and their associated risk for domestic pigs. It has 
been assumed that PRV strains from domestic pigs and wild boar display distinct infection cycles and 
that transmission between both populations does not occur frequently. Indeed, reintroductions in 
the domestic swine population in Aujeszky’s disease-free countries have only occurred sporadically. 
In such PRV-eradicated countries, biosafety measurements are however in place to avoid contact 
between both populations, which does not imply that transmission between both populations has 
not occurred before and that possibly more virulent strains are already circulating within the wild 
boar population. Nevertheless, the hypothesis that transmission between both populations may not 
occur frequently is further supported by genetic characterization by RFLP analysis. Genotype I strains 
first circulated both within the domestic swine and wild boar population in Central Europe. In the 
1970-80’s, a shift from genotype I to genotype II has occurred in European domestic pigs, which 
coincided with the emergence of more virulent strains, while in the wild boar population genotype I 
remained predominant. In line with this, our RFLP results indicated on the one hand that the shift 
from genotype I to genotype II also occurred for Belgian domestic swine PRV strains and on the other 
hand that all characterized wild boar strains were genotype I.  
More recently, partial DNA sequencing of the gene encoding glycoprotein C has been introduced in 
the epidemiological investigation of Aujeszky’s disease. This method provides more complete 
information about the variability between strains, but is restricted to a rather small part of the 
genome (Goldberg et al., 2001). Previous studies showed that PRV isolates circulating within wild 
boar in Europe represent a genetically diverse population that cluster within two clades which were 
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designated as clade A and B and overlap geographically in central Europe (Müller et al., 2010; 
Steinrigl et al., 2012). No joint phylogenetic analysis comparing wild boar and domestic swine isolates 
had however been performed.  
During our study we genetically characterized Belgian PRV isolates from domestic swine and wild 
boar origin to get more insight into the genetic variability between Belgian wild boar strains and 
those circulating in neighboring countries on the one hand and the genetic relatedness between 
strains from domestic swine and wild boar origin on the other hand. Our results showed that the 
Belgian wild boar isolates belonged to both cluster A and B, implying that also Belgian strains are 
genetically diverse. Furthermore, this was the first study combining isolates from both wild boar and 
domestic swine, which showed that all European domestic swine isolates belong to clade A. 
Interestingly, the observation that some wild boar isolates cluster together with domestic swine 
isolates or even have identical sequences for the gC fragment makes it tempting to speculate that 
spill-over between both population has occurred and that those strains could possibly pose a risk for 
a reintroduction of PRV into the domestic swine population.  
We however have to keep in mind that the gC region used for phylogenetic analysis represents only a 
small portion of the total genome that is not necessarily representative for the total genomic 
variation. Until now, phylogenetic analysis of wild boar strains has been performed using a partial 
sequence of the gC gene, because it is considered as a more variable part of the PRV genome. If the 
molecular basis for the attenuated nature of these wild boar strains becomes more clear, other parts 
of the genome may become of more interest to get a better insight into the genetic relatedness 
between strains originating from both populations and their virulence. Furthermore, full genome 
sequencing approaches might become a valuable tool for PRV molecular phylogeny in the future, but 
only limited full-genome sequences are available to date.  
The genetic differences between wild boar and domestic swine strains have been suggested to result 
in differences in virulence. Only limited information on the virulence of wild boar PRV isolates is 
available from two experimental infection studies using uncharacterized PRV strains from wild boar 
origin and some field observations (Hahn et al., 1997; Müller et al., 2001). Cell biological and 
molecular explanations for the observed differences between wild boar and domestic swine isolates 
in their capacity to induce clinical disease are lacking. Furthermore, the important genetic diversity 
among European (and Belgian) wild boar strains as described above, makes that care should be taken 
when extrapolating the attenuated nature to all wild boar isolates. Therefore, in the next study, it 
was evaluated if assumed differences in in vivo virulence are reflected by differences in in vitro 
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virulence between strains from domestic swine and wild boar. If differences in in vivo virulence were 
found to correlate with differences in in vitro assays, this could lead to the use of in vitro models to 
assess the virulence of newly isolated strains from wild boar and predict the potential consequences 
associated with a reintroduction of such strains in the domestic swine population. 
We therefore evaluated the basic in vitro replication and spreading capacity by one-step growth 
curves and plaques size assays on the one hand and the sensitivity to IFN-induced antiviral effects by 
plaque reduction experiments on the other hand for five domestic swine strains, four wild boar 
strains and the NIA3 reference strain. No clear differences in in vitro replication and spreading 
capacity were however found between strains from domestic swine and wild boar. Also, no 
consistent differences between strains from both populations to counteract the plaque-reducing 
effect of IFNs were detected. IFNs do however play an important role in limiting viral replication in 
vivo and in vitro (Yao et al., 2007) and are proposed to be involved in the induction or maintenance 
of PRV latency in the TG (Van Opdenbosch et al., 2011; De Regge et al., 2010). Thus, basic intrinsic 
replication and dissemination capacities as well as differences to counteract the IFN response can 
probably not explain differences in in vivo virulence between PRV strains of wild boar and domestic 
pigs.  
To further evaluate the (reduced) virulence of wild boar strains, two Belgian wild boar PRV strains, 
BEL24043 and BEL20075, were selected and studied during an in vivo infection experiment in 2- and 
15-week-old domestic pigs. In 15-week-old pigs, the wild boar strains did not induce any clinical 
symptoms thereby confirming the previously suggested attenuated nature of PRV strains circulating 
in wild boars. However, the capacity of these strains to induce reproductive disorders as described 
for strains from domestic pigs (Pomeranz et al., 2005), has not yet been evaluated. Despite the 
absence of symptoms, domestic pigs were susceptible to infection with the wild boar strains and 
became seropositive for PRV, as had been described by previous infection studies (Hahn et al., 1997; 
Müller et al., 2001). This is an important observation, since seroconversion of domestic pigs could 
compromise the Aujeszky’s disease-free status of a country and lead to important economic 
consequences. Interestingly, an important difference in infection and transmission capacity between 
both wild boar strains was observed. BEL24043 caused a more prolonged and disseminated infection 
in inoculated animals and spread more efficiently to contact pigs than the BEL20075 strain. This 
difference in virulence was somewhat surprising as both strains belong to clade B in the PRV 
phylogeny. Future sequencing studies could be useful to reveal if genomic differences in regions 
outside the gC region exist that could provide an explanation for the reduced virulence of the 
BEL20075 strain. The observed differences in virulence between both wild boar isolates belonging to 
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clade B suggest that it might also be interesting to evaluate the virulence of strains belonging to 
clade A. Wild boar PRV strains belonging to clade A are genetically more diverse and appear to be 
more closely related to strains originating from domestic swine by phylogenetic analysis. 
Unfortunately, we were not able to isolate the only Belgian wild boar strain that clustered within 
clade A.  
Where our study confirmed the attenuated nature of both Belgian wild boar strains in 15-week-old 
pigs, it was the first study confirming the virulence of a wild boar strain in young piglets. Infection 
with the wild boar strain BEL24043 induced a fast deterioration of the general condition and severe 
neurological symptoms in 2-week-old piglets. This interesting observation indicates that the known 
age dependency of symptoms upon infection with PRV strains circulating in domestic pigs also holds 
true for wild boar PRV isolates. This had been suggested previously by Hahn et al. (1997). 
Importantly, however, in contrast to an infection with the NIA3 strain, the clinical symptoms were 
less severe and most piglets recovered after some days. 
In conclusion, efficient monitoring seems crucial for the early detection of a potential reintroduction 
of PRV from wild boar into the domestic pig population as the absence of clinical symptoms after 
infection of older pigs with the wild boar PRV strains could allow the virus to spread unnoticed within 
the pig population. qPCR analysis of nasal swabs in combination with the serological screening of 
serum samples by ELISA, seems to be the most efficient way to rapidly detect a possible 
reintroduction of a wild boar strain in the domestic population. It seems advisable that monitoring 
should especially focus on farms with free-ranging facilities, associated with an elevated risk of 
contact between wild boars and domestic pigs. 
In a last part of this study a more detailed comparison of the pathogenesis of one of both wild boar 
strains, BEL24043, and the NIA3 strain was performed in pigs of 2- and 15-week-old to determine 
whether mechanistic factors explaining the attenuated nature of the wild boar strain could be found. 
A first important difference between NIA3 and the wild boar strain BEL24043 was found at the level 
of viral dissemination to visceral organs. Viral DNA was detected quickly after NIA3 infection in the 
visceral organs. In contrast, almost no viral DNA was detected in visceral organs after infection with 
the wild boar strain at the day of euthanasia in both 2-and 15-week-old pigs. Several hypotheses 
could explain the impaired systemic spread of the wild boar strain. The first level where the wild boar 
strain could be hindered is at the level of the nasal mucosa. PRV has to overcome several barriers to 
pass through the nasal mucosa and reach the underlying blood vessels in the lamina propria leading 
to systemic spread. A first potential explanation could be that the wild boar strain is more hindered 
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in its mobility through the mucus layer to reach the epithelial cells (Yang et al., 2012) than NIA3. A 
second explanation could be a reduced capacity of the wild boar strain to replicate at the primary 
site of infection. This however seems unlikely since only low replication at the nasal mucosa was 
found for both strains in both 2- and 15-week-old pigs. A third plausible explanation could be that 
genetic differences exist between both strains in their capacity to cross the basement membrane. 
After reaching the lamina propria, PRV can normally infect the endothelium of the widely distributed 
capillaries and can enter the bloodstream and thereby reach the visceral organs. A reduced capacity 
to infect the endothelium or blood cells on the one hand or reduced infection and spreading capacity 
in the visceral organs on the other hand could also contribute to the impaired capacity for systemic 
spread after infection with the wild boar strain. Furthermore, the local immune response at the 
different levels mentioned above or PRV immune evasion mechanisms could be different for the 
NIA3 and the wild boar strain. Based on our results, no clear upregulation of cytokine-related mRNA 
expression was found in 2-and 15-week old pigs infected with either virus strain. As described before, 
it should however be taken into account that small or local increases in cytokine expression that are 
not detectable in the current set-up could be sufficient to induce a biological significant effect. Also 
other cytokines and chemokines than the ones tested here could be involved. Furthermore, also 
antigenic differences between PRV strains could be possible making the wild boar strains more 
suspectible to the immune response of the host resulting in the attenuated nature. Such differences 
are most likely to occur in the essential glycoproteins. Sequencing of essential glycoproteins, other 
than the gC gene, could therefore be interesting. Importantly, also the venereal route has been 
suggested as an important route of transmission in wild boars. Therefore, another possible 
hypothesis for the reduced systemic spread is that wild boar strains are adapted to infect the vaginal 
mucosa more efficiently compared to the nasal mucosa. It could therefore be interesting to repeat 
this infection experiment using a genital route of inoculation instead of the intranasal route that was 
used here.  
Several of these hypotheses could be tested in vitro. Using a porcine ex vivo tracheal respiratory 
mucus model, it has been shown that the mobility of PRV through the mucus layer can be hindered 
due to a complex interplay of mucoadhesive interactions (Yang et al., 2012). Comparing both strains 
in this model could provide information about their capacity to diffuse through the mucus layer 
overlying the respiratory epithelium. Furthermore, an ex vivo model using porcine nasal respiratory 
mucosal explants has been established that can be used to provide more knowledge about 
pathogenic aspects of viral replication and invasion in nasal mucosa (Glorieux et al., 2007). Using this 
model, it has been shown that differences exist between PRV strains in their capacity to infect and 
form plaques in epithelial cells which are possibly correlated with their virulence (Glorieux et al., 
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2009b). Furthermore it has been shown that the viral gE protein appears to play a role in sorting virus 
particles to the basal side of respiratory epithelial cells towards and near the basement membrane 
barrier (Glorieux et al., 2009a) and a trypsin-like serine protease appears to be involved in PRV 
penetration of the basement membrane (Glorieux et al., 2011). Therefore these ex vivo nasal 
explants could provide an interesting tool to further evaluate if the capacity of the wild boar PRV 
strains to invade the host via the nasal mucosa is reduced as well as the possible underlying 
mechanism(s). Next to these ex vivo models, the capacity of both strains to infect blood cells could be 
tested in vitro. 
Besides an impaired systemic spread, also neuroinvasion via the trigeminal and olfactory route was 
hindered after infection of 15-week-old pigs with the wild boar strain. Also here, the underlying 
mechanism remains unclear, but some hypotheses can be formulated. In addition to a possibly 
hindered capacity to infect the nasal mucosa and cross the basement membrane as described above, 
the wild boar strain could be blocked at the level of entry or transport in axons. In contrast to the 
hindered neuroinvasion capacity in 15-week-old pigs, very efficient spread to the CNS via both the 
trigeminal and the olfactory route was observed in all 2-week-old piglets inoculated with the wild 
boar strain. Therefore, an important question remains why the wild boar strain is capable to enter 
the trigeminal and olfactory nerves in 2-week-old pigs but not, or less efficiently, in 15-week-old pigs. 
One possible explanation would be a different local immune response in pigs of both age categories, 
since it is known that the immune system is still developing in suckling piglets (Annamalai et al., 
2015). As already discussed, no clear differences in cytokine response at the nasal mucosa could be 
detected between pigs of both age categories infected with the wild boar strain. Another possible 
explanation could be that the immature neurons of the trigeminal nerve in young piglets may be 
more prone to infection than those in adult pigs. The fact that the NIA3 strain is however capable to 
efficiently invade mature neurons indicates that potentially also genetic differences in viral proteins 
involved in neuronal entry or transport in the wild boar strain could render this virus less efficient in 
invading mature neurons. To further study the replication and spreading capacity of the two PRV 
strains in TG neurons, primary porcine TG cell cultures or a more advanced homologous in vitro two-
chamber model using porcine TG neurons could be used (De Regge et al., 2006b). This could provide 
more information about the capacity of the strains to spread via retrograde transport from the axons 
to the cell bodies. However, since we observed a different neuroinvasion capacity for the wild boar 
strain between pigs of the two different age categories, it is difficult to predict how virus will behave 
in an in vitro setting.  
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Although neuroinvasion in piglets after infection with the NIA3 and the wild boar strain was 
comparable, the severity of the neurological symptoms and the mortality induced by the wild boar 
strains were clearly lower. Only one piglet showed severe neurological symptoms and had to be 
euthanized after infection with the wild boar strain BEL24043. Interestingly, in this piglet the most 
extensive viral and cytokines related mRNA expression was found in the olfactory bulb, thereby 
further supporting our hypothesis that neuronal damage in the olfactory bulb may play a significant 
role in severe PRV pathology. 
Conclusions 
Although PRV is eradicated from the domestic swine population in Belgium and several other 
European countries, the threat of a reintroduction of a wild boar strain into domestic pigs remains. 
Wild boar strains appear to be attenuated in older pigs, but still infection of domestic pigs can result 
in direct production losses by the induction of clinical disease in young piglets. Furthermore, the 
capacity to induce a sustained infection in combination with the capacity to induce seroconversion 
could compromise the Aujeszky’s disease-free status of a country. This underlines the importance of 
adequate monitoring of the PRV status in both domestic pigs and wild boar. In domestic swine, 
serosurveillance with focus on farms with free-ranging facilities using ELISA and qPCR analysis of 
nasal swabs in case of an acute infection is necessary. In wild boars, monitoring of the 
seroprevalence as well as strain-diversity in wild boar by genetic analysis is advisable. In the current 
studies, differences in the severity of the observed clinical symptoms were dependent on the strain 
used for inoculation (domestic swine or wild boar origin) as well as the age of the infected pigs. 
Although, no differences in in vitro replication and dissemination capacity as well as sensitivity to the 
antiviral effects of interferons were found between strains from wild boar and domestic swine origin, 
the in vivo study revealed interesting differences in the neuropathogenesis of strains from both 
populations. An impaired spread to visceral organs in both young piglets and older pigs as well as a 
limited neuroinvasion capacity in older pigs was observed for the Belgian wild boar strain, which 
could help to elucidate the mechanisms underlying the reduced virulence of wild boar strains. On the 
other hand, less extensive viral replication as well as associated immune response in the CNS could 
underly the observed age-dependent differences in virulence of PRV infection. 
Chapter 7: General discussion 
 
 
 
147 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
  
  
 
149 
 
 
 
 
 
 
Summary 
 
 
 
  
  
 
 
  
Summary 
 
 
 
151 
 
Aujeszky’s disease is an economically important disease in swine caused by the alphaherpesvirus 
pseudorabies (PRV). Members of the family Sus scrofa, i.e. domestic pigs and wild boar, are the 
natural host and reservoir of the virus. Infection of pigs causes respiratory, reproductive and 
neurological symptoms which depend on the age of the pig and the virulence of the strain. Because 
of the important economic consequences of PRV infection in domestic pigs, large scale vaccination 
programs have been set up, which led to the eradication of the virus in several European countries. 
However, serological studies have shown that the virus still circulates in the wild boar population. 
Despite the fact that an attenuated nature of these wild boar PRV strains has been assumed, this 
poses a risk for a possible reintroduction of the virus into the currently unprotected domestic swine 
population. 
 
The first chapter gives a brief introduction on PRV, along with its virion structure and viral replication 
cycle. Next, a general overview of the PRV induced clinical symptoms and the pathogenesis is given. 
The most important sites involved in the neuropathogenesis of PRV infection, i.e. the nasal and 
olfactory mucosa, the trigeminal ganglion (TG) and the central nervous system are discussed in more 
detail, focusing on the anatomical structure together with the current knowledge on PRV replication 
and the immune response at these sites. Furthermore, PRV infection characteristics in its natural 
host, i.e. domestic pigs and wild boar, as well as the genetic characterization of strains circulating in 
both populations are discussed. Strains circulating within the two populations differ in their capacity 
to induce clinical disease, although the underlying determinants are not clear. Therefore, the most 
important viral genes involved in neurovirulence and escape from the innate immune response that 
could potentially account for differences in virulence are described.  
The second chapter describes the aims of this doctoral dissertation. 
In the third chapter, Belgian PRV strains from wild boar and domestic swine origin were genetically 
characterized by restriction fragment length polymorphism (RFLP) analysis and phylogenetic analysis 
to get a better insight into the genetic relatedness between strains in both populations. Nine 
historical Belgian domestic swine isolates that circulated before 1990 and five recent wild boar 
isolates obtained since 2006 from Belgium and the Grand Duchy of Luxembourg were genetically 
characterized by RFLP and phylogenetic analysis. While all wild boar isolates were characterized as 
type I RFLP genotypes, the RFLP patterns of the domestic swine isolates suggest that a shift from 
genotype I to genotype II might have occurred in the 1980s in the domestic population. By 
phylogenetic analysis, Belgian wild boar isolates belonging to both clade A and B were observed, 
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while all domestic swine isolates clustered within clade A. The joint phylogenetic analysis of both 
wild boar and domestic swine strains showed that some isolates with identical sequences were 
present within both populations, raising the question whether these strains represent an increased 
risk for reintroduction of the virus into the domestic population.  
In the fourth chapter, different virulence determinants that can be assessed in vitro were 
determined for PRV strains from domestic swine and wild boar origin and the NIA3 reference strain. 
Replication kinetics and plaque formation capacity in continuous swine testicular cells and different 
primary porcine cell lines were highly similar for isolates from both populations. Treatment of these 
cell lines with IFN-α, IFN-γ or a combination of both provoked similar plaque-reducing effects for all 
strains. Therefore, our results indicate that isolates from domestic swine and wild boar differ neither 
in intrinsic replication and dissemination capacity nor in sensitivity to antiviral effects of IFNs. 
Therefore, these basic in vitro assays seem unsuitable as a screening tool to evaluate the in vivo 
virulence of PRV strains and to help in the prediction of possible consequences of a reintroduction of 
a wild boar strain into the domestic swine population. 
In the fifth chapter, the possible impact of a reintroduction of a wild boar PRV strain in a naive herd 
was assessed. Therefore, an in vivo infection study using two genetically characterized wild boar PRV 
isolates (BEL24043 and BEL20075) and the virulent NIA3 reference strain was performed in 2- and 15-
week-old domestic pigs. This study revealed an attenuated nature of both wild boar strains in 15-
week-old pigs. In contrast, it showed the capacity of strain BEL24043 to induce severe clinical 
symptoms and mortality in young piglets, thereby confirming that the known age dependency of 
disease outcome after PRV infection also holds for wild boar isolates. Despite the absence of clinical 
disease in 15-week-old sows, both wild boar PRV strains were able to induce seroconversion, but to a 
different extent. Importantly, differences in infection and transmission capacity of both strains were 
observed in 15-week-old sows. Strain BEL24043 induced a more prolonged and disseminated 
infection than strain BEL20075 and was able to spread efficiently to contact animals, indicative of its 
capacity to induce a sustained infection. Despite the fact that reports of PRV transmission from wild 
boars to the domestic population are rare, the current report thus indicates that a reintroduction of 
a wild boar isolate into the domestic swine population could have serious economic consequences 
due to the induction of clinical symptoms in piglets and by jeopardizing the PRV-negative status. 
In the sixth chapter, the neuropathogenesis of PRV in its natural host was studied and the influence 
of the age of the PRV infected pig and the strain by which it was infected was evaluated. An in vivo 
infection experiment was performed wherein domestic pigs of 2- and 15-week-old were inoculated 
with the PRV strain NIA3 or the wild boar strain BEL24043. The presence of viral DNA and mRNA and 
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the cytokine-related mRNA expression were analysed to provide more insight into the general PRV 
pathogenesis and to provide possible explanations for the observed age- and strain-dependent 
differences in virulence. The general knowledge on PRV pathogenesis was confirmed by qPCR 
analysis of viral DNA in different organs collected at different time point post inoculation and several 
new findings sorted from the detailed study of viral and cytokine mRNA expression at important sites 
of neuropathogenesis. A first interesting observation was made at the level of the nasal mucosa 
where only limited viral and cytokine associated mRNA expression was found after infection of 2- and 
15-week-old pigs with either strain, which might indicate that other sites of primary replication are 
favoured. Secondly, extensive viral replication which correlated with a robust expression of cytokine 
mRNA was detected in the olfactory bulb of pigs of both age categories after NIA3 infection. 
Although hypothetical, the high viral replication and associated immune response in the olfactory 
bulb seem to be linked with the neurological symptoms observed in pigs of both age categories, 
indicating that infection of the olfactory bulb may play a significant role in severe PRV pathology. 
Furthermore, the observed differences in clinical symptoms between pigs of 2- and 15-week-old 
could be the result of more severe neuronal damage caused by more extensive viral replication and 
associated immune response in the olfactory bulb on the one hand and the TG and the pons on the 
other hand. Last, interesting differences in pathogenesis were found when comparing the NIA3 strain 
and the low virulent wild boar strain BEL24043. The capacity of the wild boar strain to spread to 
visceral organs was impaired in pigs of both age categories, whereas neuroinvasion was only 
hindered in 15-week-old pigs via both the trigeminal and the olfactory route. The underlying 
mechanisms for these strain-dependent differences in the capacity for systemic spread and/or 
neuroinvasion remain however unclear.  
In the seventh chapter, the observations of the current doctoral dissertation are situated in the 
context of the existing literature and potential implications of the findings and potential future 
research are discussed. 
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De ziekte van Aujeskzy is een economisch belangrijke ziekte in varkens die veroorzaakt wordt door 
het alfaherpesvirus pseudorabies virus (PRV). Leden van de familie Sus scrofa waartoe de 
gedomesticeerde varkens en everzwijnen behoren, vormen de natuurlijke gastheer en het reservoir 
voor dit virus. Infectie in varkens veroorzaakt respiratoire, reproductieve en neurologische 
symptomen die afhankelijk zijn van de leeftijd van het varken en de virulentie van de stam. Gezien de 
belangrijke economische gevolgen van een PRV infectie in gedomesticeerde varkens werden 
grootschalige eradicatie-programma’s opgestart die ervoor zorgden dat het virus niet langer 
voorkomt in gedomesticeerde varkens in verschillende Europese landen. Serologische studies 
toonden echter aan dat het virus nog steeds circuleert in de everzwijnpopulatie. Ondanks het feit dat 
deze everzwijnstammen minder virulent zijn, kunnen ze nog steeds een risico vormen voor een 
herintroductie van het virus in de momenteel onbeschermde populatie van gedomesticeerde 
varkens.  
 
Het eerste hoofdstuk geeft een kort overzicht over PRV, samen met de virion structuur en de virale 
replicatiecyclus. Vervolgens wordt een algemeen overzicht gegeven van de klinische symptomen die 
een PRV infectie veroorzaakt. Verder worden de belangrijkste weefsels die betrokken zijn in de 
neuropathogenese van PRV in meer detail besproken, namelijk de nasale en de olfactorische mucosa, 
het trigeminaal ganglion and het centraal zenuwstelsel. Daarbij wordt vooral gefocust op de 
anatomische structuur van het weefsel en de huidige kennis over de PRV replicatie en de 
immuunrespons op deze plaatsen. Daarnaast worden de karakteristieken van een PRV infectie in de 
natuurlijke gastheer, namelijk gedomesticeerde varkens en everzwijnen, en de genetische 
karakterisatie van stammen die circuleren in beide populaties besproken. Stammen die circuleren in 
beide populaties verschillen in hun capaciteit om klinische symptomen te veroorzaken, hoewel de 
onderliggende mechanismen niet gekend zijn. Daarom worden in het laatste deel de belangrijkste 
virale genen beschreven die mogelijks kunnen bijdragen tot verschillen in virulentie.  
Het tweede hoofdstuk beschrijft de doestellingen van dit doctoraal proefschrift. 
In het derde hoofdstuk werden Belgische PRV stammen afkomstig uit gedomesticeerde varkens en 
everzwijnen genetisch gekarakteriseerd via ‘restriction fragment length polymorphism’ (RFLP) 
analyse en fylogenetische analyse om een beter inzicht te verkrijgen in de genetische verwantschap 
tussen stammen die circuleren in beide populaties. Negen historische Belgische stammen uit 
gedomesticeerde varkens die circuleerden voor 1990 en vijf recente everzwijnstammen die bekomen 
werden sinds 2006 uit België en Groothertogdom Luxemburg werden bestudeerd. Terwijl alle 
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everzwijnisolaten gekarakteriseerd werden als type I RFLP genotypes, werd voor de stammen uit 
gedomesticeerde varkens gesuggereerd dat een verschuiving van genotype I naar genotype II heeft 
plaatsgevonden tijdens de jaren 80. Via fylogenetische analyse werd aangetoond dat de Belgische 
everzwijnstammen tot zowel cluster A als cluster B behoren. Alle stammen uit gedomesticeerde 
varkens behoorden daarentegen tot cluster A. De gezamenlijke analyse van stammen uit zowel 
gedomesticeerde varkens als everzwijnen toonde aan dat voor enkele everzwijnstammen identieke 
sequenties bekomen werden als voor stammen uit gedomesticeerde varkens, waardoor de vraag 
wordt gesteld of deze stammen mogelijks een verhoogd risico vormen voor een herintroductie van 
het virus in de gedomesticeerde varkenspopulatie. 
In het vierde hoofdstuk werden verschillende virulentie-determinanten, die in vitro kunnen 
beoordeeld worden, bepaald voor PRV stammen uit gedomesticeerde varkens en everzwijnen en de 
NIA3 referentiestam. De replicatiekinetieken en de capaciteit om plaques te vormen in continue 
cellen en verschillende primaire cellijnen uit varkens waren sterk gelijkaardig voor isolaten afkomstig 
uit beide populaties. Behandeling van deze cellijnen met IFN-α, IFN-γ of een combinatie van beiden 
had een gelijkaardig effect op de reductie van het aantal plaques voor alle geteste stammen. Onze 
resultaten tonen dus aan dat isolaten uit gedomesticeerde varkens en everzwijnen niet verschillen in 
intrinsieke replicatie- en spreidingscapaciteit, noch in gevoeligheid voor de antivirale effecten van 
interferon. Daarom lijken deze eenvoudige in vitro testen niet geschikt om de in vivo virulentie van 
PRV stammen te testen en om als hulpmiddel te dienen om de mogelijke gevolgen van een 
herintroductie van een everzwijnstam in gedomesticeerde varkens te voorspellen.  
In het vijfde hoofdstuk werd de impact van een mogelijke herintroductie van een PRV stam uit 
everzwijnen in een niet-immune kudde onderzocht. Daarvoor werd een in vivo infectiestudie 
uitgevoerd waarbij twee genetisch gekarakteriseerde everzwijnisolaten (BEL24043 en BEL20075) en 
de virulente NIA3 referentiestam werden geïnoculeerd in gedomesticeerde varkens van 2 and 15 
weken oud. Deze studie toonde aan dat beide everzwijnstammen geattenueerd zijn in 15 weken 
oude varkens. Daarentegen werd aangetoond dat deze BEL24043 stam in staat was om ernstige 
klinische symptomen en mortaliteit te veroorzaken in jonge biggen, waarmee we bevestigden dat de 
gekende leeftijdsafhankelijkheid van klinische symptomen ook geldt voor everzwijnstammen. 
Ondanks de afwezigheid van klinische symptomen in 15 weken oude zeugen, waren beide stammen 
in staat om seroconversie te veroorzaken. Verder werden verschillen in de capaciteit om te 
infecteren en te verspreiden tussen de twee stammen waargenomen in 15 weken oude varkens. De 
stam BEL24043 induceerde een langere en meer verspreide infectie dan de BEL20075 stam en was in 
staat om efficiënt te spreiden naar contactdieren, wat een indicatie is dat een infectie de 
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mogelijkheid heeft om zich te verspreiden na een herintroductie. Ondanks het feit dat transmissie 
tussen everzwijnen en gedomesticeerde varkens slechts zelden voorkomt, toont deze studie aan dat 
een herintroductie van een everzwijnisolaat in gedomesticeerde varkens mogelijks kan leiden tot 
ernstige gevolgen door het veroorzaken van klinische symptomen in biggen en door de PRV 
negatieve status in gevaar te brengen.  
In het zesde hoofdstuk werd de neuropathogenese van PRV in zijn natuurlijke gastheer bestudeerd 
en werd gekeken naar de invloed van de leeftijd het varken en van de stam waarmee werd 
geïnfecteerd. Daarom werd een in vivo infectiestudie uitgevoerd waarbij varkens van 2 en 15 weken 
oud werden geïnoculeerd met de NIA3 en de BEL24043 stam. De aanwezigheid van viraal DNA en 
mRNA en de cytokine-gerelateerde mRNA expressie werden geanalyseerd om meer inzicht te 
bekomen in de algemene pathogenese en om een mogelijke verklaring te verkrijgen voor 
geobserveerde leeftijds- en stamafhankelijke verschillen in virulentie. De algemene kennis over de 
pathogenese van PRV werd bevestigd via qPCR analyse van viraal DNA ter hoogte van de 
verschillende organen die gecollecteerd werden op verschillende tijdstippen na inoculatie. Bovendien 
werden verschillende nieuwe bevindingen aangetoond na een gedetailleerde studie van viraal en 
cytokine geassocieerde mRNA expressie op plaatsen die belangrijk zijn in de neuropathogenese. Een 
eerste interessante bevinding werd gemaakt ter hoogte van de nasale mucosa waar enkel beperkte 
virale en cytokine gerelateerde mRNA expressie werd teruggevonden na infectie van 2 en 15 weken 
oude varkens met beide stammen. Dit toont mogelijks aan dat andere plaatsen waar primaire 
replicatie plaats kan vinden van groter belang zijn. Ten tweede werd sterke virale replicatie 
aangetoond in de olfactorische bulbus van varkens van beide leeftijdscategorieën na infectie met de 
NIA3 stam die correleerde met een robuuste expressie van cytokine mRNA. Een mogelijke hypothese 
is dat de hoge virale replicatie en geassocieerde immuunrespons betrokken zijn in het voorzaken van 
de geobserveerde neurologische symptomen in varkens van beide leeftijdscategorieën. Dit kan een 
indicatie zijn voor de betrokkenheid van de olfactorische bulbus in de ernstige pathologie die wordt 
waargenomen na PRV infectie. Verder kunnen de geobserveerde verschillen in klinische symptomen 
tussen varkens van 2 en 15 weken het resultaat zijn van ernstigere neurologische schade veroorzaakt 
door een meer uitgesproken virale replicatie en geassocieerde immuunrespons in de olfactorische 
bulbus aan de ene kant en het trigeminaal ganglion en de pons aan de andere kant. Als laatste 
werden ook interessante verschillen waargenomen tussen de pathogenese van de NIA3 stam en de 
laag virulente BEL24043 everzwijnstam. De capaciteit van de everzwijnstam om te spreiden naar 
viscerale organen was duidelijk verhinderd in varkens van beide leeftijdscategorieën, terwijl 
neuroinvasie enkel beperkt werd in 15 weken oude varkens en dit zowel via de trigeminale als via de 
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olfactorische route. Hoewel de onderliggende mechanismen voor deze stamafhankelijke verschillen 
in hun capaciteit om te spreiden naar de organen en/of naar het centraal zenuwstelsel onduidelijk 
blijven, werd ook hier extra bewijs gegeven voor het belang van virale replicatie en de geïnduceerde 
immuunrespons ter hoogte van de olfactorische bulbus in het veroorzaken van neurologische 
symptomen. 
In het zevende hoofdstuk, worden de observaties uit dit doctoraal proefschrift in de context van 
bestaande literatuur belicht. Verder worden de mogelijke gevolgen evenals de mogelijkheid tot 
verder onderzoek op basis van deze bevindingen besproken. 
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